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The work incorporates systematic bioassay-guided phytochemical and 
cytotoxicity/anticancer studies on four selected medicinal plants from the Libyan 
flora. Based on information on their traditional medicinal uses and the literature 
survey, Juniperus phoenicea L. (Fam: Cupressaceae), Asphodelus aestivus Brot. 
(Fam: Asphodelaceae), Ruta chalepensis. L (Fam: Rutaceae) and Arbutus pavarii 
Pampan. (Fam: Ericaceae) have been selected for investigation in the current 
endeavour.  The four plants are well-known Libyan medicinal plants, which have been 
used in Libyan traditional medicine for the treatment of various human ailments, 
including both tumours and cancers.  The cytotoxic activity of the n-hexane, 
dichloromethane (DCM) and methanol (MeOH) extracts of these plants were assessed 
against five human tumour cell lines: urinary bladder cancer [EJ-138], liver 
hepatocellular carcinoma [HEPG2], lung cancer [A549], breast cancer [MCF7] and 
prostate cancer [PC3] cell lines.  The cytotoxicity at different concentrations of these 
extracts (0, 0.8, 4, 20, 100 and 500 µg/mL) was evaluated by the MTT assay. The four 
plants showed notable cytotoxicity against the five aforementioned human tumour cell 
lines with different selectivity indexes on prostate cancer cells. Accordingly, the 
cytotoxic effect of various chromatographic fractions from the different extracts of 
these plants at different concentrations (0, 0.4, 2, 10, 50 and 250 µg/mL) revealed 
different cytotoxic properties.  
Twenty-nine compounds were isolated from different fractions of these plants: three 
bioflavonoids, amentoflavone (25), cupressoflavone (24) and sumaflavone (76); four 
diterpenes. 13-epi-cupressic acid (42), imbricatholic acid (41), 3-hydroxy 
sandaracopimaric acid (44) and dehydroabietic acid (46), one alkanol (heptacosanol) 
ii 
 
and two lignans, deoxypodophyllotoxin (29) and β-peltatin methyl ether (28)] from J. 
phoenicea leaves; one flavonoid, luteolin (22), four anthraquinones [aleo-emodin (13), 
chrysphanol anthrone (79), 10, 10`chrysphanol bianthrone (80) and C-α-
rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione glycoside (81) and p-hydroxy-
phenethyl trans-ferulate (82) from A. aestivus leaves and tubers; three alkaloids, 
kokusaginine (61), graveoline (60), and 4-hydroxy-2-nonyl-quinoline (85), three 
coumarins, bergapten (63), chalepin (64) and chalepensin (65), one alkane, 
tetradecane, two flavonoid glycosides, rutin (52) and methoxy rutin (83) and 3``, 6`-
disinapoylsucrose (84) from R. chalepensis aerial parts; one hydroquinone- -D-
glucopyranoside, arbutin (53) and two pentacyclic triterpenes, methyl betulinate (89) 
and ursolic acid (88) from A. pavarii leaves.  
Twenty-three isolated compounds were tested for their cytotoxicity against the most 
sensitive cancer cell lines. Eight compounds revealed  good cytotoxic activity: 
cupressoflavone (24), sumaflavone (76), epicupressic acid (42), luteolin (22), chalepin 
(64) and 4-hydroxy-2-nonyl-quinoline (85) were cytotoxic against the A549 with IC50 
values of 65, 77, 159, 76.9, 92 and 97.6 µM, respectively, whilst, compound 64 
showed toxicity also against EJ138 with an IC50 value of 117 µM. C-α-
rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione (81) and ursolic acid (88) were 
toxic against the prostate cancer cell line with IC50 values of 62 µM and 8.22 µM, 
respectively. The study findings also indicated that compounds 24, 64 and 88-induced 
cell death might involve the plasma membrane damage resulting in the release of LDH 
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Cancer is a hyperproliferative disorder starts to occur, when normal cells in a specific 
part of the body begin to grow out of control. It can be defined as a disease in which 
there is an alteration in the control mechanisms that govern cell proliferation and 
differentiation that generally is due to DNA damage. Cancer cells tend to rapidly 
proliferate or increase in number, which can result in morbidity and mortality. Cancer 
or malignant neoplasms can metastasize to new and distant tissues through the lymph 
system and blood vessels. Tumours also often have an irregular shape, invade local 
tissue, and often ulcerate through the skin (Cooper, 2000).  
 
1.1.1 History of cancer 
The earliest evidence of human bone cancer was discovered in mummies in ancient 
Egypt, which were dated about 1600 BC in some ancient manuscripts. A recorded case 
of breast cancer from ancient Egypt in 1500 BC showed that there was no treatment 
for cancer but only palliative treatment. According to inscriptions, surface tumours 
were removed by surgery in a similar manner as they are removed today (Sudhakar, 
2009).             
The origin of the word cancer came from Greek physician Hippocrates (460–377 BC), 
who used the word karkinos, meaning carcinoma. The Hippocratic Corpus (diseases 
that produced masses) were described as onkos and the ulcerative and non-healing 
masses that included lesions ranging from benign processes to malignant tumors were 
described as karkinos. Hippocrates advised his patients on their diet, rest, and exercise 
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in cases of mild illnesses, but for more serious diseases, especially karkinomas he 
advocated for the purgatives, heavy metals, and surgery (Faguet, 2015). 
In the last couple of hundred years, the innovations and advancement of research tools 
have helped researchers to explore different hypotheses on the nature of cancer, 
leading to an incremental increase in our understanding, and in the prevention and in 
the treatment of cancer. For instance, in 1775, Percivall Pott confirmed a relationship 
between exposure to chimney soot and the incidence of squamous cell carcinoma of 
the scrotum among chimney sweeps (Kipling & Waldron, 1975). Likewise, Rudolph 
Virchow in 1863 was the first person to identify the term "leukaemia" and the excess 
number of white blood cells in the blood of patients with leukaemia. He was also the 
first to describe the connection between inflammation and cancer (Androutsos, 2004). 
In 1882, the first radical mastectomy to treat breast cancer was performed by William 
Halsted, who believed that the more extensive the surgery, the less likely cancer would 
return (Young, 2013). The inheritance of a cancer risk was first reported by the 
Brazilian ophthalmologist Hilário de Gouvêa in 1886, who provided the first 
documented evidence that cancer can be inherited. Likewise, the virus-cancer link was 
confirmed by Peyton Rous. He was awarded the Nobel Prize in physiology or medicine 
in 1966 for his discovery of tumour-inducing viruses known as Rous sarcoma virus. 
He also reported the carcinogenicity of certain environmental and industrial agents as 
well as that of ultraviolet radiation (Faguet, 2015). 
1.1.2 Incidence of cancer 
Cancer is still one of the major causes of human morbidity and mortality throughout 
the world, despite notable advances in treatments. In the United States, cancer is the 
second leading cause of death after cardiovascular disease. Approximately one in four 
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deaths are caused by cancer (Manju et al., 2012). According to GLOBOCAN (a 
project of the International Agency for Research on Cancer), an estimated 14.1 million 
new cancer cases and 8.2 million deaths were reported in 2012 worldwide. These 
figures are expected to increase by at least 70% by 2030 (Torre et al., 2015). Records 
reveal that lung cancer is the leading cause of cancer death among males, whereas 
breast cancer is the leading cause of cancer death among females. On the other hand, 
colorectal cancer deaths are higher in the more developed countries in both females 
and males. However, in less developed countries, liver and stomach cancers are the 
leading causes of males' cancer death while cervical cancer is the most leading cause 
of females’ cancer deaths.  Although the incidence rates for all cancers are twice as 
high in more developed countries than less developed countries, but mortality rates 
are only 8-15% higher in more developed countries (Torre et al., 2015; Antoni et al., 
2016).   
In Libya, like all countries, cancer is also a major health problem, but epidemiological 
data in Libya are sparse (El Mistiri et al., 2015). However, ‘The Benghazi Cancer 
Registry’ has managed to collect data on all new cases diagnosed in Eastern Libya and 
also data from medical and mortality records from multiple other sources. The leading 
cancers in males were found to be lung, colorectal and bladder, whereas in females, 
the leading malignancy was breast, followed by colorectal and uterine cancers. Lung 
and breast cancers were the most common causes of cancer deaths in adults. In the 
paediatric age group, the most frequently occurring cancer was identified as lymphoid 
leukaemia. Despite some progress in cancer prevention, Libya still lacks effective 
control programmes for cancer, which is also the case within many countries of the 
Eastern Mediterranean Region (El Mistiri et al., 2015). 
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1.1.3 Anticancer natural products 
Several types of chemical compounds have been isolated from natural sources of either 
plant, marine or microbial origin and have played an important role in the drug 
discovery and treatment of different diseases. Their study includes the investigation 
of their structure, biosynthesis, potential uses, and purpose of their presence in the 
organism. The isolated products are usually secondary metabolites and their 
derivatives, which should be well-characterized molecules with a high degree of 
purity. This helps to provide the source of inspiration for FDA-approved compounds, 
drug discovery, and development (Nautiyal et al., 2013). 
Natural products have made a significant impact on the discovery of compounds that 
kill cancer cells, and over 60% of all cancer drugs that are currently in clinical use are 
either natural products or owe their origin to a natural source (Sarker & Nahar, 2012).  
There is increasing evidence suggesting that there are new anticancer drugs leads to 
be discovered from the marine environment. Many marine-derived agents have proven 
potential to inhibit the growth of human cancer cells both in vivo and in vitro models. 
Some of these agents have been approved for use in humans, for example, cytarabine, 
yondelis (ET743), eribulin, dolastatin 10 and monomethylauristatin E (MMAE or 
vedotin) (Newman & Cragg, 2014). Several steroid dimers reported from various 
marine organisms such as cephalostatins and ritterazines showed potent cytotoxicity 
against the lymphocytic leukaemia cell line (P388) (Nahar & Sarker, 2012).  
Cephalostatin 1 (Figure 1.1) (1) proved its activity as anticancer agent tested by the 
US National Cancer Institute (NCI) (Moser, 2008; Nahar & Sarker, 2012). 
Numerous plants are well-known sources of clinically useful anticancer drugs. For 
example, Catharanthus rosea (vinblastine, vincristine, and vinorelbine), Podophyllum 
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hexandrum (etoposide and teniposide), Taxus brevifolia (paclitaxel and docetaxel) and 
Campthotheca acuminata (topotecan and irinotecan) (Heinrich et al., 2012).  
Vinca alkaloids (vinblastine, vincristine, and vinorelbine) (Figure 1.1) (2, 3 and 4), 
respectively, are naturally occurring, or semi-synthetic nitrogenous bases obtained 
from the Madagascar periwinkle plant Catharanthus roseus (Apocynaceae). They are 
asymmetrical dimeric compounds formed by condensation of the vindoline and 
catharanthine subunits (Brunton et al., 2011).  Vinca alkaloids were used for the 
treatment of diabetes due to their hypoglycemic effect. It was noted that the extracts 
of C. roseus decreased the white blood cell counts and caused bone marrow depression 
in experimental rats and subsequently revealed activity against leukemic experimental 
mice (Cragg & Newman, 2005). They are primarily used in combination with other 
anticancer drugs for the treatment of different types of cancers, including breast, lung, 
haematological (leukaemias and lymphomas) and testicular cancers (Cragg & 
Newman, 2005; Brunton et al., 2011).   
The discovery of paclitaxel (Taxol) (Figure 1.1) (5), a diterpene ester from the inner 
bark of the Pacific Yew, Taxus brevifolia (Taxaceae), is another example of a natural 
product success in drug discovery. Recently, it has been revealed that Taxol was 
produced by a fungal endophyte, which can grow on semisynthetic media. The fungus 
was isolated from the phloem tissue of the Pacific Yew Tree (Priyadarshini & 
Aparajitha, 2012). Paclitaxel is an effective anticancer agent against ovarian and 
advanced breast cancer, lung, liver, leukaemia, head and neck cancers. Clinical use of 
paclitaxel was limited because of the extremely small amount of drug obtained from 
the crude bark extract, and its poor water solubility. Therefore, many studies were 
carried out in an effort to develop this product by synthetic methods. The modification 
of the side chain linked to the taxane ring at C13 has led to the identification of the 
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more potent anticancer analog, docetaxel (Brunton et al., 2011; Priyadarshini & 
Aparajitha, 2012). 
Podophyllotoxin (Figure 1.1) (6) is a lignan isolated from the rhizomes of American 
mayapple (Podophyllum peltatum) Fam. Berberidaceae. It was used traditionally by 
the American Indians as an emetic, cathartic and anthelmintic agents (Brunton et al., 
2011). Podophyllotoxin has been also found in other genera such as Anthriscus, 
Cassia, Catharanthus, Commiphora, Diphylleia, Dysosma, Haplophyllum, 
Hernandia, Hyptis, Juniperus, Nepeta, Polygala, Linum, Teucrium and Thuja 
(Gordaliza et al., 2004). Podophyllotoxin was found to be unsuitable for clinical use 
as an anticancer agent due to its toxic side effects. The semisynthetic derivatives of 
podophyllotoxin, etoposide, and teniposide have proved to be excellent antitumour 
drugs (Arroo et al., 2002). They are extensively used in the treatment of lung cancer, 
testicular cancer, ovarian, leukaemia, and lymphoma. Teniposide has higher plasma 
protein binding and higher potency than etoposide (Canel et al., 2000; Cragg & 
Newman, 2005; Lee & Xiao, 2005). β-peltatin-A-methyl ether was found in 
Anthriscus sylvestris, Bursera permollis, B. fagaroides, B. simaruba, Juniperus 
phoenicea, Libocedrus plumose and some Linum species (Cairnes et al., 1980). β-
Peltatin-A-methyl ether has been reported to have cytotoxic activity against number 
of cancer cell lines (Wickramaratne et al., 1995; Rojas-Sepúlveda et al., 2012). 
Notably, the biological activity of the semisynthetic compounds was shown to be 
affected by the presence of a transfused lactone ring (Arroo et al., 2002). 
Camptothecin (Figure 1.1) (7) is a quinoline alkaloid first derived from the Chinese 
ornamental tree Camptotheca acuminate Fam. Nyssaceae in 1966. Camptothecin 
possesses high cytotoxic activity in a variety of cell lines with the major drawback 
being its high toxicity in urinary bladder (Rauter et al., 2013). Topotecan and 
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irinotecan (Figure 1.1) (8, 9), respectively, are semisynthetic derivatives of 
camptothecin and are used for the treatment of ovarian, lung and colorectal cancers 
(Creemers et al., 1996; Bertino, 1997; Rahier et al., 2005). All camptothecins are 
characterized by the presence of a labile lactone ring (Figure 1.1) (7, 8 and 9). The 
hydroxyl group and S-conformation of the chiral center at C20 in the lactone ring are 
essential for the biological activity of the compound.  However, substitutions on the 
A and B rings of the quinoline alkaloid’s moiety improve water solubility and enhance 
the potency of camptothecins (Brunton et al., 2011).  
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Figure 1.1: Anticancer natural products 
1.1.4  Mechanism of action of anticancer natural products 
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Anticancer natural products act on multiple pathways to inhibit carcinogenesis by 
interfering with invasion, growth, survival, and metastasis. The wide activity spectrum 
of these products can result in suppression of tumour growth by induction of apoptosis, 
down-regulation of genes, anti-metastatic activity, and inhibition of microtubule 
function or alteration of the structure of DNA. A wide variety of mechanisms exist for 
anticancer activity. Different compounds have different mechanisms see 1.1.4.2 
1.1.4.1  Mechanisms of cell death  
There are two main types of cell death: apoptosis and necrosis. Necrotic cell death is 
caused by gross cell injury and results in the death of groups of cells within a tissue. 
It is characterized by cell swelling, cytoplasmic vacuoles formation, and swollen 
endoplasmic reticulum.  Apoptosis is an alternative way of cell death to necrosis, it is 
a normal process of programmed cell death (happens during development) and is 
characterized by specific DNA changes and without any inflammatory response. It 
triggers if mistakes are identified in DNA replication. Loss of this protective 
mechanism would allow mutant cells to continue to divide and grow, thereby 
conserving mutations in subsequent cell divisions. Many anticancer agents and 
radiotherapy induce mutations in cancer cells, which are not sufficient to cause cell 
death, but which can be recognized by the cell, triggering apoptosis (Elmore, 2007; 
Payne & Miles, 2008; Matsuura et al., 2016). 
 
1.1.4.2  Classification of anticancer agents according to their chemical structure 
and mechanism of action 
In general, anticancer drugs were categorized as chemotherapy, hormonal therapy, and 
immunotherapy. The chemotherapeutic agents can be classified according to their 
chemical structure and mechanism of action into the following classes: alkylating 
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agents, antibiotics, antimetabolites, mitosis inhibitors, platinum compounds and 
topoisomerase I and II inhibitors (Espinosa et al., 2003; Payne & Miles, 2008). 
Alkylating agents 
 
Alkylating agents are compounds that specifically link with their alkyl group to a 
chemical moiety in nucleic acids or proteins by a covalent bond. Mostly, they are 
bipolar compounds, which help them to form bridges between DNA strands and to 
interfere with the enzymes action involved in DNA replication leading to cell death. 
The most serious damage happens during the S-phase because the cell has less time to 
get rid of the damaged fragments. Examples of these Alkylating agents are tetrazines, 
nitrogen mustards, nitrosureas, and procarbazine (Payne & Miles, 2008). 
Antibiotics 
Mostly, anticancer antibiotics have been produced from bacterial and fungal sources 
(Streptomyces species) by affecting the synthesis and function of nucleic acids in 
different pathways. For instance, anthracyclines antibiotics such as daunorubicin, 
doxorubicin, and epirubicin. These antibiotics intercalate with DNA and the enzyme 
topoisomerase II. The anthracyclines stabilize the DNA topoisomerase II complex and 
thus prevent reconnection of the strands (Payne & Miles, 2008). 
Antimetabolites 
Antimetabolites are compounds that compete with naturally occurring substances (due 
to the similarity in structure) such as amino acids, nucleosides, and vitamins for the 
active site of an essential enzyme or receptor. These antimetabolites may be phase-
specific, i.e. act during the S-phase of the cell cycle or may be directly incorporated 
into DNA or RNA. These antimetabolites are folic acid antagonists, purine analogues 





Vinca alkaloids are cell cycle specific agents that specifically target β tubulin (the 
building block of the microtubules) and block its polymerization with α tubulin, 
causing further inhibition of the microtubule mitotic spindle assembly, leading to 
metaphase arrest and subsequent inhibition of mitosis (Himes, 1991; Payne, 2008; 
Brunton et al., 2011; Moudi et al., 2013).  
Paclitaxel and other taxanes bind to the protein tubulin, stabilizing and protecting 
microtubule against disassembly, leading to cell cycle arrest in mitosis. They differ 
from the vinca alkaloids in that they bind to a different β-tubulin site (Brunton et al., 
2011). Direct activation of apoptotic pathways has also been suggested to be critical 
to the cytotoxicity of these anticancer drugs. Paclitaxel may also have a role in treating 
some kinds of cancer by enhancing or mutating certain signaling factors (Cragg & 
Newman, 2004; Kingston, 2005; Payne 2008; Priyadarshini & Aparajitha, 2012).   
Heavy metals  
Platinum agents such as carboplatin, cisplatin, and oxaliplatin are organic heavy metal 
complexes, which diffuse into a cell, lose their ions and cross-link with the DNA 
strands (intra- and inter strand), resulting in inhibition of DNA, RNA and protein 
synthesis (Payne & Miles, 2008). 
Topoisomerase inhibitors 
The DNA topoisomerases are nuclear enzymes that are responsible for altering the 3D 
structure of DNA by reducing the twisting stress in supercoiled DNA, allowing 
selected regions of DNA to become sufficiently relaxed to ease replication, repair, and 
transcription. Topoisomerase I and II inhibitors mediate DNA strand breakage and 
resealing and have become the target of cancer therapy (Brunton et al., 2011).  
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Camptothecin analouges irinotecan and topotecan act as topoisomerase I inhibitors 
(Rahier et al., 2005). They bind to the topoisomerase I–DNA covalent complex 
preventing DNA replication. This binding yields an intermediate complex in, which 
the tyrosine of the enzyme is bound to the phosphate end of the DNA strand preventing 
DNA re-ligation during synthesis and causes the complex to collide with the 
replication fork, leading to DNA double-strand breaks and cell death (Brunton et al., 
2011). Podophyllotoxin derivatives etoposide and teniposide inhibit topoisomerase II 
enzyme preventing DNA synthesis and replication (Liu, 1989) These drugs form a 
stable ternary complex with topoisomerase II and DNA leading to their breakage and 
the accumulation of DNA strand breaks leads to cell-cycle arrest (Arroo et al., 2002; 
Brunton et al., 2011).    
Despite the advancements in the treatment of cancer over the last decades, cancer is 
still one of the major causes of death. Currently, many anticancer drugs exhibit limited 
efficacy, severe side effects, and are expensive. For this reason, the discovery of novel 
anticancer agents that lack some of these disadvantages is still required. The Libyan 
Mediterranean Coast is characterized by its rich biodiversity. Its natural resources 
constitute a source of income for many poor rural people.  In Libyan folk medicine, a 
number of medicinal plants have been used as remedies for cancers and tumours, but 
potential anticancer properties of these plants have not yet been fully and 
systematically investigated to provide the scientific rationale for their folklore uses 
(Elmezogi. et al., 2013).  
The current study has been designed to evaluate four selected medicinal plants 
(Arbutus pavarii, Asphodelus aestivus, Juniperus phoenicea and Ruta chalepensis) 
from the Libyan flora as putative sources of anticancer agents and incorporates a 
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rational, systematic bioassay-guided phytochemical and cytotoxic/anticancer 
approach aimed at discovering any bioactive molecules that may be responsible for 
their reported cytotoxic/anticancer activity.  
1.2 The family Asphodelaceae 
The Asphodelaceae is a relatively small but widespread plant family. It is widely 
distributed in the arid areas throughout South Africa, but some species occur naturally 
in the Mediterranean region e.g. Asphodelus species (Dagne & Yenesew, 1994; 
Heinrich et al., 2012; Myanmar Medicinal Plant Database, 2006). 
 
1.2.1 Classification of the family Asphodelaceae 
The Asphodelaceae family is represented by 12 genera and 600 species. The 
Asphodelaceae is often included in the Liliaceae family, which comprises more than 
250 genera and 3700 species. It has recently been reclassified into smaller families 
namely, the Asphodelaceae, Alliaceae, Asparagaceae, Dracaenaceae, Eriospemiaceae, 
and Hyacinthaceae. The Asphodelaceae family consists of the sub-families 
Asphodeloideae and Alooideae (Dagne & Yenesew, 1994). The widely recognized 
genera in the sub-family Asphodeloideae are Asphodeline, Asphodelus, Bidbine, 
Eremriis, Emiphlacirs, Jodrellia, Paradisea, Sirnethis, and Trachandra. However, a 
few genera are identified in the succulent sub-family Alooideae, namely Aloe, 
Astroloba, Chortolirion, Gasteria, Haworthia, and Kniphofia. Most species classified 
under this family, are perennial herbs with rhizomes and bulbs (Dagne & Yenesew, 




1.2.2 Chemical characteristics of the family Asphodelaceae  
The phytochemical information on the Asphodelaceae family is still quite sparse. 
Therefore, it is so difficult to provide a general chemotaxonomic data. However, most 
species of this family are rich in anthraquinones and anthraquinone glycosides, which 
are responsible for the laxative effect of these species. The most commonly known 
anthraquinones are aloe-emodin, anthrone-C-glycosides, and chrysophanol. 
Polysaccharides also accumulate in the gel of the Aloe vera leaves. Many of the health 
benefits associated with Aloe vera have been attributed to the polysaccharides (Dagne 
& Yenesew, 1994; Heinrich et al., 2012; Myanmar Medicinal Plant Database, 2006). 
 
1.2.3 Traditional uses of the family Asphodelaceae  
Most species of the Asphodelaceae family have been used traditionally as laxatives 
and purgatives. They have also been used in the treatment of arthritis, hypertension, 
stress, eczema, skin irritations and burns. Aloe leaves are extensively used in the 
cosmetics preparations and for the treatment of many diseases (Edhun & Qian, 2010; 
Radha & Laxmipriya, 2015). 
1.2.4 The genus Asphodelus L. 
The genus Asphodelus consists of approximately 17 species, namely, Asphodelus 
acaulis, A. aestivus, A. ayadii, A. bakeri, A. bentorainhae, A. cerasiferus, A. fistulosus, 
A. gracilis, A. lusitanicus, A. macrocarpus, A. ramosus, A. refractus, A. roseus, A. 
serotinus, A. tenuifolius and A. viscidulus. The species are rich in anthranoids, 
anthraquinones glycosides, flavonoids, steroids, triterpenes (El-Fattah et al., 1997; 
Calis et al., 2006). 
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1.2.4.1  Active constituents of the genus Asphodelus  
The genus Asphodelus has also been extensively studied, again because it contains a 
variety of valuable active ingredients. Its species are rich in anthranoids, 
anthraquinones glycosides, flavonoids, steroids and triterpenes (El-Fattah et al., 1997; 
Calis et al., 2006). 
1.2.4.2  Traditional uses of the genus Asphodelus 
Several species of the genus Asphodelus have been used in folk medicine in the 
treatment of skin disorders such as psoriasis, parasites and microbial infection and as 
skin lightening agents in freckles (Petrillo et al., 2016). 
1.2.5 Asphodelus aestivus Brot. 
Asphodelus aestivus (Figure 1.3), commonly known as White Asphodel or Gamon is 
a common spring-flowering geophyte distributed along the Southern Alps to the 
western Balkans, in meadows and heathland of central Spain.  It is also found in the 
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Figure 1.2:  Asphodelus aestivus 
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1.2.5.1  Traditional uses of A. aestivus 
A. aestivus has been utilized traditionally for culinary and medicinal purposes. 
Traditionally, the tuber and roots of this plant are used to treat hemorrhoids, nephritis, 
burns, wounds and some skin diseases (Aslantürk & Çelik, 2013). It has been also 
used in the eastern Mediterranean region of Libya for the treatment of arthritis, 
rheumatic diseases, ovulation and skin diseases (El-Mokasabi, 2014). 
1.2.5.2  Previous phytochemical work of A. aestivus 
All the previous phytochemical investigations performed on the tubers of Asphodelus 
species resulted in the isolation of anthranoides, flavonoids and triterpenes. However, 
a study applied by Calıs et al. in 2006 on the fresh leaves of A. aestivus revealed also 
the presence of flavone C-glycosides, anthranoides (1, 8-dihydroxy-anthraquinones), 
adenosine nucleoside, two amino acids, phenylalanine (10) and tryptophan (11), and 
chlorogenic acid (12) (Calıs et al., 2006; Birincioglu et al., 2015). 
Anthranoids 
Three anthranoides were isolated from the MeOH extract of A. aestivus leaves by 
using chromatographic techniques (CC) using Sephadex LH-20. These anthranoides 
are aloe-emodin (13), aloe-emodin acetate (14) and chrysophanol 1-O-gentiobioside 
(15) (Calıs et al., 2006). 
Flavonoids 
Five flavone C-glycosides were isolated from the water-soluble part of the MeOH 
extract of A. aestivus fresh leaves. These flavonoids are isoorientin (16), isovitexin 
(17), isoorientin 4’-O-β–glucopyranoside (18), 6”-O-(malonyl)-isoorientin (19) and 
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6”-O-[(S)-3-hydroxy-3-methylglutaroyl]-isoorientin (20). The main components of 
the extract are apigenin (21), luteolin (22) and their β-D-glucopyranosides. (Calıs et 
al., 2006). 
Micellaneous   
The isolated oil from A. aestivus seeds was analyzed by gas chromatography (GC) to 
reveal two components, butyric acid (76.26%) and nervonic acid (3.65%), which were 
identified by GC-FID and GC/MS analysis (Fafal et al., 2016). 
High amounts of n-alkanes, saturated fatty acids and minor amounts of acyclic 
diterpenes were isolated from the flowers essential oil of A. aestivus from Cyprus. 
Seventeen compounds were identified in the essential oil comprising 96.2% of the oil. 
The major components of the essential oil were hexadecanoic acid 35.6%, pentacosane 
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1.2.5.3  Previous biological work of A. aestivus 
Toxicity  
A severe neurologic syndrome with intense neuronal pigmentation was reported in the 
sheep after ingestion of A. aestivus leaves and seeds in the meadow in Aydin region 
(Turkey.)  Neurological signs were observed, such as ataxia, paresis, and convulsion. 
Toxicity was reported for anthranoids (from the green leaves of Asphodelus spp.) and 
bianthrone C-glycosides in tubers of Asphodelus spp.  (Birincioglu et al., 2015).  
 
The antioxidant activity 
A study was undertaken in Turkey on A. aestivus leaves to investigate the antioxidant 
activity of the plant. The study analyzed the total flavonoid, the contents of chlorophyll 
and carotenoid, the metal chelating ability, the carotene bleaching effect and the 
antioxidant activity, 2,2-diphenyl-1-picryl-hydrazyl (DPPH), 2,2'-azino-bis (3-
ethylbenzothiazoline-6sulfonic acid) diammonium salt (ABTS), N, N-dimethyl-p-
phenylenediamine dihydrochloride (DMPD), superoxide, hydroxyl and nitric oxide 
(NO) scavenging assays. The results revealed that they all had strong antioxidant 
activity. The radical scavenging and the metal chelating activities of the aqueous 
extract were higher than that of the ethanolic extract whereas the ethanolic extract 
revealed higher levels of carotene bleaching activity (Peksel et al., 2012; Peksel et al., 
2013).    However, another antioxidant study was applied on the tubers of A. aestivus, 
which also showed significant scavenging antioxidant activity using the (DPPH) assay 
(Aslantürk, 2013). 
The antimicrobial activity    
The antifungal activity of both the ethanol and water extracts of A. aestivus leaves was 
tested against Aspergillus niger. The results showed higher activity in the ethanol 
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extract than water extract at the concentrations of 0.25 and 0.50 mg/mL. However, 
both the ethanol and water extracts exhibited similar activities at the concentration of 
1 mg/mL. Standard antifungal drug fluconazole exhibited higher activity than the 
extracts tested (Peksel et al., 2012).        
The antimicrobial activity of the oil from A. aestivus seeds was assessed against both 
Gram+ve and Gram-ve bacteria and three strains of yeast using the disc diffusion and 
broth micro-dilution methods. The oil showed moderate antibacterial activity against 
Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, Staphylococcus 
aureus, Staphylococcus epidermidis, and as well as antifungal activity against 
Candida albicans and Candida krusei (Fafal et al., 2016).     
The antimicrobial activity of A. aestivus tuber extracts (n-hexane, MeOH, and aqueous 
extracts) was assessed against seven species of bacteria and two strains of fungus. The 
results showed higher antibacterial activity against Gram+ve bacteria than the Gram-
ve bacteria with the highest activity in the n-hexane layer (Bozyel et al., 2016).  
 
The cytotoxic activity 
The cytotoxic and apoptotic activities of A. aestivus extracts on MCF-7 breast cancer 
cells were evaluated by trypan blue exclusion assay, comet assay and Hoechst 
propidium iodide double staining (Aslantürk & Celik, 2013). The results demonstrate 
that cytotoxic and apoptotic properties of A. aestivus extract show differentiation to 
extract type. Several studies have demonstrated that the main anthraquinones of 
rhubarb: emodin, aloe-emodin, and rhein, inhibit the growth and proliferation of 




The pesticidal activity 
The roots of A. aestivus Brot. were investigated against Tetranychus cinnabarinus 
Boisd (the carmine spider mite) as a biopesticide. The root extract revealed ovicidal 
activity and reduced hatched number compared with the standard dicofol. The results 
showed the strong acaricide activity of the root extract, which could be helpful in 
reducing environmental pollution associated with synthetic pesticides used in the 
management of pest programmes (Gencsoylu, 2009).  
1.3   The family Cupressaceae  
 
The Cupressaceae consists of ornamental plants. It is characterized by monoecious, 
subdioecious or (rarely) dioecious shrubs and trees, the leaves are scale to linear, 
opposite or whorled and usually paired or in threes, the ovules of female cones: 1-
20/cone scale; the cone scales are fused to bracts. The microsporangia of male cones: 
2-10/ microsporophyll; the pollen is usually without any appendages. Members of this 
family are found worldwide, but particularly in North Africa, Mediterranean region, 
and South America. This family includes all the gymnosperm family, which are 
considered as the most important conifer family in recent horticulture.  Members of 
this family are important for their woody plants, fruit, and resinous matter and as 
ornamentals (Bell & Hemsley, 2001; Encyclopedia Britannica 2012; Taghreed et al., 
2017). 
1.3.1 Classification of the family Cupressaceae  
The family Cupressaceae is considered as the largest conifer family in terms of genera, 
and the third-largest one in terms of species, it includes 27 genera and 142 species and 





Subkingdom: Tracheobionta (Vascular plants) 
Superdivision: Spermatophyta (seed plants) 




The following are the genera included in the Cupressaceae family: Chamaecyparis, 
Cryptomeria, Cunninghamia, Cupressus, Diselma, Fitzroya, Glyptostrobus, 
Juniperus, Libocedrus, Metasequoia, Microbiota, Neocallitropsis, Papuacedrus, 
Platycladus, Sequoia, Sequoiadendron, Taiwania, Taxodium, Tetraclinis, Thuja, 
Thujopsis and Widdringtonia (Rich. ex Bartling. 1830. Cupressaceae. The 
Gymnosperm Database, assessed on 12-2017). 
1.3.2   Chemical characteristics of the Cupressaceae family 
Numerous publications have reported the presence of many biologically active 
compounds from the Cupressaceae such as bioflavonoids, diterpenes, essential oils 
and sterols (List & Horhammer, 1979; Morte & Honrubia, 1996). 
1.2.3 Traditional uses of the Cupressaceae 
Many species of the Cupressaceae family have been used traditionally as antiseptic, 




1.2.4 The genus Juniperus L. 
The Juniperus is the largest genus in the family Cupressaceae. It consists of 
approximately 60 species. These are distributed in the northern hemisphere from the 
Arctic Circle to the African Tropics Mountains. The genus Juniperus has been 
categorized into three sections: Caryocedrus, oxycedrus, and sabina. Caryocedrus is 
mainly distributed in the eastern Mediterranean region whereas, the other two sections 
are distributed throughout the Northern Hemisphere (Zanoni & Adams, 1975; Seca & 
Silva, 2005).   
1.3.4.1  Species of the genus Juniperus 
The following are some juniper species included in the genus Juniperus 
Juniperus angosturana, J. arizonica,  J. ashei,  J. barbadensis,  J. bermudiana,  J. 
blancoi, J. brevifolia, J. californica, J. cedrus, J. chinensis, J. coahuilensis,  J. 
comitana,  J. communis, J. convallium, J. deppeana, J. drupacea,  J. durangensis,  J. 
excelsa,  J. flaccida,  J. foetidissima,  J. formosana, J.gracilior,  J. horizontalis,  J. 
indica,  J. jaliscana, J. komarovii,  J. maritima,  J. martinezii, J. monosperma, J. 
monticola,  J. occidentalis J. osteosperma,  J. oxycedrus, J. phoenicea, J. pinchotii,  
J. pingii,  J. poblana, J. procera, J. procumbens,  J. przewalskii,  J. pseudosabina,  J. 
recurva, J. rigida,  J. sabina,  J. saltillensis, J. saltuaria, J. saxicola, J. scopulorum,  
J. semiglobosa, J. squamata,  J. standleyi,  J. taxifolia,  J. thurifera, J. tibetica,  
J.virginiana,   (Linnaeus, 1753; Kangshan et al., 2010). 
1.3.4.2  Active constituents in the genus Juniperus  
The genus Juniperus is considered as the main source of cedarwood oil, which has 
high industrial importance. The genus revealed the presence of terpenoids 
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(sesquiterpenoids, bicyclic diterpenoids, and tricyclic diterpenoids), coumarins, 
flavonoids, lignans and with significant biological activity (Seca & Silva, 2005). 
 
1.3.4.3  Traditional uses of the genus Juniperus 
Juniperus species have been used traditionally as antiseptic, antitussive, diuretic, 
carminative, hypoglycaemic, haemostatic activities, antifertility agents, stomachic and 
carminative and as cold remedies. They have also been used in the treatment of 
rheumatic arthritis and urinary infections (Prakash, 1986; Swanston-Flatt et al., 1990; 
Wichtl, 1994; But et al., 1997; Wang et al., 2002). In Saudi Arabia, Juniperus species 
have been used as a remedy for jaundice and tuberculosis, whereas in Bhutan, they are 
used as an insect repellent and for treatment of fever. On the whole, these traditional 
uses have supporting positive scientific evidence showing various bioactivities of 
Juniperus species (Seca & Silva, 2005). 
1.2.5 Juniperus phoenicea L. 
Juniperus phoenicea (Phoenician Juniper or Arâr) (Figure 1.5) is an evergreen plant 
usually growing as either a bush or tree.  It is distributed throughout the Mediterranean 
region, ranging from Morocco and Portugal east to Turkey and Egypt. It is also found 
in Madeira, the Canary Islands and on the mountains of Western Saudi Arabia near 
the Red Sea. It mostly prefers to grow at low altitudes close to the coast but can be 
found at an altitude of 2,400 m in the south of its range within the Atlas Mountains  
(El Sawi & Motawe, 2008). J. phoenicea is a well-known Libyan medicinal plant, 
which has been used in the Libyan traditional medicine for the treatment of various 
human ailments. Although 70 Juniperus spp. grow throughout the world, only J. 
phoenicea and J. oxyderus are found in Libya.  
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Figure 1.4:  Juniperus phoenicea. 
    
1.3.5.1  Traditional uses of J. phoenicea 
J. phoenicea has been used in Libyan traditional medicine for the treatment of various 
human ailments including tumours and cancers. This plant is used in folk medicine to 
treat rheumatism, gout, oedema, diarrhoea, poor appetite and urinary tract diseases. It 
is also reported to eliminate gastrointestinal bacteria and parasites (Qnais et al., 2005; 
Aljaiyash et al., 2014). Some tribes use it as a female contraceptive (Aljaiyash et al., 
2014). The juniper berry has been studied as a possible treatment for diet-controlled 
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1.3.5.2  Previous phytochemical work of J. phoenicea 
Several compounds have previously been isolated from the leaves and berries of J. 
phoenicea grown in various countries i.e., carbohydrates, fatty acids, furanone 
glycosides, phenolics (e.g., flavonoids and biflavones, phenylpropanoids and lignans), 
terpenoids and sterols (El-Sawi et al., 2007; El-Sawi & Motawe, 2008; Ennajar, et al., 
2010; Derwich, et al., 2011; El-Sawi et al., 2013: Alzand et al., 2014) (Figure 1.5).  
Coumarins    
Eight species from the genus Juniperus revealed the presence of six coumarins but 
only the coumarin skimmin compound (23) was detected in J. phoenicea (Figure 1.5) 
(Comte et al., 1996; Seca & Silva, 2007). 
 Flavonoids 
More than sixty flavonoid compounds were identified in different Juniperus species  
 mainly biflavonol and flavone derivatives. The following flavonoids were isolated 
 from J. phoenicea compounds (24-27): 
cupressuflavone (24), amentoflavone (25), hinokiflavone (26) and robustaflavone (27) 
(Fatma et al., 1979; Seca & Silva, 2007). 
Lignans 
Sixty-two lignans were isolated from different Juniperus species. The lignan 
Podophyllotoxin found in small amounts in these species. A study published in 1998 
by Muranaka et al. about the production of podophyllotoxin by callus culture of J. 
chinensis, to increase its production (Muranaka et al., 1998; Seca & Silva, 2007). The 
following lignans were reported from J. phoenicea, compounds (28-30) (Seca & Silva, 
2007): β-methylpeltatin A (28), deoxypodophyllotoxin (29) (Cairnes et al., 1980; 
Dawidar et al., 1991; San Feliciano et al., 1992) and shonanin (30) (San Feliciano et 




Four types of sterols were revealed in different species of the Juniperus (Seca & Silva, 
2007). Sitosterol is the most abundant one in these species and only β-sitosterol (31) 
was isolated by Tabacik and Laporthe from J. phoenicea in 1971 (Seca & Silva, 2007).      
Terpenoids  
Terpenoids (sesqui-, di- and triterpenoids) have been used as special chemosystematic 
markers in conifers (Otto and Wilde, 2001), being both cuparanes and widdranes were 
restricted to species of the family Cupressaceae. Triterpenes were not identified yet in 
Juniperus species and monoterpenes were mainly detected in juniper essential oil. 
Monoterpenes: 
Monoterpenes (Figure 1.6) predominantly α-pinene (32), β-carene (33), limonene 
(34), myrcene (35), phellandrene (36), sabinene (37), and terpinyl acetate (38) were 
identified in berries and leaves of J. phoenicea ssp. from different regions with 
chemical variability in their composition (Angioni et al., 2003; Cosentino, et al., 2003; 
Barrero et al., 2006; El-Sawi et al., 2007; Achak et al., 2008; Ennajar, et al., 2009; 
Ennajar, et al., 2010; Mazari et al., 2010; Ait-Ouazzou et al., 2012; Bekhechi et al., 
2012). 
 
Sesquiterpenoids:   
A large number of sesquiterpenoid classes are identified in the Juniperus genus (Seca 
& Silva, 2007).  The following sesquiterpenoids were isolated from J. phoenicea: α-
cadinol methyl ether, β-caryophyllen, caryophyllene oxide, elemol (Dawidar et al., 
1991), γ-cadinene (39), β-selinene, germacrene and α-humulene (40) (Dawidar et al., 
1991; San Feliciano et al., 1992; Seca & Silva, 2007). 
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Bicyclic diterpenoids:  
Bicyclic diterpenes, mainly the diterpene labdane type are found in the Juniperus 
genus (Seca & Silva, 2007). The following diterpenoids were isolated from J. 
phoenicea: eperu-13(14)-ene-8β,15-diol, labd-8(17)-ene-12-hydroxy-19-oic acid 
(Tabacik and Laporthe, 1971), 8,15-dihydroxy-labda-13E-en-19-oic acid (San 
Feliciano et al., 1992), sclareolic acid (San Feliciano et al., 1993), imbricatolic acid, 
imbricatalic acid (41), 15-methyl-imbricatalic acid, (+)-enantio-oliveric acid, cis-
communic acid and trans-communic acid (Tabacik and Laporthe, 1971; Pascual-
Teresa et al., 1978; Dawidar et al., 1991; Barrero et al., 2004). 
Tricyclic diterpenoids:  
A large number of the tricyclic diterpenes, exclusively abietane, labdane, and 
pimarane type, were isolated from the Juniperus species (Seca & Silva, 2007). The 
following diterpenes were isolated from the leaves and the fruits of J. phoenicea: 
sandaracopimaric acid (42), 3β-hydroxy-sandaracopimaric acid (43), pimaric acid 
(44), 3α-acetoxy-labda-8,13(16)-14-triene-19-oic acid (juniperexcelsic acid), 3α-
hydroxy-labda-8(17), 13(16)-14-triene-19-oic acid, 4-epi-abietic acid, 4-epi-abietol, 
dehydroabietic acid (45) and dihydroxyabieta-8,11,13-triene-1-one (San Feliciano et 
al., 1992; Comte et al., 1995; El Sawi & Motawe, 2008; Gonzáleza et al., 2010). 
Phenylpropane glycosides: 
Juniperoside was isolated from the acetone extract of the aerial parts of J. phoenicea. 
Two phenylpropanoids, junipetrioloside A (3-methoxy-4-hydroxy-phenylpropane-
7.8-(2′,1′-O-β-D-glucopyranosyl-7.8,9-triol) and junipetrioloside B (3-methoxy-4-O-
β-D-glucopyranosyl-phenylpropane-7,8,9-triol) were isolated from the MeOH extract 
of J. phoenicea aerial parts along with the rare compound, guaiacylglycerol (3-
29 
 
methoxy-4-hydroxy-phenylpropane-7,8,9,-triol) (Comte et al., 1997). Two 
norterpenoids were isolated from the aerial parts of J. phoenicea, which are 3-oxo-α-
ionol glucosides named junipeionoloside and 6-hydroxy-junipeionoloside & along 
with a known norterpenoid glucoside: roseoside, dearabinosyl pneumonanthoside and 
a sesquiterpenoid glucoside, dihydrophaseic acid 4'-O-β-D-glucopyranoside 
(Champavier et al., 1999). 
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Figure 1.5: Isolated compounds from J. phoenicea 
 
1.3.5.3  Previous biological work of J. phoenicea 
Various biological activities for J. phoenicea have been reported to date.  
Toxicity study  
The median lethal doses (LD50) of the total and successive extracts of J. phoenicea L. 
growing in Egypt revealed the safety of the plant. The leaf extract was less toxic than 
the fruit extract where their LD50 recorded 7.9 g. kg
−1 b.wt and 7.5 g. kg−1 b.wt, 





The antioxidant activity 
Antioxidant activity of this plant was determined using the ABTS radical-scavenging 
assay with the strongest antioxidant effect being found with the MeOH extract 
(Ennajar et al., 2009; Ennajar et al., 2010). Evaluation of fruit extracts of Turkish 
Juniperus species for their antioxidant, anticholinesterase, and antimicrobial activities 
revealed the effective inhibition of linoleic acid oxidation by the MeOH extract of J. 
phoenicea (Ozturk et al., 2011). 
The antimicrobial activity 
 J. phoenicea essential oils from different countries exhibited moderate antibacterial 
and antifungal activities (Stassi et al., 1996; Angioni, et al., 2003; El-Sawi, et al., 
2008; Derwich et al., 2010; Ennajar, et al., 2010; Mazari et al., 2010; Ait-Ouazzou, et 
al., 2012; Alzand et al., 2014).  Elmhdwi et al. (2015) demonstrated that the extracts 
from J. phoenicea had antibacterial activity against both Gram +ve and Gram -ve 
bacteria including multiple-drug-resistant (MDR) strains. This activity was attributed 
to the abundance of α-pinene and the overall chemical constituents of these extracts.  
 Accordingly, the Sardinian Juniperus essential oils and the isolated compound δ-3-
carene showed antimicrobial activity against fungi, particularly Aspergillus flavus, 
when tested on some foodborne pathogens and spoilage microorganisms (Cosentino, 
et al, 2003). Two studies were applied on the Algerian J. phoenicea essential oils, the 
first study was applied against five bacterial strains (three Gram +ve and two Gram -
ve), and 3 fungi and showed a moderate antibacterial and antifungal activities 
(Khadidja & Nassima, 2010). The second study was applied against nine bacterial 
strains, e.g., Enterobacter cloacae, E. coli, Pseudomonas syringae, Salmonella sp, 
Serratia liquefaciens S. marcescens, Shigella sp., S. aureus, S. aureus (MRSA). The 
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results showed that the Gram-ve bacteria were more resistant than the Gram+ve 
bacterial strains (Ramdani1 et al., 2013). The antiviral activities of fifty extracts 
prepared from fifteen species of Tunisian traditional medicinal plants (including the 
extract of J. phoenicea aerial parts) were tested against herpes simplex virus type 1 
(HSV-1). Only eight extracts showed some degree of antiviral activity where J. 
phoenicea did not exhibit any antiherpetic activity.  (Sassi, et al., 2008). Notably, the 
essential oils of J. phoenicea leaves and berries are grown in Egypt showed high 
activity against  A. flavus, Bacillus subtilis, Candida pseudotropicalis, E. coli, and S. 
aureus (El-Sawi et al., 2007). Another study was applied by Ennajar et al., 2010, 
showed that essential oils strongly inhibited the growth of Gram+ve microorganisms 
and Mucor ramamnianus, but was inactive against Gram-ve strains (Ennajar et al., 
2010). Lastly, the antimicrobial activity of Mentha pulegium, J. phoenicea and 
Cyperus longus essential oils from Morocco has been evaluated against seven bacterial 
strains of significant importance for food hygiene (four Gram +ve, S. aureus, 
Enterococcus faecium, Listeria monocytogenes and L. monocytogenes and three Gram 
-ve bacteria: Salmonella Enteritidis, E. coli and Pseudomonas aeruginosa). According 
to the results, M. pulegium showed the best bacteriostatic and bactericidal effect, 
followed by J. phoenicea and C. longos (Ait-Ouazzou et al., 2012).   
 
 The antidiarrhoeal activity 
The aqueous extract of J. phoenicea showed an antidiarrhoeal effect in vivo on 
experimental rat models of diarrhoea by reducing intestinal fluid accumulation and 






The cytotoxic activity  
The cytotoxicity of the abietane diterpenoids isolated from Moroccan J. phoenicea 
and J. thurifera was tested against five tumour cell lines (A-549, HCT-116, PSN1, 
SKBR3 and T98G cell lines) and one normal BAE-1 cell line. Three of the abietane 
derivatives showed cytotoxic activity at 2.5 µg/mL (Barrero et al., 2004).J. 
phoenicea extracts obtained using different pressures (200 and 300 bar) showed 
cytotoxic activity against different cell lines and were also active against a single-
stranded RNA+virus (Marongiu et al., 2004). The essential oils of J. phoenicea leaves 
and berries grown in Egypt showed high cytotoxic activities against brain and cervix 
human cell lines, while berry oil was slightly more active than leaf oil against lung, 
liver, and breast human cell lines (El-Sawi et al., 2007). 
The cytotoxic activity of the extracts of J. phoenicea fruits grown in Egypt against 
Erlich ascitis carcinoma was confined to petroleum ether extract, which was also 
highly active against three human tumour cell lines, namely, liver, lung, and breast 
carcinoma cell lines. Seven diterpenes were isolated from the petroleum ether fruit 
extracts together with β-sitosterol and tested against a human liver carcinoma cell line. 
Four diterpenes (sandaracopimaric acid, juniperexcelsic acid, 4-epi-abietic acid, 4-epi-
abietol) showed higher activity than cisplatin (El Sawi & Motawe, 2008).  
Cairnes & Ekundayo (1980) showed that the ethanolic extract of J. phoenicea twigs 
and leaves and two isolated compounds, desoxi-podophyllotoxin and p-peltatin-
methyl ether, were cytotoxic in the KB cell cultures (human cervix carcinoma). A 
MeOH extract of J. phoenicea from Saudi Arabia and Indonesia displayed high 
cytotoxicity in Vero (normal monkey kidney) and HEP-2 (human laryngeal 
carcinoma) cell lines (Latif et al., 2014). In addition, this plant was also displayed 
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significant cytotoxicity against both MCF7 (human breast adenocarcinoma) and HCT-
116 (human colon carcinoma) cell lines (Aljaiyash et al., 2014). 
1.4 The family Ericaceae 
                                                                                                                                              
The Ericaceae is represented by 124 genera and approximately 4250 species and it is 
considered the 14th species-rich family in the flowering planta (Stevens, 2001; 
Christenhusz & Byng, 2016). 
The botanical taxon of the family is classified as follows: 
Kingdom: Plantae 
Subkingdom: Tracheobionta (Vascular plants) 
Superdivision: Spermatophyta (seed plants) 
Division: Magnoliophyta (flowering plants) 
Class: Magnoliopsida- Dicotyledons 
Subclass: Dilleniidae 
Order: Ericales 
Family: Ericaceae –Health family 
The following are some genera from the Ericaceae family: Agarista, Andromeda, 
Arbutus, Arctostaphylos, Bejaria, Calluna, Cassiope, Chamaedaphne, Elliotia, Erica, 
Galtheria, Oxydendrum, Symphyia, and Zenobia (Kartesz et al., 2018).     
1.2.1 Traditional uses of the family Ericaceae 
Some members of Ericaceae family produce fleshy berries which are edible and 
commonly eaten fresh or dried. Traditionally some genera are used as antiseptic, 
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diuretics and laxatives and in the treatment of a headache, arterial hypertension, 
arthritis and urinary infections (Migue et al., 2014; Pavlović et al., 2014). 
1.4.2 The genus Arbutus L. 
The genus Arbutus L. belongs to the subfamily Arbutoideae or Vaccionioideae and 
the family Ericaceae or Arbuteae. It includes approximately twelve species; three are 
distributed in the Mediterranean region and Europe (A. andrachne, A. pavarii, and A. 
unedo), eight in America, mainly in Mexico (A. arizonica, A. glandulosa, A. Gray, A. 
madrensis, A. mollis, A. occidentalis, A. tessellate and A. xalapensis) and one in the 
Canary Islands (A. canariensis).  Arbutus pavarii Pampanini is a species endemic to 
Al-Jabal El-Akhdar on the Northeastern coast of Libya (González–Elizondo. et al., 
2012; Alsabri et al., 2013; Miguel et al., 2014). 
 
1.4.2.1  Active constituents in the genus Arbutus 
The phytochemical studies on the Arbutus Genus revealed the presence of many 
constituents such as flavonoids, irridoid glycosides, organic acids, phenolic 
compounds, tannins, sterols and triterpenes (Hasan et al., 2011). 
 
1.2.1.2  Traditional uses of the genus Arbutus 
The Arbutus species are cultivated as ornamental and food plants. The leaves and barks 
are traditionally used for treatment of cold and tuberculosis (Hasan et al, 2011). 
1.4.3 Arbutus pavarii Pamp. 
Arbutus pavarii (Figure 1.9) (Strawberry tree) is commonly known as “Shmeri’’. It is 
an evergreen shrub or a small tree that is recorded among endemic medicinal species 




Figure 1.6: Arbutus pavarii 
 
1.4.3.1  Traditional uses of A. pavarii 
A. pavarii has been used traditionally as a remedy for gastritis and kidney diseases 
(El-Darier & El-Mogaspi, 2009; Hasan et al., 2011; Louhaichi et al., 2011; Hegazy et 
al., 2013).  Berries are a good source of minerals, nutrients, carbohydrates, and 
antioxidants (due to high vitamin C contents). It is also used in honey production and 
as ornamental trees. The branches are used as a fuel, the leaves, fruits, and barks are 
used in tanning processes (Hasan et al., 2011; Alsabri et al., 2013). 
1.4.3.2  Previous phytochemical work of A. pavarii 
The phytochemical screening of A. pavarii revealed the presence of simple phenolics, 
polyphenolic such as flavonoids, tannins, glycosides, free reducing sugars, triterpenes, 
and sterols (Alsabri et al., 2013; Asheg et al., 2014) (Figure 1.7). 
Flavonoids 
Apigenin (47) epicatechin (48), hespiridin (49), querecetin (50), naringin (51), and 
rutin (52), were isolated from the A. pavarii aerial parts (El Hawary et al., 2016). The 
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MeOH extract of A. pavarii revealed total flavonoid contents 206.1-μg rutin 
equivalent/g.  HPLC analysis revealed that rutin (52) was the most abundant in A. 
pavarii MeOH extract (5096.13 ppm), whereas kaempferol was the least abundant 
flavonoid (2.20 ppm).  
Simple phenolics 
Arbutin (53), gallic acid (54), pyrogallol (55) are simple phenolic compounds, which 
were reported from the A. pavarii aerial parts (El Hawary et al., 2016). Assessment of 
the total phenolic contents of A. pavarii aerial parts was performed by HPLC. The 
MeOH extract of A. pavarii revealed total phenolic 163.6 μg gallic acid equivalent / 
g. HPLC analysis of the phenolic contents in the extract revealed that pyrogallol was 
the most abundant phenolic compound in A. pavarii MeOH extract (11041.9 ppm) 
while the least abundant phenolic was cinnamic acid (8.6 ppm) (El Hawary et al., 
2016).  
A study has been carried out recently on the aerial parts of A. pavarii. Work using high 
performance thin layer chromatography (HPTLC) showed a profile of constituents 
including arbutin, methyl gallate as the major phenolic components in the butanol 
fraction of A. pavarii (El Shibani, 2017) 
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Figure 1.7: Isolated compounds from A. pavarii 
                                     
1.4.3.3  Previous biological work of A. pavarii 
Few scientific studies have confirmed the traditional uses of A. pavarii. There are only 
a couple of studies that have provided evidence for the antioxidant, antimicrobial and 
antiproliferative activities of A. pavarii (Hasan et al., 2011; Alsabri et al., 2013; El 
Hawary et al., 2016).  
The antioxidant activity Alsabri et al. (2013)  carried out an antioxidant study on the 
aerial parts of A. pavarii. The antioxidant evaluation was performed using the 2,2, 
diphenyl-1-picrylhydrazyl (DPPH) assay. The results exhibited a potent antioxidant 
activity using both the MeOH and chloroform extracts with IC50 of 4.55±1.90 μg/mL 
and 21.55±1.1 μg/mL, respectively, while the n-hexane extract showed negative 
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results (Alsabri et al., 2013). In addition, the leaves of A. pavarii exhibited the highest 
antioxidant activity among three Libyan plants (Pegnanum harmal, Pistachia 
atlantica, and Fagonia bruguieri) with the highest content of flavonoids 
(1504.28±80.89 mg Rutin g-1), a relatively high phenolics content (1217.14±50.52 
mg GAE g-1) and significant free-radical-scavenging activity (Alghazeer et al., 2016). 
 
The antimicrobial activity 
The antimicrobial study was performed using the ethanolic extract of A. pavarii. The 
results revealed high activity against Pseudomonas areugenosa and some Gram +ve 
bacteria with low antifungal and antibacterial activity against most of the tested Gram 
-ve bacteria such as Klebsiella pneumonia and E. coli (Hasan et al., 2011).   
Moreover, an antimicrobial study was carried out by Alsabri et al. (2013) on the aerial 
parts of A. pavarii by using the agar well diffusion method. The MeOH extract showed 
an antimicrobial effect against S. aureus, E. coli and C. albicans with zones of 
inhibition of 20 mm, 18 mm and 21 mm and the (MICs) of 4.8 mg/mL, 9.30 mg/mL, 
and 4.76 mg/mL, respectively, using ciprofloxacin (MIC of 0.25 and 10 mg/mL, zones 
of inhibition of 24, 32 mm against S. aureus, E. coli ) and amphotericin B (MIC of 0. 
5 mg/mL, zone of inhibition of 22 mm against C. albicans) as positive controls.  
Another study by Alghazeer et al. (2016) showed the high growth inhibition capacity 
towards five bacterial strains: Staphylococcus aureus, Bacillus subtilis, Streptococcus 
faecalis, Escherichia coli, and Salmonella typhi. 
The cytotoxic activity 
A. pavarii phytochemical screening revealed the presence of simple and polyphenolic 
active compounds that have been documented to reduce the risk of cancer. The 
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antproliferative activity of the aerial parts of A. pavarii extracts (n-hexane, 
chloroform, and MeOH) on both lung carcinoma (A549) and breast adenocarcinoma 
(MCF7) cancer cells was evaluated by the MTT assay. The results were within the 
limits of the American National Cancer Institute for cytotoxic activity (less than 30 
μg/mL) (Alsabri et al., 2013).  Another cytotoxic study was undertaken by El Hawary 
on the MeOH extract of the aerial part of A. pavarii against the HEPG2 and T47D 
cancer cell lines. A. pavarii extract resulted in potential cytotoxicity on both types of 
cells with IC50 of 19.7±2.8 and 19±0.65 (μg/mL), respectively (El Hawary et al., 
2016). 
Miscellaneous 
A study was carried out using A. pavarii to determine its effect on performance and 
cecal coliform count of 1260 one-day-old male Cobb broiler chickens. The dietary 
treatments included a basal diet with no additive (control) and other dietary treatments 
with (A. pavarii) at the rate of 0.5 g and 1 g/kg of basal diet. The results revealed that 
A. pavarii had a significant effect on body performance of broiler chickens compared 
to the control. Coliform counts in the cecum of birds receiving 1% A. pavarii were 
significantly lower than those of control group from early weeks of treatments. These 
results emphasize the potential biotic role of A. pavarii together with the immune 








1.5   The family Rutaceae 
The Rutaceae family is commonly known as Rue or citrus family. It is a family of 
flowering plants, herbs, shrubs or trees. The leaves are simple or compound, alternate 
or opposite, gland-dotted, and exstipulate. Flowers are usually hermaphrodite and 
actinomorphic (Gunaydin & Savcib, 2005). The Rutaceae family is widely distributed 
throughout the tropical and temperate regions, especially in Australia, the 
Mediterranean region and South Africa (Roy& Rahman, 2016).    
1.5.1   Classification of the family Rutaceae 
The Rutaceae family is represented by 150 genera and approximately 1500 species 
and it is usually placed in the order Sapindales (Roy& Rahman, 2016). The following 
is the botanical taxon of the family:  
Kingdom: Plantae 
Subkingdom: Tracheobionta (Vascular plants) 
Superdivision: Spermatophyta (seed plants) 




Family: Rutaceae          {USDA, NRCS, 2017} 
The principal genera of this family are Citrus, Fortunella, Ptelea, Ruta, Murraya, and 
Zanthoxylum (Supabphol & Tangjitjareonkun, 2014). 
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1.5.2   Chemical characteristics of the family Rutaceae 
Most members of the Rutaceae family are aromatic plants due to the presence of a 
mixture of volatile aroma compounds concentrated in the leaves, fruits, and seeds of 
the plants (Supabphol & Tangjitjareonkun, 2014). The aromatic smell of these plants 
is due to the presence of a pellucid gland. 
Many publications reported the presence of different chemical constituents from the 
Rutaceae including alkaloids, coumarins, furanocoumarins, flavonoids and volatile 
oils (Lewis, 1983; Supabphol & Tangjitjareonkun, 2014). The most abundant 
alkaloids derived from this family are dictamnine (58), graveoline (60), kokusaginine 
(61) and skimmianine (62). Moreover, coumarins such as bergapten (63), psoralen 
(71), and xanthotoxin (70) are widely distributed in the plant kingdom and are present 
in notable amounts in the Rutaceae family (Kostova et al., 1999; Emam et al., 2010; 
Benazir et al., 2011; Adamska-Szewczyk et al., 2016). 
 
1.5.3   Traditional uses of the family Rutaceae 
The members of the Rutaceae family are potential sources of many medicinal 
substances and have been used traditionally in the treatment of insomnia, headaches, 
nervousness, bronchitis, stomatitis, menstrual problems, abortifacient, rheumatism, 
snake bites and also in perfume industry (Benazir et al., 2011; Adamska-Szewczyk et 
al., 2016). 
1.5.4   The genus Ruta 
The genus Ruta might include from eight to forty species. The most well-known 
species are R. graveolens, R. montana, R. chalepensis, subsp. latifolia and R. 
chalepensis subsp. Angustifolia (Zellagui et al., 2012). The three most distributed 
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species R. chalepensis L., R. graveolens L. and R. montana (L.) L. are 
morphologically similar (Zeichen de Sa et al., 2000). The genus is represented in 
Libya by two species: R. chalpensis L. and R. graveolens L. 
1.5.4.1  Active constituents in the Ruta genus 
The Ruta genus is rich in essential oils with variability in composition among species. 
2-Undecanone, nonanone, decanone are the most abundant essential oils of R. 
chalepensis L. from Greece, where the main component was found to be 2-methyl 
octyl acetate (44.0%). Additionally, thirty-six compounds were reported in the aerial 
parts of R. corsica, with 2-nonyl acetate (42.9%) as the major component. Moreover, 
R. montana from Tunisia yielded 5.51% of essential oils (Mejrib et al., 2010). The 
main factors, which influence the chemical composition of leaf essential oils, were the 
collection period, geographical origin and genetic structures (Zellagui et al., 2012; 
Bennaoum et al., 2017). 
1.2.1.2  Traditional uses of the genus Ruta 
The Ruta genus was used in the ancient Corpus Hippocraticum (the systematic record 
of the medical practice of the Mediterranean world), the collection of sixty-two 
documents written between the 5th century BCE and the 2nd century (Pollio et al., 
2008). The Ruta spp. was mainly administered by Hippocratic physicians as an 
abortifacient and emmenagogue and as a specific remedy against pulmonary diseases 
(Pollio et al., 2008). The ethnobotanist Paolo Maria Guarrera (Italy) listed more than 
hundred uses for the following species: R. angustifolia Pers., R. chalepensis L., R. 






1.5.5   Ruta chalepensis L. 
Ruta chalepensis (fringed rue) (Figure 1.11) is an ancient native Libyan medicinal 
herb of the Mediterranean region and is also found in many parts of the temperate and 
tropical countries in the world. The flowers are cymes with 4–5 sepals, 4–5 petals, 8–
10 stamens and a superior ovary. The oil glands are present in leaves, which have a 
strong deterrent odour (Gunaydin & Savcib, 2005; Gonzalez-Trujano et al., 2006).  
                 
                              
                                           Figure. 1.8:   Ruta chalepensis 
 
1.5.5.1  Traditional uses of R. chalepensis 
The medicinal value of R. chalepensis for the treatment of nervous disorders was 
recorded by Dioscorides. In Saudi Arabia, a decoction of R. chalepensis aerial parts is 
used as antipyretic, analgesic and for the treatment of rheumatism. R. chalepensis is 
also used traditionally in India for the treatment of rheumatism, menstrual disorders, 
dropsy, and neuralgia. In China, the roots are used as an antivenom and the leaves are 
infused with vinegar and used in the treatment of convulsions and other nervous 
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disorders in children (Gunaydin & Savci, 2005).  The Libyan R. chalepensis was used 
against rheumatic affections, ecchymosis and as a scorpion repellent and also for some 
dermatological diseases. It was also used in Libya as a contraceptive, an abortifacient, 
an emmenagogue for women, an anti-epileptic and as a tonic to new-born babies (De 
Natale and Pollio, 2008 & 2012). 
 
1.5.5.2  Previous phytochemical work of R. chalepensis 
Several phytochemical studies on R. chalepensis indicated that it is a valuable plant 
because of its composition (Gunaydin & Savci, 2005).  This plant produces alkaloids, 
coumarins, essential oil, flavonoids and tannins (Emam et al., 2010) (Figure 1.9). 
Alkaloids 
Phytochemical screening of R. chalepensis has shown the presence of many alkaloids 
such as arborinine (56), chaloridone (57), dictamnine (58), furoquinoline (59), 
graveoline (60), kokusaginine (61) and skimmianine (62) (Emam et al., 2010; 
Schmelzer & Gurib-Fakim, 2013).  
Coumarins 
The roots of R. chalepensis var. latqolia revealed the isolation of coumarins:  
bergapten (63), chalepin (64), chalepensin (65), daphnoretin (66), isopimpinellin (67), 
rutacultin (68), 1-hydroxy-N-methylfuroacridone, marmasin (69) and xanthatoxin 
(70) (Ulubelen & Güner, 1988). Phytochemical screening of R. chalepensis aerial 
parts revealed the presence of coumarins 63-66, 69, 70 and psoralen (71): (Emam et 






The characteristic odour of R. chalepensis and its essential oil is due to the compound 
methyl n-nonyl ketone (72). This compound was extracted (47.25% yield) from the 
volatile oil of R. chalepensis grown in Anatolia. The essential oil was obtained by 
steam distillation and investigated by using gas-liquid chromatography and further 
separation by column chromatography (Gunaydin & Savci, 2005).   
The volatile oils extracted from the flowers and leaves of R. chalepensis were found 
mostly to be dominated by ketone compounds, particularly 2-undecanone derivative 
(89.89 and 85.94 % of flowers and leaves oils, respectively) (Akkaria et al. 2015). 
Another study reported the domination of ketone constituents in the essential oil 
composition of R. chalepensis; 2-undecanon (48.28%) and 2-nonanon (27%) 
(Majdoub et al. 2014).  However, the analysis of R. chalepensis essential oils that were 
collected from the north of Tunisia showed qualitative and quantitative differences in 
their composition, depending on the parts used, the drying process and the duration of 
extraction. Thirteen major compounds were isolated during this study using GC–MS. 
The main components were 2-undecanone (77.18%), 2-decanone (8.96%) and 2-
dodecanone (2.37%). The ketone 2-Undecanone yielded 100% of R. chalepensis 
essential oil from the flowers. Camphor was identified exclusively in the essential oil 
of leaves (2.46%) while pulegone was identified only in the stem essential oil 
(32.11%) (Mejrib et al., 2010).         
Flavonoids 
Phytochemical screening of R. chalepensis has shown the presence of flavonoids, rutin 




Shikimic acid derivatives 
 Two shikimic acid derivatives were also obtained from the chloroform extract of R. 
chalepensis aerial parts: moskachan D (74) and dehydromoskachan C (75). (Ulubelen 
































Compound No. R1 R2 R3 R4 
63 H -OCH3 H H 
64 H H -C(CH3)2-CH-CH2 -C(CH3)2(OH) 
65 H H -C(CH3)2-CH-CH2 H 
67 -OCH3 -OCH3 H H 
70 -OCH3 H H H 
71 H H H H 
 
                                                                                                                
Compound No. R 
74 (CH2)4CHOH-CH2 
75 (CH2) CH=CH2 
 
Figure 1.9: Isolated compounds from R. chalepensis 
1.5.5.3  Previous biological work of R. chalepensis 
Different biological activities have been associated with the Rutaceae family, for 
example, antimicrobial (Ali et al., 2008; SSSA et al., 2010), antidiarrhoeal (Mandal 
et al., 2010), anticholinesterasic (Cardoso-Lopes, 2010), antileishmanial (Carlos 
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Andres et al., 2011), antiprotozoal (Severino et al., 2009), larvicidal (Rajkumar & 
Jebanesan, 2008; Emam et al., 2009) and antioxidant activities (Wansi et al., 2006). 
The analgesic antipyretic, anti-inflammatory activity 
R. chalepensis aerial parts were studied for their analgesic, antipyretic and anti-
inflammatory activities. The ethanolic extract did not show any analgesic activity 
using the hot plate reaction-time test in mice. However, it produced a significant 
inhibition of cotton pellet granuloma and carrageenan-induced paw oedema in the 
mice and in rats. The reputed antipyretic activity was tested by the reduction of yeast-
induced hyperthermia in mice (Al-Said et al., 1990). 
The central nervous system depressant activity (CNS) 
R. chalepensis aerial parts were studied for their CNS depressant activity. The 
spontaneous motor activity in mice and conditioned avoidance responding (CAR) in 
rats revealed a dose-dependent depression of the central nervous system in treated 
animals (Al-Said et al., 1990). 
The antifertility activity 
The antifertility activity of R. chalepensis and R. chalepensis var. latifolia was carried 
out on female rats (Zeichen et al., 2000). Some species from the Rutaceae are reputed 
to possess such an activity, for instance, R. graveolens, which is a close congener of 
R. chalepensis (Ulubelen et al., 1986) and has been used as an abortifacient and 
emmenagogue (Kong et al., 1989). Alkaloids and coumarins were isolated from the 
R. chalepensis and R. chalepensis var. latifolia to find the source of activity. 
Coumarins such as chalepin (64), and xanthotoxin (70) exhibited antifertility effect, 
with the development of cystic and atretic follicles in the ovaries of female rats as well 
as glomerulocapsular adhesion in the kidneys. Alkaloids such as arboririne (56), 
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fagarine, graveoline (60), kokusaginine (61) and skimmianine (62) did not show any 
antifertility activity (Ulubelen et al. 1994). Infusions of R. chalepensis leaves were 
administered orally at doses of 0.16, 0.80-and1.60 g/kg/ day during the organogenic 
period in pregnant mice. The results revealed perinatal and histological changes in 
placenta and foetuses, which confirmed the toxic effect of R. chalepensis on the 
embryo (Zeichen et al., 2000).  
The antioxidant activity 
The ethanol and aqueous extracts of R. chalepensis collected from Bejaia region in 
Algeria were investigated in vitro for their antioxidant activity. The phenolic 
compounds composition of the extracts was separated by HPLC-UV. The antioxidant 
activity was assessed by the scavenging activity of DPPH (2,2-diphenyl-2-
picrylhydrazyl). R. chalepensis ethanol extract of was found to have a higher amount 
of total phenolics (72. 08 ± 1.94 mg), flavonoids (31.90 ± 2.12) and flavonols (13.22 
± 0.86 mg) compared to the aqueous extract, which had total amounts of phenolics of 
39.71 ± 0.22 mg, flavonoids of 1.96 ± 0.12 mg and flavonols of 3.00 ± 0.2586 mg.  
The ethanol extract also showed potent antioxidant activity (IC50 = 51.18 ± 1, 14 
μg/mL) and a high reducing power (IC50 = 660 ± 8, 3 μg/mL). This study suggests 
that R. chalepensis could be used as a promising source of natural antioxidant agents 
and as an encouragement for the isolation of more bioactive and phenolic compounds 
(Terkmane et al., 2017).  
A study was undertaken in Tunisia on the MeOH and aqueous extracts of R. 
chalepensis aerial parts to investigate the antioxidant activity of the plant using DPPH 
and ABTS assays. Both extracts exhibited high antioxidant activity with IC50 values 
of 54.1±1.5 and 73.6±2.6 µg/ml, respectively, for DPPH assay. Likewise, the results 
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showed high antioxidant against the ABTS˙+ radical 92.4 % and 87.5% at the highest 
concentration of 3 mg/mL.  R. chalepensis exhibited potent antioxidant activities, 
which could be well correlated with the phenolic and flavonoid contents of this plant 
(Ben Sghaier et al., 2018). 
The antimicrobial activity 
Two quinoline alkaloids (2-{6′-(2H-benzo[d]1′′,3′′-dioxolen-5′′-yl)hexyl}-
hydroquinolin-4-one and 2-{6′-(2Hbenzo[d]1′′,3′′-dioxolen-5′′-yl)hexyl}-4-methoxy-
quinoline and nine other alkaloids, dictamnine (58), pteleine, skimmianine (62), 
rutacridone, isogravacridonechlorine, maculosidine, graveoline (60), graveolinine, 
and 4-methoxy-1-methyl-2(1H)-quinolinone, and coumarins, chalepensin (65) and 
umbelliferone, were isolated from R. chalepensis roots collected from the Saudi 
desert. All the isolated compounds were tested for their antimicrobial activity against 
a wide range of microorganisms, using a modified microtiter-plate method. The 
furoquinoline alkaloid, pteleine showed moderate antimicrobial activity by inhibiting 
the growth of Mycobacterium smegmatis, Bacillus subtilis, S. aureus and C. albicans, 
with an MIC range of 50-100 µg/ mL, while moskachan C (75), dictamnine (58), 
skimmianine (62) and isogravacridone chlorine were less active (MIC 100 µg/ mL) 
against M. smegmatis and B. subtilis and inactive against the other microorganisms 
(El Sayed et al., 2000). 
Another antimicrobial study was carried out by Emam (2010), to investigate the 
antifungal activity of compounds from the chloroform layer of R. chalepensis leaves. 
This work yielded the new furanoalkaloid quinolone 5-(1ʹ, 1ʹ-dimethylallyl)-8-
hydroxyfuroquinoline as well as, biscoumarin daphnoretin. The antifungal activity of 
the isolated compounds was evaluated against the three fungi; Rhizoctonia solani, 
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Sclerotium rolfsii, and Fusarium solani, a phytopathogenic types of fungi, which 
affect some crops e.g., potato, sugar beet and tomato crops. The results showed a 
decrease in the germination percentage (G %) of R. solani and S. rolfsii sclerotia. This 
decrease in the germination was enhanced by the increase in the concentration of the 
two compounds. Biscoumarin daphnoretin exhibited stronger inhibition of S. rolfsii 
sclerotia (79.83%, 83.7%, and 88%) whereas lower inhibition in the range of 70.03%, 
76.7%, and 70.7% was shown by the furanoalkaloid quinolone for R. solani, S. rolfsii, 
and F. solani, respectively, at a concentration of 20 μg/mL. However, S. rolfsii was 
found to be more sensitive to both compounds than the fungus R. solani (Emam et al., 
2010).  
The antibacterial activities of the ethanol, acetone and aqueous extracts of R. 
chalepensis collected from Eritrea were investigated against S. aureus and E. coli 
using the disc diffusion method and minimum inhibitory concentration assays. The 
acetone extract of R. chalpensis exhibited the maximum growth inhibition (8.5 mm) 
against E. coli while the ethanol extract showed the maximum growth inhibition 
against S. aureus (8 mm) (Babu-Kasimala et al., 2014). 
The Cytotoxic activity 
The cytotoxicity of MeOH extract of R. chalepensis aerial parts was evaluated against 
three cell lines (human bladder carcinoma RT112, human laryngeal carcinoma Hep2 
and human myelogenous leukaemia K562). R. chalepensis extract showed dose 
dependant cytotoxic activity, when incubated with the three tumour cell lines (ranging 
from 2.53 ± 0.21 to 133.05 mg/L) and did not show any activity on the normal human 
cells PBMC (Khlifia et al., 2013). Another cytotoxic study on T-leukaemic cells and 
lymphoblast cancer cells and normal blood cells was carried out on the ethanol extract 
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of R. chalepensis collected from Algeria using the MTT assay. The results revealed a 
high cytotoxic effect of the extract on the blood cancer cells but no effect on the normal 
blood cells (Terkmane et al., 2017).  These results of the last two studies suggest that 
R. chalepensis might be a potential source of a novel pharmaceutical agent for 
treatment of cancer and further investigations should be carried out to isolate bioactive 
compounds from this plant.  
The pesticidal activity 
A bioassay-guided insecticidal study was undertaken on R. chalepensis leaves. The 
aqueous ethanol extract has revealed larvicidal and antifeedant activities against the 
larvae Spodoptera littoralis (Boised). The study involved the isolation of some 
compounds from the ethanol extract that might be responsible for the larvicidal and 
antifeedant activities. This study resulted in the separation of two different alkaloidal 
compounds, which were characterized as rutamine and 3 (2″,2″dimethyl butenyl) 3′-
hydroxy di-hydrofuropsoralen that were responsible for larvicidal and antifeedant 
activities against S. littoralis larvae with LC50 of 1.598, 1.215 mg/mL (Emam et al., 
2009).  Accordingly, the volatile oils extracted from the flowers and leaves of R. 
chalepensis exhibited significant insecticidal and anthelmintic activity against third 
and fourth instars larvae of Orgyia trigotephras compared with the chemical standard 
insecticide delta-metrine and the reference anthelmintic drug albendazole.The flowers 
oil of R. chalepensis at a concentration of 0.5% showed higher activity than the leaves 
oil on the third instar larvae with a mean mortality time (MMT) of 1.40 min and 1.27 
min, respectively. The MMT of the fourth instar larvae was found to be 42.53min for 
the oil form the flowers and 20.68 min for the oil from the leaves. The anthelmintic 
effects against Haemonchus contortus worm in sheep were measured by egg hatching 
and inhibition of worm motility, when compared with the reference drug albendazole. 
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Both essential oils exhibited ovicidal activity at all the tested concentrations (0.125, 
0.25, 0.5 and 1 mg/mL). The leaves volatile oil had higher inhibitory effects on egg 
hatching than flowers volatile oil with IC50 = 0.145 mg/mL and IC50 = 0.398 mg/mL, 
respectively. The chemical composition study showed that the essential oils samples 
were mostly dominated by ketone compounds, particularly 2-undecanone derivative 
(89.89 and 85.94 % of flowers and leaves oils, respectively). It was found that 2-
undecanone might be a potential constituent for the insecticidal and anthelmintic 
constituent of R. chalepensis volatile oil (Ntalli et al., 2011; Akkaria et al., 2015). 
The essential oil of R. chalepensis showed insecticidal activity against both the adults 
and larvae Tribolium castaneum (a stored product pest). The results showed higher 
activity against adults (LC50 = 176.075 µL/L air and LC90 = 291.9 µL/L air) than larvae 
(LC50 = 415.348 µL/L air and LC90 = 685.907 µL/L air).  These R. chalepensis results 
are promising and might have future potential use in the food storage industry 
(Majdoub et al. 2014). The efficacy of MeOH extract of R. chalepensis aerial parts 
was evaluated against Culex pipiens larvae. The larvicidal activity of R. chalepensis 
proved to be effective against C. pipiens larvae without any human or animal risk 
(Abdel-Sattar et al., 2014).  
1.6   Objectives of this study 
i. The main objectives of this study were to: obtain crude extracts from a 
selection of four Libyan medicinal plants: Arbutus pavarii, Asphodelus 
aestivus, Juniperus phoenicea and Ruta chalepensis by Soxhlet extraction 
using various solvents of different polarities; 
ii. carry out a systematic, bioassay-guided phytochemical and 
cytotoxic/anticancer study on the different crude extracts and assess 
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quantitative bioactivity and cytotoxicity of the purified compounds using 
the 3-(4,5-dimethyl thiazolyl-2)-25-diphenyltetrazolium bromide (MTT) 
assay; 
iii. isolate and identify bioactive molecules with potential anticancer and/or 




























2.0 Materials and Methods 
2.1 Phytochemical work 
2.1.1 General materials 
The chemicals, solvents and materials used in the phytochemical work are illustrated 
in Table 2.1 
Table 2.1: Chemicals, solvents and materials  
Chemicals, solvents and materials Manufacturer 
n-Hexane Fisher Scientific 
Dichloromethane Fisher Scientific 
Methanol Fisher Scientific 
Ethyl acetate Fisher Scientific 
SPE cartridge (Strata)® Phenomenex 
Silica gel for column Fluka® 
Silica TLC plates Merck® 
Silica gel for VLC Merck® 
 
2.1.2 Plant materials 
Four Libyan medicinal plants were collected from different sites from Libya between 
2013-2016. Specimens from these plants were identified based on the Flora of Libya 
at the Faculty of Science Herbarium, Tripoli-Libya, and a voucher specimens numbers 
have been retained there (Table 2.2). All parts used were air-dried, powdered and kept 
in a tightly closed amber coloured container. 
Table 2.2: The Libyan medicinal plants used in this study 
Plant Name Site Collection Year Voucher Number 
Juniperus phoenicea L. Al-Bydaa city 2013 D68122 
Asphodelus aestivus Brot. Tarhona city 2014 D6857302 
Arbutus pavarii Pamp. Al-Jabal Al Akhdar 2016 D6854201 




2.1.3 Extraction of plant materials 
The different parts (dried and ground) of the four plants (Table 2.3) were separately 
extracted by Soxhlet, sequentially, with n-hexane, DCM, and MeOH (800 mL each).  
Ten cycles were allowed for each extraction at temperatures near the boiling point of 
the solvents. All extracts were filtered, evaporated to dryness in a rotary evaporator 
(Cole-Parmer) ® and finally stored at 4°C.   
Table 2.3: The weights of different dried and ground parts of the four Libyan 
medicinal plants 
Plant Name Part Used Weight (g) 
A. pavarii Leaves 150 
A. aestivus Leaves 208.5 
Tubers 159.3 
J. phoenicea Leaves 86.5 
R. chalepensis Aerial parts 138.6 
 
2.1.4 Fractionation techniques 
The different crude extracts of the four plants were initially fractionated into various 
discrete fractions using solid-phase extraction (SPE) for any MeOH extracts and 
vacuum liquid chromatography (VLC) for any n-hexane or DCM extracts. 
2.1.4.1  Solid phase extraction (SPE)  
Portions of the polar MeOH extracts of the four plants were pre-HPLC fractionated 
using the SPE technique. An SPE cartridge (20 g), which was pre-packed with 
reversed-phase silica C18 was used as described by Sarker et al. (2005). The SPE 
cartridge was connected to a vacuum flask with an appropriate adapter, pre-rinsed by 
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flushing with 50 mL of MeOH followed by 100 mL of water.  Each MeOH extract 
was dissolved in 10% MeOH in water and was loaded onto the SPE cartridge. A Step 
gradient protocol was applied successively with 200 mL each of 20%, 50% and 80% 
MeOH in water, and finally 100% MeOH.  Four fractions were collected from each 
plant, dried by rotary evaporator and freeze dryer techniques and kept to be used for 
separation by HPLC (Sarker et al., 2005). 
2.1.4.2  Vacuum liquid chromatography (VLC) 
VLC was carried out as described by Sarker et al. (2005). Portions of the non-polar 
extracts (n-hexane and DCM extracts) of the four plants were further fractionated by 
VLC where vacuum was used to achieve a compact packing of the column and to 
increase the flow rate of the mobile phase.  In this method, the column was a Büchner 
funnel with a medium-porosity fritted glass disk with a piece of filter paper fitted flat 
into the bottom. The stationary phase was then poured (TLC-grade silica gel, 60 H). 
The funnel was then placed on the top of a vacuum flask fitted with a rubber vacuum 
seal and a vacuum applied to immobilise the stationary phase (Sarker et al., 2005). 
The column was pre-equilibrated with the first solvent in the elution series. Enough 
volumes of solvent were added through the column to wet the column thoroughly.  
Vacuum was released each time before the column dried and the wash solvent was 
then poured off.           
Step gradient elution was carried out using n-hexane- EtOAc mixtures (200 mL) of 
increasing polarity (100% n-hexane, 20% EtOAc/n-hexane; 40% EtOAc/n-hexane; 
60% EtOAc/n-hexane; 80% EtOAc /n-hexane; 100% EtOAc; 50% MeOH/ EtOAc). 
Similarly, the DCM extracts were fractionated by VLC on silica gel, starting elution 
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with n-hexane-DCM mixtures, and then increasing polarity with MeOH to yield seven 
fractions, which were dried by rotary evaporator and stored for further evaluation on 
cultured cells using the MTT assay. 
2.1.5 Chromatographic techniques 
Different chromatographic techniques were further applied for screening and 
separation of pure compounds from the extracts and fractions. These techniques were:   
2.1.5.1  Thin layer chromatography (TLC) 
Silica TLC plates (200 mm x 200 mm x 0.25 mm) were used for preliminary screening 
and separation of compounds. 
Analytical thin layer chromatography 
The lipophilic portions were preliminarily screened for the identification and 
verification of the purity of isolated compounds using different proportions of 
different mobile phases, for instance: EtOAc: n-hexane, MeOH/DCM and toluene: 
EtOAc: acetic acid (TEA), to achieve the best separation of pure compounds. 
Preparative thin layer chromatography (PTLC) 
The lipophilic portions were further purified using the PTLC technique. Thin bands 
(10-20 mg /mL) of the extracts or fractions to be purified were applied to the silica gel 
plates using capillary tubes. The plates were developed in a suitable freshly prepared 
solvent system. Single or multiple developments were employed to achieve a 
satisfactory separation.  
Detection (location of compounds on chromatograms) 
The three extracts, as well as the isolated pure compounds, were shown under short 
UV (254 nm) and long UV (366 nm).  The separated compounds were detected by 
observing the plates under UV light then spraying with different reagents. 
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Anisaldehyde spray reagent for detection of the different types of compounds was 
colour specific for various classes of compound.  For instance, flavonoids (yellow 
colour), glycosides (violet colour), tannins (dark brown colour at the bottom of the 
plate), sesquiterpenes (phosphorous green colour) and diterpenes (violet colour).  The 
plates were heated at 100oC for 5 min or until coloration appears (Houssen & Jaspars, 
1998; Sarker et al., 2005). Dragendorff's reagent was used for the detection of 
alkaloids and heterocyclic nitrogen-containing compounds (orange, dark brown 
colour) (Houssen & Jaspars, 1998; Sarker et al., 2005).  Qualitative DPPH assay was 
sometimes performed by spraying a developed TLC plate with a DPPH solution (80 
µg/mL) and a colour change was observed, from purple to yellow, on certain spots. 
This colour change showed that the stable free-radical DPPH can be reduced by some 
extracted phytochemicals, which therefore may act as free-radical scavengers (Sarker 
& Nahar, 2012). 
 
2.1.5.2  Column liquid chromatography (CLC) 
Normal column chromatography 
Column chromatography (CLC) (15 x 2.5, 35 x 2.5 cm) was used for separation of 
pure compounds from both n-hexane and DCM fractions obtained from VLC, using 
silica gel as an adsorbent (60 A, 70-230 mesh, 63-200 µm).  Preparation of column 
was carried out by using the wet method; the adsorbent was mixed well with solvent 
(n-hexane) creating a slurry, this was immediately poured into a sintered-glass column 
and allowed to settle by gentle tapping and washing with the solvent. The lipophilic 
fractions were mixed separately with silica gel and EtOAc in an alternative way to get 
freely loose powders.  The powder was applied on the surface of the adsorbent and 
elution was performed with a gradient system of EtOAc: n-hexane (0%, 2%, 4%, 6% 
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and so on) as a mobile phase (52 mL each).  Four mL fractions were collected in 13 
test tubes each time. The collection of a large number of small portions improved the 
probability that each fraction may contain a pure compound, which may require 
significant work in the analysis of each fraction (Sarker & Nahar, 2012). 
High-performance liquid chromatography (HPLC) 
Reversed-phase HPLC was used in this study for both screening and isolation of 
compounds.  The stationary phase in reversed-phase HPLC is non-polar, and the 
eluent is polar. The mobile phase comprises mixtures of water and organic solvents 
(or modifiers).  Other additives, such as buffers, acids, bases, and ion-pair reagents 
may be incorporated into the eluting solvent.  In this study 0.1%, TFA was added to 
all solvents used to help in sharpening the separated peaks. The organic solvents most 
commonly used in reverse phase HPLC are acetonitrile, MeOH and tetrahydrofuran 
(THF). Solutes tend to elute in order of increasing hydrophobicity, and elution is 
speeded up by increasing the proportion of organic modifier in the eluent. The yields 
were based on peak areas of the HPLC chromatogram (Kaushal & Srivastava 2010). 
Analytical HPLC 
All the MeOH extracts and the SPE fractions (F1- F4) were analytically screened by 
analytical reversed-phase HPLC (Dionex Ultimate 3000 UPLC). The Dionex HPLC 
is coupled with an autosampler, degasser, a photodiode array detector, and a computer 
with control and data analysis software (Chromeleon 7).  Thermo Scientific™ 
Hypersil GOLD™ C18 column (150 mm x 4.6 mm, 5 mm), which connected to a 
guard column.  The volume of injection used for analytical screening was 10-20 μL 
with a flow rate of 1 mL/min. This screening provided significant information on the 
types of compounds present, based on their retention times and their UV spectra. 
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Semi-preparative and preparative HPLC 
The SPE fractions (F1- F4) of the MeOH extracts were dissolved in MeOH to achieve 
a concentration of 10 mg/mL. The fractions were then separated by semi-preparative 
and preparative reversed-phase HPLC using modular HPLC Systems (Agilent 
Technologies, 1200 Series), with a binary gradient pump, photodiode array detector 
and computer with control and data analysis software.  In the semi-preparative 
isolation of compounds, a Phenomenex LC-18 stainless steel column (150 mm x 10 
mm) was used for separation of small amounts of fractions with a volume of injection 
of 120 -200 μL using a flow rate of 2 mL/min. For the isolation of large amounts of 
fractions, a preparative Phenomenex LC-18 stainless steel column 150 mm x 21.2 mm 
connected to a guard column was used and a larger injection volume of 900 μL and a 
higher flow rate of 10 mL/min were also used. 
 
2.1.6 Spectroscopic techniques 
The following spectroscopic techniques were used for the structure elucidation of our 
isolated pure compounds. 
2.1.6.1  Ultraviolet-visible spectroscopy (UV-Vis) 
Ultraviolet (UV) spectra of the isolated compounds were obtained in methanol using 
WinAspect Plus, Specord® 210 Plus UV-Vis spectrometer.    
2.1.6.2  Mass spectrometry (MS) 
Mass spectrometry has played an essential role in the structure elucidation of isolated 
compounds from natural products due to its high sensitivity (microgram amounts of 
compounds can be detected) and because nominal molecular weight can be used as a 
search query in nearly all databases (Houssen & Jaspars, 1998). It is used to determine 
the molecular weights of compounds where the molecular ions or fragments are 
65 
 
formed with sufficient excitation energy and the relative abundances of these 
fragments usually are unique to the structure of the molecular ion. The mass-to-charge 
ratio (m/z) of the resulting molecular ions, fragmentation reactions, the types of 
functional groups, as well as the manner in, which they are joined to form a unique 
molecular structure, will help to deduce structure from the mass spectrum. Molecules 
that cannot be ionized will not be detected (Smith et al., 1991).  
HPLC-MS is a hyphenated technique, which combines chromatographic (LC) with 
spectral methods (MS) to exploit the advantages of both.  Chromatography produces 
pure or nearly pure fractions of chemical components in a mixture. Spectroscopy 
delivers particular information for identification using standards or library spectra 
( Phonde & Magdum, 2015). In this study, all the isolated pure compounds were sent 
to the EPSRC National Mass Spectroscopy Service (NMSS), Swansea, for the MS 
experiments to be carried out. Mass spectroscopic analyses were performed on a 
Finnigan MAT 95 spectrometer, GCT Premier, GCT Premier GC/MS and LTQ 
Orbitrap XL1. 
LC-MS, Alliance system 2695 (Waters) was applied on the J. phoenicea crude extracts 
and the MeOH F4 of A. aestivus tubers o detect any tentative compounds using 
electrospray ionization (ESI).  A Phenomonex HPLC column C18 (150 x 4.6) was used 
with a flow rate of 1 mL/min and a gradient of (10-100 % ACN/ H2O) for 30 min and 
hold for 10 min. Using LC-MS-MS, some molecular ions are separated and subjected 
to a second fragmentation. The fragmentation pattern produced can give a lot of 
daughter peaks, which may help to get information about the parent structure ( Phonde 





2.1.6.3 Nuclear magnetic resonance (NMR) 
Nuclear Magnetic Resonance (NMR) spectroscopy is a technique which is based on the 
interaction of radio frequency (RF) of the electromagnetic radiation (EMR) with unpaired 
nuclear spins. It revealed information on the number and types of protons (hydrogen) and 
carbons in the molecule and their relationships and other nuclei such as:  9F, 35Cl, 31P etc. 
(Pretsch, 1997; Tesso, 2005). 
The NMR experiments used can be classified into two major categories:     
2.1.6.3.1 One dimensional technique   
In one-dimensional NMR (1D-NMR), the conventional NMR spectrum are plots of 
frequency vs intensity, the chemical shifts and couplings are displayed on the same 
frequency axis (e.g. ¹H NMR, ¹³C NMR, ¹³C DEPT) (Williams and Fleming., 1989; Balci, 
2005). 
1H NMR (Proton NMR) technique 
Proton NMR is a plot of peak intensity signals arising by the different protons in a 
compound which is measured in parts per million (0-10 ppm).  The area under the peaks 
revealed information regarding the protons number in the molecule, the signals position 
(chemical shift) describes the chemical and electronic environment of the protons, and the 
spin-spin splitting pattern provided information about the neighboring number of protons 
(vicinal or geminal) (Williams and Fleming, 1989; Balci, 2005).   
¹³C NMR technique                                                                                                         
The comparison of the natural abundance of 13C and 1H nuclei clearly indicates that the ^H 
nucleus is approximately 100 times more sensitive than that of 13C (Balci, 2005).   
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The 13C chemical shift ranges (0-200 ppm) for organic compounds is a plot of signals arising 
from the different carbons (13C) in the molecule and can be identified by their characteristic 
shift values in the 13C NMR spectra. The ¹³C NMR signals normally appeared as singlets in 
the experiments because of the decoupling of the attached protons (Breitmaier, 2002).   
DEPT technique   
The distortionLess enhancement by polarization transfer (DEPT) is an important NMR 
technique for determining the number of hydrogens attached to a given carbon atom to 
differentiate between CH, CH2 and CH3 (Breitmaier, 2002).   
2.1.6.3.2 Two-dimensional techniques   
Two-dimensional NMR (2D-NMR) spectroscopy may be defined as a spectral method in 
which the data are collected in two different time domains (X-Y co-ordinate axes). 2D-
NMR are used to determine the structure of more complicated molecules (Pretsch and Clerc, 
1997).  In the case of 2-D NMR, the X-Y co-ordinate axes can be two frequency domains, 
and the observed signals are in the third dimension eg. ¹H-¹H COSY, ¹H-¹H NOESY, ¹H-
¹³C HMBC and ¹H -¹³C HMQC (Kessler et al., 1988; Rahman and Choudhary, 1996).  
a) The Homonuclear correlated spectroscopy 
H-H COSY technique     
¹H-¹H Correlation spectroscopy is a homonuclear HH coupling in which the chemical shift 
range of the proton spectrum is plotted on both dimensions which has square symmetry 






H-H NOESY technique    
The Nuclear Over Hauser Enhancement Spectroscopy is a useful technique to traces out the 
groups that are close in space in larger molecules, so that the nucleus irradiation detect the 
other nuclei by its resonance frequency (Williams and Fleming, 1989; Breitmaier, 2002).  
b) The Heteronuclear correlated spectroscopy 
HSQC: Heteronuclear single quantum coherence is the 1H-13C correlation via one-bond 
coupling (Breitmaier, 2002). 
HMBC: Heteronuclear multiple bond correlation is the 1H-13C correlation via long-range 
coupling between proton and carbon (two or three bonds away) with great sensitivity. 
HMBC is a very useful technique for assigning complex structures (Kessler et al., 1988; 
Breitmaier, 2002). 
In this study, crude extracts and pure compounds were subjected to NMR analysis at 300 
MHz or 600 MHz (Ultra shield Bruker AMX 300 & 600 NMR spectrometers). NMR sample 
tubes (Wilmad) ®, OD: 5 mm, length: 7 inches, glass A material) and NMR solvents 
(Cambridge Isotope Laboratories (CIL) Inc.) were used to apply the samples of pure 
compounds. Despite the complex composition of the crude extracts, NMR spectra help to 
show the occurrence of secondary metabolites. For instance, aromatics, fatty acid esters, 
peptides, phenolics, steroids, sugars and terpenoids, functional groups such as –CHO, –NH, 
–OH, or –OMe. This tentative elucidation indicates the presence of the most abundant 
compound (s) or class of compounds in the extract. This information will help in the 
decision of whether the chromatographic separation should be either over normal or 
reversed phase chromatography, or size-exclusion chromatography (Gray et al., 2012).   
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2.1.7 Isolation of compounds 
The techniques used for fractionation of extracts and separation of pure compounds from A. pavarii leaves, A. aestivus leaves and tubers, J. 
phoenicea leaves and R. chalepensis aerial parts are summarized in Table 2.4.  
Table 2.4: Isolation of compounds from the four Libyan medicinal plants under study 
Plant Extract Wt (g) Fractionation 
Technique 





MeOH 1.45 SPE 30, 50, 80 and 100% MeOH / 
H2O 
Prep-HPLC F1 and F2 (30- 100 % MeOH/ H2O) 
F3 and F4 (50-100% MeOH/ H2O) 
DCM 2.4 VLC 0, 5, 10, 30, 50, 80 and 100% 
EtOAc/ n-hexane and 50% 
MeOH / EtOAc 
Prep-HPLC 50-100% gradient of ACN/H2O. 
n-Hexane  Not 
fractionated 
Not fractionated Not isolated Not isolated 
A. aestivus 
leaves 
MeOH 1.8 SPE 30, 50, 80 and 100% MeOH / 
H2O 
Prep-HPLC 30- 100 % MeOH/ H2O 
DCM 0.5 Not 
fractionated 
Not fractionated Prep-HPLC Different gradients of ACN/ H2O 
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n-Hexane  Not 
fractionated 
Not fractionated Not isolated Not isolated 
A. aestivus. 
tubers 
MeOH  1.33 Not 
fractionated 
Not fractionated Prep-HPLC 30- 100 % ACN/ H2O every 5 min. 
DCM 1.86 VLC 
 
0, 10, 30, 50, 80 and 100% 
EtOAc / n-hexane and 50% 
MeOH / EtOAc 
Prep-HPLC Different gradients of ACN/ H2O 
n-Hexane  Not 
fractionated 
Not isolated Not isolated Not fractionated 
J. phoenicea 
leaves 
MeOH  1.4 SPE 30, 50, 80 and 100% MeOH / 
H2O 
Prep-HPLC F1 and F2 (30- 100 % MeOH/ H2O) 
F3 and F4 50-100% MeOH/ H2O 
DCM 1.29 VLC 
 
0, 50, 100% DCM / n-hexane, 
10, 20, 30 and 50% MeOH/ 
DCM. 
Prep-HPLC 50-100% gradient of ACN/H2O 
n- Hexane 2.6 VLC 0, 5, 10, 30, 50, 80 and 100% 
EtOAc / n-hexane and 50% 
MeOH / EtOAc 
CLC 
PTLC 
gradient system of EtOAc: n-hexane 
R. chalepensis 
aerial parts 
MeOH  3.0 SPE 20, 50, 80 and 100% MeOH / 
H2O  
Prep-HPLC F1 and F2 30- 100 % MeOH/ H2O 
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F3 and F4 50-100% MeOH/ H2O 
DCM 2.05 VLC 
    
0%, 50% and 100% DCM/ n-






Different gradients of the following 
mobile phases: 
1. EtOAc: n-hexane  
2. Toluene: EtOAc: acetic acid 
(TEA) 
Different gradients of ACN/ H2O. 
n-Hexane 3.26 VLC 0- 100% EtOAc / n-hexane and 
50% MeOH / EtOAc 
PTLC Different gradients of the following 
mobile phases: 
1. EtOAc: n-hexane  
2. MeOH/ DCM. 






2.2 Bioassays for potential cytotoxic/anticancer effects of extracts, 
fractions and compounds 
2.2.1  Cancer cell lines selected 
The human tumour cell lines that were selected for used during this study were 
obtained from the European Collection of Authenticated Cell Cultures (ECACC). Five 
human cancer cell lines were selected, which derived from different tumour types.  
These cell lines were A549, EJ-138, HEPG2, MCF7 and PC3. In addition, one normal 
human prostate cell line PNT2 was also selected (Table 2.5).  All of the cancer cell 





Table 2.5  The cancer cell lines used in this study (ECACC)*. 
 A549 EJ-138 HEPG2 MCF7 PC3 PNT2 
Catalogue No 86012804 85061108 85011430 86012803 90112714 95012613 
Tissue Lung Bladder Liver Breast Prostate Prostate 




















Derived from a 
58-year-old 
Caucasian male. 
It has been shown 
by isoenzyme 
analysis and HLA 
profiles that EJ138 
is in fact T24 
human bladder 
carcinoma. 
The Hep G2 cell 
line has been 
isolated from a 
liver biopsy of a 15 
years Caucasian 
male suffering from 
hepatocellular 
carcinoma. B virus 
surface antigens 
have not been 
detected. 
Established from 
the pleural effusion 
from a 69 year 
female Caucasian 
suffering from a 
breast 
adenocarcinoma. 
Derived from a 
62-year-old 
male Caucasian 
with a grade 4 
prostatic 
adenocarcinoma 
PNT2 cells were 
established by 
immortalisation of 
normal adult prostatic 
epithelial cells by 
transfection with a 
plasmid containing 
SV40 genome with a 
defective replication 
origin. The primary 
culture was obtained 
from a prostate of a 
33-year-old male at 
post-mortem. 
 




2.2.2 Routine cell culture 
The cells were cultured in RPMI 1640 medium with w/stable glutamine (Biosera), 
supplemented with 10% (v/v) foetal bovine serum (FBS; Biosera) and 1% (v/v) 100X 
antibiotic/antimycotic solution (Gibco®) (complete medium). All cells were routinely 
cultured in T75 flasks at 37°C, 95% humidity, and 5% CO2 in a Binder® incubator.  Cells 
were grown to approximately 80% confluent before sub-culturing (passaging).  To 
passage the cells, the complete medium was aspirated from each T75 flask and 20mL of 
phosphate buffered saline (PBS) was added to wash the cells of any remaining medium. 
The PBS was then removed and 1mL of 0.05% trypsin-EDTA solution (Gibco®) added 
to each T75 flask of cells. The cells were returned to the incubator to allow the enzyme to 
detach the cells from the flask surface.  Cellular detachment was confirmed using light 
microscopy.  The action of the trypsin-EDTA solution was neutralised by the addition of 
5ml/flask complete medium.  The subsequent cell suspension was used to seed new T75 
flasks for routine cell maintenance or to seed 24-well plates for experimental purposes.  
For routine cell maintenance, the cells in the cell suspension were counted using a 
haemocytometer. This was used with complete medium to achieve a seeding 
concentration of 1 x 104 cells/mL (12.5 mL/T75 flask). Flasks of cells were returned to 
the incubator and the complete medium replaced with fresh complete medium daily until 
they had grown to approximately 80% confluent, when the passaging process was 





2.2.3 Cryopreservation of cells 
The primary purpose of cryopreservation is to ensure the continuous supply of each cell 
line during this study.  Cell lines can be cryopreserved in a living state of suspended 
cellular metabolism at -196°C in liquid nitrogen (Bakhach, 2009). To achieve this, T75 
flasks of cells for cyropreservation were harvested, when approximately 50% confluent 
(log phase of growth) by trypsinisation (as described in Section 2.2.2 above). The cell 
suspension from each flask was centrifuged at 1200 g for 5 min at 4oC to pellet the cells.  
The supernatant was aspirated off and the pellet of cells from each flask was re-suspended 
in freeze mixture [45% FBS, 45% RPMI 1640 medium, 10% dimethylsulfoxide (DMSO)] 
to achieve a cell concentring of 2-4x106 cells/mL.  This cell suspension/freeze mixture 
was transferred to labelled cryovials (1 mL/cryovial).  Cryovials of cells were 
immediately transferred to a cryogenic freezing container (able to provide -1ºC/min 
cooling) and cooled to -80oC in a freezer.  After 24 h, the cryovials of cells were moved 
to a liquid nitrogen storage vessel for long-term storage. 
Thawing frozen cells 
Cryovial/s of cells were removed from liquid nitrogen storage vessel as required and 
thawed rapidly at 37oC in a water bath.  The contents of each cryovial was transferred to 
a universal tube and 10 mL of complete medium added to dilute the DMSO in the freeze 
mix because DMSO is toxic to cells at temperatures above 4oC.  The cells were then 
centrifuged at 1200 g for 5 min at 4oC to pellet the cells.  The supernatant containing 
DMSO was removed and the pellet of cells was re-suspended in 12.5 mL of complete 




humidity, and 5% CO2 to allow the cells to recover and continue growing until passage or 
for experimental purposes. 
2.2.4 The MTT cytotoxicity assay 
The MTT assay is a simple colorimetric assay developed by Mosmann (1983) for 
measuring the metabolic activity in cells. A soluble, yellow, MTT substrate is taken up 
into cells through the endocytosis process, and then reduced by both the mitochondrial 
enzymes and the endosomal/lysosomal compartments to form a solid, crystalline, purple, 
formazan product (figure 2.1) (Evans, 2003; Lu et al., 2012; Stockert et al., 2012; Kuete 
et al., 2017). A solubilisation solution (dimethyl sulfoxide or isopropanol) is added to 
dissolve the water-insoluble formazan crystals into a purple solution. The absorbance (560 
nm) of purple solution after treatment of cells is measured using a spectrophotometer and 
compared to that of the untreated control.  MTT assay is one of the most widely used 
methods in academic laboratories to analyse cell proliferation and viability as evidenced 
by thousands of publications (Lu et al., 2012, Riss et al., 2016; Kuete et al., 2017). 
        NADH          NAD+            
    MTT (yellow substrate)                      Formazan (purple product) 






In this study, the cytotoxic activity of the n-hexane, dichloromethane and MeOH extracts 
of A. pavarii leaves, A. aestivus leaves and tubers, J. phoenicea leaves and R. chalepensis 
aerial parts were assessed against the five human tumour cell lines using the MTT assay. 
The cancer cells used were breast adenocarcinoma cell line [MCF7], liver hepatocellular 
carcinoma cell line [HEPG2], lung carcinoma cell line [A549], prostate adenocarcinoma 
cell line [PC3] and urinary bladder carcinoma cell line [EJ-138]. The complete medium 
was aspirated from flasks of cells, and the cells then were then trypsinised to dislodge the 
cells (as described in Section 2.2.1).  The trypsin was neutralised by the addition of a 
volume of complete medium to achieve a final cell concentration of 5 x 104 cells/ mL.  
This was then used to seed the wells of 24-well plates (1 mL/well). The 24-well plates of 
cells were incubated under 5% CO2 at 37
oC for 24 hr to allow the cells to adhere and start 
proliferating. The cells were then treated for 24 h with complete medium containing 
different concentrations of each extract (0, 0.005, 0.01, 0.05, 0.1 and 0.5 mg/mL), 
fractions (0, 0.00004, 0.002, 0.01, 0.05 and 0.25 mg/mL) or the isolated pure compounds 
(concentrations according to the amounts of the separated compound).  The extracts, 
fractions and pure compounds had initially been solubilised in DMSO and so all 
treatments in complete medium were supplemented with varying amounts of DMSO to 
yield a final DMSO concentration of 0.01% (v/v) in every treatment (including the 
negative control). After the 24 h treatment, the medium in each well was replaced by 1 
mL MTT working solution (500 μg/mL in complete medium) and incubated at 37°C for 
two hours.  The MTT working solution was then removed, and the formazan crystals 




on an orbital shaker until a homogeneous colour was obtained.  100l (x4 from each well 
of the 24-well plate) was transferred into wells of 96-well plates.  The absorbance of the 
reduced MTT was then determined by a Clario-star plate reader at 560  nm (Nemati et al., 
2013).  The absorbance readings of the treated cells were expressed as a percentage of the 
mean absorbance reading for the negative control cells.  
2.2.5 Determination of IC50 values 
Data interpretation  
 
The absorbance values of treated cells that are found to be lower than the control cells 
indicate a reduction in the viability of the cells and is taken as a measure of cytotoxicity. 
The cytotoxicity results were evaluated by plotting the percentage of control absorbance 
against the correspondent concentrations. Linear regression analysis with 95 % 
confidence limit and R2 were used to define dose-response curves and to compute the 
concentration of extracts, fractions, and compounds needed to reduce absorbance of the 
formazan by 50 % (IC50) (Patel, et al., 2009). 
Determination of IC50 value  
IC50 is the concentration of a drug that is required to reduce viability by 50 % of the 
cells. IC50 values were determined from a plot of a dose-response curve between the log 
of concentration and percentage viability. IC50 values were determined as a 
concentration of drug at 50 % position on the Y-axis. IC50 values were calculated using 
the nonlinear regression program ‘Origin’ (Patel, et al., 2009). The US National Cancer 




activity at IC50 values in carcinoma cells less than 20 μg/ml for crude extracts and 4 
μg/ml for pure compounds (incubation time between 48 and 72 h) (Boik, 2001; 
Mahvorasirikul et al., 2010). However, in this study, the incubation time was 24 h and 
values for crude extracts greater than 100 µg/mL were considered as non-cytotoxic  
(Sahranavard et al. 2012).   
 
2.2.6 Determination of selectivity index (SI) 
The degree of selectivity of the extracts or compounds can be expressed by its selectivity 
index (SI) value. The selectivity index (SI) = The IC50 (µg/mL) of extracts against the 
normal cells divided by the IC50 (µg/mL) of extracts against the cancer cells. Selectivity 
value higher than 2 gives a selective toxicity towards cancer cells (Badisa, et al., 2009; 
Demirgan, et al., 2015). 
2.2.7 Statistical analysis 
All experiments were carried out in triplicate on separate occasions. Data were expressed 
as means a ± standard error of the mean derived from n ≥12 from three separate occasions. 
The graphs were plotted using nonlinear regression with the use of Microsoft Excel 
version 2013. Statistical analyses were performed with Graph Pad Prism version 7.04. 
One-way ANOVA of multiple comparisons was applied (between control and different 
concentrations) using Dunnett`s multiple comparison tests. The differences between 
groups were considered statistically non-significant (ns) at a P value ≥ 0.05, significant 
(*) at a P value < 0.05 (0.01-0.05), very significant (**) at a P value < 0.01 (0.001 to 




2.2.8 LDH assay of cell membrane integrity (LDH release assay) 
The Lactate Dehydrogenase (LDH) assay is a useful method for detection of necrosis. 
LDH is a soluble cytoplasmic enzyme that is released into extracellular space, when the 
plasma membrane is damaged. The leakage level can be determined by the conversion of 
a substrate into a product that is then quantified spectrophotometrically (Evans, 2003; 
Chan et al., 2013). In this assay, the leakage of LDH into cell culture medium is detected 
by the presence of a substrate, a tetrazolium salt. Firstly, the LDH enzymes catalyze the 
oxidation of lactate to pyruvate, which leads to the release of reduced nicotinamide 
adenine dinucleotide (NADH) and secondly, the formation of a colored formazan product, 
which can be quantified using a spectrophotometer (Chan et al., 2013). 
Reagents 
Stop solution (1M acetic acid), 10X lysis buffer (9% v/v Triton X-100 in distilled H2O), 
LDH cytotoxicity detection kit produced by Roche (REF 11644793001), five bottles 
Catalyst (lyophilized), five bottles Dye Solution (45 ml each).The reaction mixture was 
prepared by mixing the catalyst one mL with 11.25 mL of the dye solution, 96 –well tissue 
culture plates. 
Method 
The columns 1 to 9 of the 96-well plate were seeded with cells in complete medium at a 
density of 1 x 105 cells/ ml (100 μL/ well) and columns 10 to 12 filled with complete 
medium only (100 μL/ well). The plates of cells were incubated under 5% CO2 at 37
oC 
for 24 hr to allow the cells to adhere and start proliferating. The pure compound to be 




value. For treatment, wells of cells in columns 1 to 3 of the 96-well plate were treated 
with the pure compound in complete medium (100 μL/well).  Wells in columns 4 to 12 
were given complete medium only.  After the 24 h treatment, the LDH release assay was 
carried out. Firstly, 10X lysis buffer (5μL/well) was added to the complete medium in 
wells in columns 7 to 9 and returned to the incubator for 15 min for lysis of cells to occur 
(high LDH release controls).  After this period, 100 μL/well of reaction mixture was added 
into every well on the 96-well plate (columns 1 to 12) and incubated for a further 15 min. 
at 37oC.  After 15 min. incubation, 50 μL/ well stop solution was added to each well of 
the 96-well plate (columns 1 to 12). Columns 1 to 3 of the 96-well plate were the 
compound-treated cells (test), columns 4 to 6 were untreated viable cells (low LDH 
release controls), columns 7 to 9 were viable cells that had been lysed to release LDH 
(high LDH release controls) and columns 10 to 12 were complete medium only 
(background reading controls). The absorbance values of each well were measured and 
recorded at 490 and 690 nm and the 690 nm values were then subtracted from the 490nm 
values.  The average background reading (from wells in columns 10 to 12) was then 
subtracted from all other values.  The average readings from wells in columns 1 to 3 were 
taken as the treated cell value, columns 4 to 6 as the low LDH release control value and 
























3.0 Results and Discussions 
3.1 Juniperus phoenicea  
3.1.1  Extraction  
Sequential Soxhlet extraction of the dried and ground leaves of Juniperus phoenicea (JPL) 
(85 g) afforded three extracts: n-hexane (JPH), dichloromethane (JPD), and MeOH 
(JPM).  The percentage yields of these extracts are summarized in Table 3.1 
Table 3.1.1: Percentage yield of the three extracts obtained from J. phoenicea leaves  
Extract % Yield 
n-Hexane (JPH) 5.14 
DCM (JPD) 2.48 
MeOH (JPM) 28.57  
 
3.1.2  Preliminary analytical TLC screening 
The developed TLC plates of three extracts obtained from J. phoenicea were viewed 
under short (254 nm) and long (366 nm) UV light and then sprayed with anisaldehyde 
reagent followed by heating at 100ºC for 5 min to reveal many violet coloured spots with 
Rf values ranging from 0.16 to 0.94 (Table 3.1.2). The violet colour suggested the 
presence of diterpenes in both the n-hexane and the DCM extracts (Kristanti & Tunjung 
2015). Another plate was developed and sprayed with DPPH reagent and exhibited yellow 
spots, which indicated the presence of compounds with antioxidant properties (Figure: 





       
Short UV (254 nm)             Long (366 nm) UV 
            
Sprayed with anisaldehyde               Sprayed with DPPH 
Mobile phase: n-Hexane: EtOAc = 80:20 
Figure 3.1.1:  TLC for the three extracts of J. phonecia leaves 
 
Table 3.1.2: Rf values of different extracts of J. phoenicea 
n-Hexane Rf values DCM Rf values MeOH Rf values 







3.1.3 Analytical HPLC screening for the MeOH extract of J. phoenicea leaves  
The MeOH extract of J. phoenicea leaves (10 mg/mL) was analysed by Dionex Ultimate 
3000 analytical HPLC coupled with a photodiode detector using a gradient mobile phase, 
30-100% MeOH/H2O for 30 min with a volume of injection of 20 µL and a flow rate of 
1 mL/min. (Figure 3.1.2; Table 3.1.3). 
 
Figure 3.1.2: Analytical HPLC chromatogram of the MeOH extract of J. phoenicea 
leaves (observed at 320 nm, the green chromatogram) 
Table 3.1.3: UV-Vis data for all major peaks obtained from diode array detector 
Peak No. Retention Time (min) UV-Vis absorbances (λmax) (nm) 
1 3.2 224, 241 and 277 
2 5.3 225and 311 
3 20 226, 273 and 330 
4 21.9 225, 271and 333 







3.1.4  Screening of J. phoenicea extracts for cytotoxic activity 
The cytotoxic activity of JPH, JPD and JPM was assessed against five cancer cell lines; 
EJ138 (human bladder carcinoma), Hep G2 (human liver hepatocellular carcinoma), 
A549 (human lung carcinoma), MCF7 (human breast adenocarcinoma), and prostate 
cancer cell lines (PC3). The n-hexane (JPH) extract showed the highest level of activity 
against the different cancer cell lines with the only exception of the PC3 cancer cell line, 
against, which the JPD was most active (Figures: 3.1.3 and 3.1.4) and (Table 3.1.4). The 
selectivity index (SI) was also determined using the human normal prostate cell line 
(PNT2) for both active extracts JPH and JPD, which   revealed a high degree of cytotoxic 
selectivity on prostate cancer cells (SI = 5). This indicated that the extracts were more 
cytotoxic to cancer cells than against normal cells (Musiliyu et al., 2010). The IC50 values 
of the extracts and the selectivity index are summarized in Table 3.1.4.b 
Table 3.1.4a: The IC50 (µg/mL) of n-hexane, DCM and MeOH extracts of J. phoenicea 
leaves on the selection of five human cancer cell lines  
 
 
Values greater than 100 µg/mL were considered as non-cytotoxic (Sahranavard et al. 2012). 
The results were mean values ± standard error of the mean derived from n ≥12 from three separate occasions. 
Cell type IC50 values (µg/mL) (JPL) 
JPH JPD JPM 
EJ138 40 ± 0.75 50 ± 0.97 ˃ 100  
Hep G2 10 ± 1.48 42 ± 1.08 100 ± 0.90 
A549 16 ± 1.56 13 ± 1.70 100 ± 1.47 
MCF7 14 ± 1.30 16 ± 1.13 ˃ 100 




Table 3.1.4b: The IC50 (µg/mL) values for JPD and JPH extracts on PC3 and PNT2 
cells and the selectivity index (SI) using the normal human prostate cells (PNT2). 
Cell type IC50 values 
(µg/mL) 
 JPH JPD 
PC3 25 ± 1.84 4.9 ± 0.76  
PNT2 140 ± 1.84 20 ± 0.92 
       Selectivity index 5.6 4.08 
 
Selectivity index (SI)= The IC50 (µg/mL) of extracts against the normal cells divided by the IC50 (µg/mL) of extracts 
against the cancer cells, where IC50 is the concentration required to reduce viability by 50% of the cell population 
(Badisa, et al., 2009). 
 
3.1.5  Chromatographic fractionation of the extracts 
The primary objective undertaken to fulfill this study was to carry out a systematic, 
bioassay-guided phytochemical and cytotoxic/anticancer survey on the different crude 
extracts. To approach this aim further fractionation of the J. phoenicea active extracts 
(JPH and JPD) was performed. Also, the inactive MeOH extract was fractionated aiming 
at isolation of major metabolites to have thorough understanding of the phytochemistry 
of J. phoenicea.  
3.1.5.1  Vacuum liquid chromatography fractionation (VLC) 
The active extracts JPH (2.6 g), and JPD (1.28 g) were further fractionated by VLC step 
gradient elution over silica gel to collect seven fractions from each extract (Figures 3.1.3 





Figure 3.1.3: TLC analysis (mobile phase: 20% EtOAc in n-hexane) of the VLC 
fractions of the n-hexane extract of the leaves of J. phoenicea 
 
 
Figure 3.1.4: TLC analysis (mobile phase: 5% MeOH in DCM) of the VLC 

















Table 3.1.5: Weights of the VLC fractions of the extracts JPH and JPD  
 
3.1.5.2  Solid phase extraction (SPE) 
The MeOH extract of J. phoenicea leaves (JPM) was fractionated by SPE to collect four 
fractions (Figures 3.1.5-3.1.8; Table 3.1.6).  
Table 3.1.6: Weights of the SPE fractions of the MeOH extract of J. phoenicea leaves  
Fraction Mobile phase gradient Weight of fraction (mg) 
JPMF1 20% MeOH in H2O 895  
JPMF2 50% MeOH in H2O 135  
JPMF3 80% MeOH in H2O 54  
JPMF4 100% MeOH in H2O 25  








JPHF1 100% n-hexane 82.5 JPDF1 100% n-hexane 15 
JPHF2 10% EtOAc in 
n-hexane 
555 JPDF2 50% DCM in n-
hexane 
20 
JPHF3 30% EtOAc in 
n-hexane 
998.7 JPDF3 100% DCM 41 
JPHF4 50% EtOAc in 
n-hexane 
655.5 JPDF4 10% MeOH in 
DCM 
134 
JPHF5 80% EtOAc in 
n-hexane 
118.8 JPDF5 20%MeOH in 
DCM 
128.5 
JPHF6 100% EtOAc 22.1 JPDF6 30% MeOH in 
DCM 
9.3 
JPHF7 50% MeOH in 
EtOAc 







Figure 3.1.5: Analytical HPLC chromatograms of SPE fraction 1 of JPM (observed at 310 
nm) 
 
Figure 3.1.6: Analytical HPLC chromatograms of SPE fraction 2 of JPM (observed at 310 
nm) 
 






Fig. 3.1.8: Analytical HPLC chromatograms of SPE fraction 4 of JPM (observed at 310 nm) 
3.1.6 Screening of J. phoenicea fractions for cytotoxic activity 
The cytotoxic activity of the n-hexane, DCM, and MeOH fractions of J. phoenicea leaves 
was assessed against the most sensitive cancer cell line (human lung carcinoma cell line 
A549).  The highest activity was revealed in the n-hexane F5, the DCM F4, and MeOH 
F3 and F4. The IC50 values for the n-hexane, DCM and MeOH fractions of J. phoenicea 
leaves on A549 (human lung carcinoma) are summarised in Table 3.1.7. 
Table 3.1.7: The IC50 (µg/mL) of the VLC and SPE fractions of the three extracts of J. 
phoenicea leaves against A549 (human lung carcinoma) cells   
Fraction IC50 values (µg/mL)  
F1 F2 F3 F4 F5 F6 F7 F8 
n-
Hexane 
>100 62 ± 
1.32 
90 ± 1.33 30 ± 1.79 9.5 ± 
0.87 
NA 40 ± 1.14 NA 
DCM NA 60 ± 
2.13 
92 ± 1.44 19 ± 0.83 >1000 >1000 >1000 >1000 
MeOH >1000 >100 50 ± 1.46 85 ± 3.42 NA NA NA NA 
NA--- Non-applicable All experiments were carried out in triplicate on separate occasions. Data were expressed as 




3.1.7  Isolation of compounds from J. phoenicea 
3.1.7.1  The MeOH extract (JPM)    
Isolation of compounds from the SPE fractions 3 and 4 of JPM was done using semi-
preparative HPLC technique (Agilent) employing a 30-100% gradient of MeOH in water 
for 30 min with a volume of injection of 200 L and a flow rate of 2 mL/min  
The following compounds were isolated: JPMF3-1 (12 mg, tR = 20.0 min), and JPMF3-2 
(2.5 mg, tR = 21.9 min) from SPE fraction 3, and JPMF4-1 (8 mg, tR = 19.9 min), JPMF4-
2 (2.0 mg, tR = 21.7 min) and JPMF4-4 (0.7 mg, tR = 26.3 min) from SPE fraction 4. 
JPMF3-1 had the same retention time of JPMF4-1, and similarly, JPMF3-2 and JPMF4-
2 had the same retention time (Figures 3.1.19 and 3.1.20). 
 
Figure 3.1.19: Analytical HPLC chromatogram of isolated compounds from SPE 





Figure 3.1.20: Analytical HPLC chromatogram of isolated compounds from SPE 
fraction 4 JPM (observed at 310 nm) 
 
3.1.7.2  The n-hexane extract (JPH)  
The active VLC fractions (F2, F3, and F5) of the n-hexane extract were subjected to 
normal column chromatography over silica gel, using a step gradient mobile phase 
comprising EtOAc (2%, 4%, 6% ----20%) in n-hexane (52 mL each) and collecting 4 mL 
each time leading to the isolation of JPH3 (8.2 mg, Rf = 0.6) and JPH567 (1.7 mg, Rf = 
0.86), which was isolated with some impurity (Figure 3.1.22). JPHF2D was precipitated 





.              
Mobile phase: Toluene: EtOAc: Acetic acid= 25:24:1 
Figure 3.1.22: Isolation of the compounds JPH3 and JPD567 from J. phoenicea.n-
hexane F3 and F5 
 
3.1.7.3  HPLC-MS screening of the n-hexane extract (JPH) 
The JPH was analysed by HPLC-MS to detect the molecular weights of the major 
metabolites, and thus to tentatively identify 3-hydroxy-sandaracopimaric acid (44), 13-
epi-cupressic acid (42), and some essential oils components such as borneol, terpineol, δ-














Figure 3.1.23: LC-MS screening for the n-hexane extract of J. phoenicea leaves 
 
3.1.7.4  The DCM extract (JPD)    
Separation of the active DCM VLC Fraction 4  
The active DCM VLC Fraction 4 (130 mg) of J. phoenicea leaves was isolated by prep-
HPLC using a gradient solvent system 50-100% ACN in water. This lead to the isolation 
of the compounds: JPDF4-1 (1 mg, tR= 9.82 min), JPDF4-2 (0.5 mg, tR= 10.19 min), 
JPDF4-3 (2.4 mg, tR= 11.14 min), JPDF4-5 (3.2 mg, tR= 14.12 min), JPDF4-6 (10.3 mg, 
tR= 15.56 min), JPDF4-8 (3 mg, tR= 17.5 min), JPDF4-11 (4 mg, tR= 24.60 min) and 





Figure 3.1.24: HPLC chromatogram of the active VLC fraction 4 of the DCM 
extract (JPD) (observed at 250 nm) 
 
Separation of the DCM extract every 5 min 
The total DCM extract (JPD) (1 g) was fractionated every 5 min by preparative reversed-
phase HPLC using a gradient solvent system 50-100% ACN in water and a flow rate of 
10 mL/min. Eight fractions [F1= 10.6 mg (0-5 min), F2= 12.2 mg (5-10 min), F3= 55 mg 
(10-15 min), F4= 35 mg (15-20 min), F5= 133 mg (20-25 min), F6= 40 mg (25-30 min), 
F7= 61 mg (30-35 min) and F8= 41 mg (35-40 min)] were obtained and allowed to dry 
(Figure 3.1.25). 
JPD fraction 4 (35 mg) was further purified using the gradient of 50-100% MeOH /water 
over 30 min and flow rate of 10 mL/min. This led to the isolation of JPD4-2 (0.6 mg, 
tR=18 min.) (Figure 3.1.26). 
JPD fraction 5 (133 mg) was purified using the gradient of 60-80% MeOH /water over 30 
min and flow rate of 10 mL/min to obtain two pure compounds JPD5-4 (11 mg, tR= 34 




JPD fraction 5 (40 mg) was analysed by the linear gradient of 70-100% MeOH/water and 
flow rate of 10 mL/min to afford JPD6-2 (1.3 mg, tR= 29.5) (Figure 3.1.28).   
 
Figure 3.1.25: Fractionation of JPD extract every 5 min (observed at 250 nm) 
 
Figure 3.1.26: HPLC chromatogram of JPD fraction F4 (observed at 250 nm) 
 





Figure 3.1.28: HPLC chromatogram of JPD fraction F6 (observed at 250 nm) 
 
3.1.8  Characterization of isolated compounds from J. phoenicea 
3.1.8.1  Characterization of biflavonoids 
Three biflavonoids 24, 25 and 76 were isolated from the SPE fractions F3 and F4 of JPM 
(Figures 1.5 and 3.1.29). All showed absorption bands at 270-275 nm and 330-332 nm, 





Amentoflavone (25) H 
Sumaflavone (76) OH 
 




Characterization of JPMF3-1 and JPMF4-1 as cupressoflavone (24)  
Pale yellow powder; UV (MeOH)  λmax: 204, 228, 274 and 330 nm (Figure 3.1.30); 
1H 
NMR (600 MHz, DMSO-d6) Table (3.1.8) and Figure (3.1.31) indicated 5, 7, 4'-
trihydroxy flavone dimers and showed two signals at δH 13.09 and 12.96 due to chelated 
phenolic hydroxyls. It also showed two single H-3 and H-3``protons at δH 6.78 and 6.64 
and two doublets (J = 8.9 Hz) at δ H 6.74 and 7.49 assigned for H-3`, 5` and H-2`,6`, 
respectively. 13C NMR (150 MHz, DMSO-d6): Table 3.1.9 and Figure 3.1.32 exhibited 
30 carbon atoms, two carbonyls at δHC 182.5. Analysis of the HMBC spectrum (Figure 
3.1.33) showed correlations of the hydroxyl group with hydrogen bonded by cross peak 
at δH 13.22 (OH-5) (OH-5``) with C-5, C-5`` (δ 161.5), C-6, C-6`` (δ 99.3), and C-10, C-
10`` (δ 104.0), which agree to those of cupressolavone (24) (Figure 1.5). ESIMS m/z 539 
[M+H]+, suggested the molecular formula C30H18O10. All data were comparable to the 
published data (Alqasoumi et al., 2013).  
 

















Figure 3.1.33: HMBC spectrum of cupressoflavone (24) 
 
 
Characterization of JPMF3-2 and JPMF4-2 as amentoflavone (25) 
Pale yellow amorphous powder; UV (MeOH) λmax:212, 270 and 332 nm; 
1H NMR (600 
MHz, CD3OD); Tables (3.1.8 and 3.1.9) and Figure (3.1.34). ESIMS m/z showed a peak 
at 539 [M+H]+, indicating that the molecular formula could be C30H18O10. 
1H NMR of 
compound 25 exhibited two doublets at δH 7.58 (J = 8.8 Hz, H-2```, H-6```), and 6.74 (J 
= 8.8 Hz, H-3```, H-5```) assigned to an AA’BB’ aromatic system. Signals of a 
trisubstituted aromatic ring containing one oxygenated carbon were observed at δH 8.00 
(d, J = 2.3 Hz, H-2`), 7.14 (d, J=8.6 Hz, H-6`), and 7.96 (dd, J = 8.5; 2.2 Hz H-5`), along 
with two broad singlets of a tetra substituted aromatic ring at δH 6.22 (br s, H-6) and 6.42 
(br s, H-8) and one singlet at δH 6.40. 




signals at δH 13.12 and 12.99 due to chelated phenolic hydroxyls (Figure 3.1.35).  All data 
were comparable to the published data for amentoflavone (Markham et al., 1987; 
Carbonezi et al., 2007; Shaoguang et al., 2014;  Bais  Abrol, 2016). 
Figure 3.1.34: 1H NMR spectrum (600 MHz, CD3OD) of amentoflavone (25) 
 
 





Characterization of JPMF4-4 as sumaflavone (76)  
Amorphous yellow powder; UV (MeOH) λmax: 224, 270  and 332 nm; 
1H NMR (300 
MHz, DMSO-d6); Table (3.1.8) and Figure (3.1.36) showed similar peaks to that of 
amentoflavone (25) with the absence of the singlet peak at δH 6.40 indicating the hydroxyl 
group at position C-6``. ESIMS m/z showed a peak at 554 [M]+, indicating that the 
molecular formula could be C30H18O11. All data were comparable to the published data of 
sumaflavone (76) (Markham et al., 1987). 
 
 
Figure 3.1.36: 1H NMR spectrum (300 MHz, DMSO-d6) of sumaflavone (76) 






Table 3.1.8: 1H NMR for the biflavonoids: Cupressoflavone (24), amentoflavone (25), 
and sumaflavone (76)  
              
              24 25                                                                        76 
Position Chemical Shift δ (ppm), multiplicity and J in Hz 
1H 24* (300 MHz) 25** (600 MHz) 76** (300 MHz) 
3 6.78 (s) 6.66 (s) 6.78 (s) 
5 13.22 (s) (OH) - 13.01 (s) (OH) 
6 6.45 (s) 6.22 (br s) 6.16 (d, 2.0) 
7 10.33 (s) (OH) - 13.06 (s) (OH) 
8  6.42 (br s)  
2` 7.49 (d, 8.9) 8.00 (d, 2.3) 8.17 (s) 
3` 6.74 (d, 8.9) -  
4` 10.33 (s) (OH) -  
5` 6.74 (d, 8.9) 7.96 (dd, 8.5, 2.2) 7.0 (d, 8.6) 
6` 7.49 (d, 8.9) 7.16 (d, 8.6) 7.92 (d. 8.8) 
3`` 6.78 (s) 6.64 (s) 6.71 (s) 
6`` 6.45 (s) 6.40 (s)  
2``` 7.49 (d, 8.9) 7.58 (d, 8.8) 7.63 (d, 8.7) 
3``` 6.74 (d, 8.9) 6.74 (d, 8.8) 6.61 (d, 8.6) 
5``` 6.74 (d, 8.9) 6.74 (d, 8.8) 6.61 (d, 8.6) 
6``` 7.49 (d, 8.9) 7.58 (d, 8.8) 7.63  (d, 8.7) 






Table 3.1.9: 13C NMR data of biflavonoids: Cupressoflavone (24), and amentoflavone 
(25) 
 Position Chemical Shift δ (ppm), Position Chemical Shift δ (ppm) 
13C 24* (75 MHz) 25** (150 MHz) 13C 24* (75 MHz) 25** (150 MHz) 
2 163.9 166.0 2`` 163.9 166.2 
3 103.0 103.5 3`` 103.0 100.3 
4 182.5 184.0 4`` 182.5 184.4 
5 161.5 163.4 5`` 161.5 163.4 
6 99.3 100.3 6`` 99.3 95.3 
7 164.1 166.2 7`` 164.1 162.7 
8 98.9 95.3 8`` 98.9 105.5 
9 155.2 159.6 9`` 155.2 159.6 
10 104.0 105.5 10`` 104.0 105.5 
1` 121.7 123.2 1``` 121.7 123.4 
2` 128.4 133 2``` 128.4 129.0 
3` 116.3 122.0 3``` 116.3 117.0 
4` 161.3 161.5 4``` 161.3 163.4 
5` 116.3 129 5``` 116.3 117.0 
6` 128.4 117.0 6``` 128.4 129.0 
*= (DMSO-d6), **= (CD3OD) 
 
3.1.8.2  Characterization of diterpenes 
Five diterpenoids, one from the VLC fraction 3 of the n-hexane extract (JPH3), three from 
fraction 4 of the DCM extract (JPD4-5, JPD4-6, and JPD4-8) and one JPDF6-2 from 
fraction 6 of the DCM extract, were isolated. Two bicyclic diterpenes labdanes: 13- epi-
cupressic acid (42) and imbricatolic acid (41), two tricyclic diterpenes; one pimarane, 3-
hydroxy sandaracopimaric acid (44) and the other is an abietane, dehydroabietic acid (46) 




that they had 20 carbons, keto and hydroxyl groups, suggesting that they were diterpenes 
(Su et al., 1994). 1H- and 13C-NMR of 42 and 41 showed two proton singlets at δH 4.49, 
4.83 assigned for H-17. Both compounds showed an 18-CH3 singlet (δH 1.24, δ C 29.2) 
(δH 1.24, δC 30.6); 19-COOH (δC 183.2) (δC 183.4); 20-CH3 singlet (δH 0.59, δC 12.9) (δH 
0.60, δC 13.1) suggesting identical data for labdan-8(17)-ene skeleton (Su et al., 1994). 
Characterization of JPHF3, JPDF5-4, JPDF4-5 as 13- epi-cupressic acid (42)    
Amorphous white powder; 1H NMR (600 MHz, CDC13) and 
13C NMR (150 MHz, 
CDC13): Tables (3.1.10 and 3.1.11) and Figures (3.1.37 and 3.1.38) of 42 showed mono-
substituted double bond (CH at δH 5.91, dd, J = 10.2, 17.6 Hz and δC 145.8; CH2 at δH 
5.06 dd, J = 0.8, 10.6 Hz, δH 5.21 dd, J = 1.3, 17.2 Hz and δC 145.8, 112.0 assigned for 
C-14 and C-15. The methyl singlet (δH 1.27, δC 28.3) was assigned to C-16 on an 
oxygenated fully substituted C-13 at δC 74.1 as indicated from HMBC experiment (Figure 
3.1.39). ESIMS m/z showed a peak at 319 [M-H]-, indicating that the molecular formula 
could be C20H32O3. The data of 42 was identical with those reported for 13-epi-cupressic 
acid (Su et al., 1994; Alqasoumi et al., 2013).  
 






Figure 3.1.38: 13C NMR spectrum (150 MHz, CDC13) of 13-epi-cupressic acid (42) 
 
 





Characterization of JPDF4-6, JPDF5-4 as imbricatolic acid (41) 
Amorphous white powder; data of both 1H NMR (600 MHz, CDC13) and 
13C NMR (150 
MHz, CDC13):  Tables (3.1.10 and 3.1.11) and Figures (3.1.40 and 3.1.41) suggested the 
presence of carboxyl, hydroxyl (7.87, 7.90, 9.77 br s) and terminal methylene groups at 
δH 0.6 (s, -CH3 at C-10); δH 0.90 (s, -CH3 at C- 13); 1.24 (s, -CH3 at C-4); 3.67 (m, -
CH20H), 4.83 and 4.49 (both s,= CH). The ESIMS m/z at 323 [M-H]
- suggestedthe 
molecular formula C20H34O3. All data were comparable to the published data (Wenkert & 
Buckwalter, 1972; Campelo & Fonseca 1975; Su et al., 1994; Alqasoumi et al., 2013).    
MS, 1H and 13C-NMR data Figures of 41 indicated the lack of the second double bond. 
The appearance of the C-16 methyl as doublet at δH 0.90 (J = 6.5 Hz) and the appearance 
of CH2OH (δH 3.67 (m), δC 61.6) indicated a C-15 hydroxyl in 41. The data of 41 was 
consistent with those reported for imbricatolic acid (Wenkert & Buckwalter, 1972). 
 
 






Figure 3.1.41: 13C NMR spectrum (150 MHz, CDC13) of imbricatolic acid (41) 
 
Characterization of JPDF5-7, JPDF4-8 as 3-hydroxy sandaracopimaric acid (44) 
Amorphous white powder; UV (MeOH):  λmax: 210, 236 and 306 nm;
1H NMR (600 MHz, 
CDC13) and 
13C NMR (150 MHz, CDC13): Tables (3.1.10 and 3.1.11) and Figures (3.1.42 
and 3.1.43) showed pimarandiene skeleton with a C-8, C-14 double bond (δC 137.8 and δ 
C 130.6) (Su et al., 1994). There was also an oxygenated CH at δH 4.02 (dd, J = 4.6, 11.8 
Hz) and δC 76.6, the location of the hydroxyl groups was assigned to C-3 based on the 
HMBC correlation. It also showed ESIMS m/z 317 [M-H]-, consistent with the molecular 
formula C20H30O3. Comparison of the data with data recorded in the literature identified 
44 as 3β−hydroxysandaracopimaric acid (Kozo & Takami, 1972; Wenkert and 






Figure 3.1.42: 1H NMR spectrum (600 MHz, CDC13) of 3-hydroxy sandaracopimaric 
(44) 
 









Table 3.1.10: 1H NMR (600 MHz, CDCl3) for diterpenes: 13- Epi-cupressic acid (42), 
imbricatolic acid (41), 3-hydroxy sandaracopimaric acid (44) (CDCl3).  
                         42   41 44 
Position Chemical Shift δ (ppm), multiplicity and J in Hz 
1H 42 41 44 
1 1.05 (br s), 1.71(m) 0.95 (m); 1.86 (m) 1.07 (m), 1.21 (m) 
2  1.50 (m), 1.71 (m) 1.45 (m); 1.86 (m) 1.38 (m), 1.45 (m) 
3 1.04 (dd; 4.8; 13.9) 
1.97, (br s) 
1.06 (dd; 4.2; 13.3) 
2.14 (br s) 
4.02 (dd; 4.6, 11.8) 
5 1.32 (m) 1.32 (m) 1.53 (m) 
6 1.83 (m), 1.89 (m) 1.85 (m), 1.87 (m) 0.92 (m), 1.25 (m) 
7 1.86,(m), 2.40 (br s) 1.88 (m), 1.99 (m) 1.86 (m), 2.23 (m) 
9 1.50, m 1.91 (m) 
2.40 (dd, 2.8, 8.8) 
 
11 1.32 (m), 1.45, (m) 1.36 (m) 1.38 (m), 1.50 (m) 
12 1.32 (m), 1.57, (m) 1.29 (m) 1.2 (m), 1.24 (m) 
13  1.34 (m) - 
14 5.91, dd, 10.2, 17.6 1.34 (m) 5.24 (s) 
15 5.21, dd, 1.3. 17.2  
5.06, dd, 10.7, 0.8 
3.67 (m) 5.76 (dd; 10.4, 17.7) 
16 1.27, s 0.90 (d, 6.5) 4.89 (d, 10.6),  
4.90 (d, 17.5) 
17 4.49 (s), 4.83 (s) 4.83 (s), 4.49(s) 1.04 
18 1.24 (s) 1.24 (s) - 
19 - - 1.18 (s) 




Table 3.1.11: 13C NMR (150 MHz, CDCl3) for diterpenes: 13-epi-cupressic acid (42), 
imbricatolic acid (41), 3-hydroxy sandaracopimaric acid (44)  
                      
Position Chemical Shift δ (ppm) Position Chemical Shift δ (ppm) 
13C 42 41 44 13C 42 41 44 
1 39.4 39.1 38.5 11 18.1 21.5 28.1 
2 20.2 20.2 20 12 41.6 40.0 35.9 
3 38.2 36.8 76.6 13 74.1 29.4 38.7 
4 44.5 44.5 54.9 14 145.8 41.0 130.6 
5 56.7 56.7 52.0 15 112.0 61.6 150.0 
6 26.4 26.4 25.7 16 28.3 21.5 111.0 
7 39.0 38.4 36.7 17 107.1 106.6 26.7 
8 148.2 148.6 137.8 18 29.2 30.6 181.5 
9 56.7 57.0 51.6 19 183.2 183.4 11.9 
10 40.9 39.5 38.7 20 12.9 13.1 15.8 
 
Characterization of JPDF6-2 as dehydroabietic acid (callistrisic acid) (46) 
Amorphous white powder, The ESIMS m/z 301 [M+H]+, confirmed the molecular 
formula C20H28O2  as that of a diterpene.  
1H NMR data (600 MHz, CDC13) (Figure 
3.1.44) showed aromatic protons including: two ortho- meta coupling at δH 7.00 (1H, dd, 
J = 8.2 Hz, 1.7) assigned to H-2` and δH 2.89 (1H, dd, J = 5.6 Hz, J= 16.6 Hz) assigned 
to H-7,  two ortho-coupling at δH 7.18 (1H, d, J = 8.2, H-1`) and δH 1.22 (6H, d, J = 7.0, 
H-7`, H-8`) and a broad singlet at δH 6.89 (1H, H-4`). All the aromatic signals indicated 
that this diterpene is abietane type. The signals at 2.82 (2H, m, H-6`), 1.60 (2H, m, H-6), 
1.27 (3H, s, H-12), , 1.1 (3H, s, H-13) indicated that this compound might be 




it showed the 20 carbon signals of the tricyclic diterpenes including six aromatic carbons, 
carbonyl carbon at  δC 181.6, four methyl signals at δC 21.7 (C-13), 20.9 (C-8`) and 19.9 
(C-12). All data were comparable to the published data of dehydroabietic acid (callistrisic 
acid) (46) (Gonzáleza et al., 2010).                    
 
 
Figure 3.1.44: 1H NMR spectrum (600 MHz, CDC13) of dehydroabietic acid 
(46) 
                                                                               
 






3.1.8.3 Characterization of lignans 
Two lignans were isolated from the active F4 of J. phoenicea DCM extract [JPD4-1 (29) 
and JPD4-2 (30)] (Figure 1.5). The 1H and 13C NMR spectroscopic data (Figure 3.1.46, 
and Figure 3.1.47) and (Figure 1, Appendix) indicated that they belong to the furan 
subgroups. The presence of 3, 4, 5-trimethoxyphenyl, which are the most frequently 
occurring aromatic rings found in lignans (Tsopmoa et al., 2013). The protonated 
aromatic carbons show signals at 106.2, 108.1 and 109.3 ppm. The singlet signal at 108.1 
ppm was assigned to C-2` and C-6` (δH 6.53 and 6.36) for the two compounds 28 and 29, 
respectively, while those at 106.2 and 109.3 ppm were attributed to C-3 and C-6, 
respectively for the compound 29.  By comparison with related data carbons suggesting 
that they are deoxypdophyllotoxin 29 and β-peltatin methyl ether 28 (Figures 1.5) 
(Fonseca, et al., 1980; Rojas-Sepúlveda et al., 2012; Tsopmoa et al., 2013). 
 
Characterization of JPDF4-1 as a mixture of deoxypdophyllotoxin and terpenoid (29) 
Amorphous white powder; 1H  NMR (600 MHz, CDC13)  δ 6.67 (1H, s, H-6), 6.53 (1H, 
s, H-3), 6.35 (2H, s, H-2`, H-6`), 5.94 (2H, d, J = 5.9, O-CH2-O), 5.04 (1H, m, H-9α, H-
7`), 4.03 (1H, dd, J = 11.5, 3.7 Hz, H-9β ), 3.81 (3H, s, CH3O -4`), 3.75 (6H, s, CH3O-3`, 
CH3O-5`), 2.92 (1H, dd, J = 6.5, 17.4 Hz, H-7),  2.80 (1H, m, H-8, H-8`) and 
13C NMR 
(150 MHz, CDC13) δ 182.2 (C-9′), 151.8  (C-3′, C-5′), 148.1 (C-4), 146.5 (C-6), 138.1 
(C-1′, C-4′), 136.6 (C-5), 134.0 (C-2), 132 (C-1), 111.9 (C-2′, C-6′), 109.0 (C-6), 107.2 
(C-3), 101.9 (O-CH2-O), 72.8 (C-9), 61.5 (CH3O-4′), 56.5 (CH3O-3′, CH3O-5′),  47.7 (C-




indicating that the molecular formula could be C22H22O7. All comparable data confirmed 
the structure of deoxypdophyllotoxin (Rojas-Sepúlveda et al., 2012). 
 
Characterization of JPDF4-2 as β-peltatin methyl ether (28) 
Amorphous white powder;1H NMR (600 MHz, CDC13) (Figure 3.1.46) δ 6.36 (2H, s, H-
2`, H-6`), 6.28 (1H, s, H-3), 5.88 (2H, d, J = 5.9, O-CH2-O), 4.58 (1H, d, J = 4.3 Hz, H-
7), 4.47 (1H, dd, J = 7.3, 1.3 Hz, H-9), 4.07 (3H, s, CH3O -6), 3.94 (1H, t, J = 9.6 Hz), 
3.80 (3H, s, CH3O-4), 3.76 (6H, s, CH3O-3, CH3O-5), 3.17 (1H, dd, J = 5.1, 16.8 Hz, H-
7), 2.66 (1H, d, J = 4.5, H-8`), 2.64 (1H, m, H-8), 2.45 (1H, dd, J = 10.6, 17.1 Hz, H-7) 
and 13C NMR (150 MHz, CDC13) (Figure 3.1.47) δ 175.5 (C-9′), 152.9  (C-3′, C-5′), 
148.6 (C-4), 145.1 (C-6), 138.1 (C-1′, C-4′), 136.6 (C-5), 132.0 (C-2), 121.3 (C-1), 108.7 
(C-2′, C-6′), 104.8 (C-3), 101.3 (O-CH2-O), 72.8 (C-9), 59.7 (CH3O-6), 56.7 (CH3O-3′, 
CH3O-5′), 55.7 (CH3O-4′) 47.7 (C-8′), 44.2 (C-7′), 32.7 (C-8), 27.9 (C-7). ESIMS m/z 
showed a peak at 429 [M+H]-, indicating that the molecular formula could be C23H24O8. 
All data confirmed that compound 28 is β-peltatin methyl ether comparable to the 















Characterization of JPHF2 D as aliphatic alcohol (heptacosan-14-ol) (77) 
It appeared as a white amorphous powder. ESIMS showed the highest significant peak at 
m/z: 397 [M+H] +. Consequently, the expected molecular weight was (396.73) attributed 
to C27H56 O. 
1H (400 MHz, CDCl3 and 
13C NMR 75 MHz, CDCl3), (Figures 3.1.49 and 
3.1.50): δ 0.9 t (6H), 1.28 s, 1.4 m (4H), 3.61 (m), δ 14.094 (C-1-1′), 29.69 (C-2-13, C-2-
13′) and 125.00 (C-14). The NMR and MS spectra confirmed the structure of heptacosan-
14-ol (Figure 3.1.48). 
 
Figure 3.1.48: Structure of heptacosane-14-ol (77) 
 
 






Figure 3.1.50: 13C NMR spectrum (75 MHz, CDCl3) of heptacosane-14-ol (77) 
 
3.1.9 Cytotoxic effect of the isolated compounds from J. phoenicea leaves 
Results presented in Table 3.1.12 and Figures (3.1.52-3.1.58) show the IC50 values of the 
isolated compounds from the leaves of J. phoenicea compared with the positive control, 
etoposide (Figure 3.1.51). The most prominent cytotoxicity was observed with the 
deoxypdophyllotoxin mixture (29) separated from the DCM VLC F4, which revealed 
high cytotoxicity against the human lung carcinoma cell lines (A549). The IC50 value of 
imbricatolic acid against the human prostate carcinoma cell lines (PC3) is also presented 





Figure 3.1.51: The structure of etoposide standard (78) 
Table 3.1.12:  The IC50 (µM) of different isolated compounds from J. phoenicea leaves 
on A549 lung cancer cells. 
Pure compound IC50 µM 
Cupressoflavone (24) 65 ± 1.55 
Amentoflavone (25) No activity 
Sumaflavone (76) 77 ± 1.64 
13-Epi-cupressic acid (42) 159 ± 1.16 
Imbricatolic acid (41) 263 ± 2.45 
3-Hydroxy sandaracopimaric acid (44) 223 ± 2.47 
Deoxypdophyllotoxin mixture (29) 2.79 ± 0.09 
Etoposide (78) 61 ± 1.56 
All experiments were carried out in triplicate on separate occasions. 
Data are expressed as means a ± standard error of the mean. 
 
Table 3.1. 13:  The IC50 (µM) of Imbricatolic acid 41 on PC3 lung cancer cells 
Pure compound IC50 µM 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Figure 3.1.52: The cytotoxic activity of cupressoflavone (24) against lung 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 




All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Figure 31.57: The cytotoxic activity of 3-hydroxy sandaracopimaric acid (44) against 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Figure 3.1.58: The cytotoxic activity of deoxypdophyllotoxin (29) mixture against lung 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 




3.1.9.1 The LDH results 
Results of the LDH assay presented in Figure 3.1.60 suggest that cupressoflavone (24) 
(isolated from JPM) causes cytotoxicity to the lung cancer cell lines (A549) at IC50 value 
of 65 µM, through damage to the cell membranes by measuring the LDH activity at two 
absobances: 490 and 690 nm. The LDH activity was performed using a commercial 
cytotoxicity assay kit produced by Roche (REF 11644793001). The necrotic percentage 
was 54 %, which was expressed using the formula: (sample value/maximal release) × 
100% (Chan et al., 2013). 
 
Data were expressed as means a ± standard error of the mean derived from n =24. 
Figure 3.1.60: LDH Release result for cupressoflavone (24) against the lung cancer cell 
lines (A549) 


































Assessment of plasma membrane damage 
resulting from cupressoflavone (24)  treatment 





The Cupressaceae family is a conifer family with worldwide distribution. Many genera 
and species of this family have been reported for their cytotoxicity by inducing apoptosis 
in cancer cells (Kuetea et al., 2013). In the present study, the cytotoxic effect of J. 
phoenicea leaves from the Cupressaceae family was tested against five human cancer cell 
lines, MCF7, HepG2, EJ138, A549, and PC3 using the MTT assay. J. phoenicea leaves 
extracts showed the highest level of cytotoxic activity against the human lung 
adenocarcinoma cell line A549 with the IC50 values of 16, 13 and 100 µg/mL, 
respectively, for the n-hexane, DCM and MeOH extracts (Table 3.1.4). Whilst the DCM 
extract appeared to be the most cytotoxic extract against the PC3 cells, the n-hexane 
extract was the most cytotoxic across the board against HepG2 (human liver 
hepatocellular carcinoma), EJ138 (human bladder carcinoma) and MCF7 (human breast 
adenocarcinoma) having respective IC50 values of 10, 40 and 14 µg/mL. Several 
phytochemicals, e.g., alkaloids, flavonoids, lignans, phenols, steroids and terpenes have 
been demonstrated to possess prominent cytotoxic properties against cancer cells 
(Fernando & Rupasinghe, 2013). Notably, all these groups of phytochemicals have 
previously been isolated from the leaves and berries of J. phoenicea (JP) and other 
Juniperus species (Cupressaceae) grown in different countries (Cairnes et al., 1980; 
Comte et al., 1997; Barrero et al., 2004; Aboulela et al., 2005). It was earlier reported that 
the genus Juniperus contains biflavones, which are mainly, amentoflavone (25), 
cupressuflavone (24) and hinokiflavone. Compounds 24 and 25 might act as useful 
taxonomic markers. However, in the present study applied on the species J. phoenicea, 




the two biflavonoids cupressuflavone (24) and amentoflavone (25). In addition, 
cupressuflavone (24) and sumaflavone (76) showed for the first time cytotoxic activity 
against human lung cancer cells lines (A549) with IC50 of 65 and 77 µM, respectively 
using the MTT assay. The LDH assay was also applied on cupressoflavone (24) against 
the lung cancer cell lines (A549), the results (Figure 3.1.60) suggest that cytotoxicity 
might be through damage to the cell membranes. The necrotic percentage was calculated 
as 56.3 % by using the formula (sample value/maximal release) × 100% (Chan et al., 
2013). Amentoflavone (25) did not show any activity against these cancer cells. It has 
also been reported as weak cytotoxic agent against lung cancer cells A549 (Lee et al., 
2012). However, it exerted potent cytotoxic effects against both MCF-7 and HeLa cells, 
with IC50s of 25 and 20 μM, respectively (Lee et al., 2012). The presence of the aromatic 
hydroxyl group at position 5 in the sumaflavone (76) structure may have played a role in 
the potentiation of the cytotoxic activity against the lung cancer cells A549 where is, the 
lack of this hydroxyl group in the amentoflavone (25) structure inhibited this activity. It 
has also been reported that the substitution of the aromatic hydroxyl group at position 5 
in the A ring is essential for inhibiting the cell growth of human promyelocytic leukaemia 
cells (HL-60) (Li-Xia Chen et al., 2014).  
The chemical investigations of the genus Juniperus have revealed the presence of terpenes 
e.g. monoterpenes, diterpenoids, and sesquiterpens (Seca & Silva 2007), which reported 
their cytotoxicity against many cancer cell lines (Zhao et al., 2011). In this study, four 
diterpenoids (42, 41 and 44) were isolated from J. phoenicea VLC n-hexane F3 and DCM 
(F4 and F6). Three terpenoids were tested for their cytotoxicity against the A549 cell 




cells with IC50 value of 159 µM. Previously, cytotoxic activity against human lung cancer 
cells lines (A549) has been also reported with IC50 > 30 µM, while the imbricatholic acid 
(41) showed the least cytotoxic effect with IC50value of 263 µM. It has been suggested 
that imbricatholic acid (41) induces cell cycle arrest in cellosaurus cell line cells (CaLu-
6) (human, Caucasian, lung, adenocarcinoma) (De Marino et al., 2011), and presented 
moderate cytotoxicity IC50 values of 134 and 280 µM towards AGS cells and human lung 
fibroblasts, respectively (Hirschmann et al., 2007). The diterpene 3-hydroxy 
sandaracopimaric acid (44) showed a moderate cytotoxicity with IC50 value of 223 µM. 
against human lung cancer cells lines (A549). However, there was no report on the the 
diterpene 3-hydroxy sandaracopimaric acid (44) against (A549). Lignans, which are also 
present in many species of the Juniperus genus at a low level (Seca & Silva, 2007; 
Renouard et al., 2011) are well-known cytotoxic compounds against cancer cell lines. 
However, in our study, the VLC DCM F4 obtained from JP yeilded two lignans. The 1H 
and 13C NMR spectroscopic data indicated that they belong to the furan subgroups 
(Tsopmoa et al., 2013), suggesting that they are deoxypdophyllotoxin (29) and β-peltatin 
methyl ether (28). Deoxypdophyllotoxin (29) was impure, as it is appeared to be mixed 
with diterpenoid compound, but its presence in the DCM F4 with the other lignan β-
peltatin methyl ether (28) indicated the high potency of this fraction (IC50 value = 19 
µg/mL). The impure deoxypdophyllotoxin (29) was tested against the A549 lung cancer 
cells and exhibited high level of cytotoxicity with IC50 value of 1.1 µg/mL. 
Conclusion 
The current findings support the traditional use of J. phoenicea for the treatment of 




and fractions of J. phoenicea leaves was contributed by various cytotoxic terpenes 41, 42 
and 44 and lignans 28 and 29. The cytotoxic activity revealed in the polar MeOH extract 






3. 2  Aesphodelus aestivus 
3.2.1  Extraction  
Sequential Soxhlet extraction of the dried and ground leaves of Aesphodelus aestivus 
(AEL) (150 g) and tubers (AET) (159.26 g) afforded three extracts for each part: n-hexane 
(AELH and AETH), dichloromethane (AELD and AETD), and MeOH (AELM and 
AETM). The percentage yields of these extracts are summarized in Table 3.2.1 
Table 3.2.1: Percentage yield of the three extracts obtained from both A. aestivus leaves 
(AEL) and tubers (AET) 
Extract % Yield Extract % Yield 
n-Hexane (AELH) 1.87 n-Hexane (AETH) 0.714 
DCM (AELD) 1.06 DCM (AETD) 1.48 




3.2.2  Preliminary analytical TLC screening of A. aestivus leaves extracts 
The developed TLC plates of three extracts obtained from A. aestivus leaves were viewed 
under short (254 nm) and long (366 nm) UV light and then sprayed with anisaldehyde 
reagent followed by heating at 100ºC for 5 min to reveal many violet and yellow coloured 
spots with Rf values ranging from 0.35 to 0.95 (Table: 3.2.2). The violet and the yellow 
colours suggested the presence of phenols, flavonoids, terpenes or sugars (Figure: 3.2.1) 





            Visible           Sprayed with anisaldehyde 
 
     
Long UV (366 nm)         Short UV (254 nm) 
Mobile phase: Toluene: EtOAc: Acetic acid = 25:24:1  
Figure 3.2.1:  TLC for the three extracts of A. aestivus leaves 
 
Table 3.2.2: Rf values of different extracts of A. aestivus leaves 
Rf values 
 AELH  AELD AELM 







3.2.3  Preliminary analytical TLC screening of A. aestivus tuber extracts 
The developed TLC plates of three extracts obtained from A. aestivus tubers were viewed 
under short (254 nm) and long (366 nm) UV light and then sprayed with anisaldehyde 
reagent followed by heating at 100ºC for 5 min to reveal many orange and phosphorus 
green coloured spots (Figure 3.2.2) with Rf values ranging from 0.16 to 0.94 (Table: 
3.2.3).  
 
       
               Short UV (254 nm)        Sprayed with anisaldehyde 
Mobile phase: Toluene: EtOAc: Acetic acid= 25:24:1 
 
Figure 3.2.2:  TLC for the three extracts of A. aestivus tubers. 
                          
Table 3.2.3: Rf values of different extracts of A. aestivus tubers 
Rf values 
AETH AETD AETM 







3.2.4  Analytical HPLC screening of the A. aestivus leaves MeOH extract  
The MeOH extract of A. aestivus leaves (10 mg/mL) was analysed by Dionex Ultimate 
3000 analytical HPLC coupled with a photodiode array detector using a gradient mobile 
phase, 30-100% MeOH/H2O for 30 min with a volume of injection of 20 µL and a flow 
rate of 1 mL/min. (Figure 3.2.3 and Table 3.2.4). 
 
Figure 3.2.3: Analytical HPLC chromatogram of the MeOH extract of A. aestivus 
leaves (observed at 220 nm) 
 
Table 3.2.4: UV-Vis data for all major peaks obtained from diode array detector 
Peak No. Retention time (min) UV-Vis absorbances λmax (nm) 
1 6.2 257 
2 9.2 263 
3 11.8 279 
4 17.9 270, 350 





3.2.5  Analytical HPLC screening of the A. aestivus tubers MeOH extract  
The MeOH extract of A. aestivus tubers (10 mg/mL) was analysed using the same HPLC 
set up and the mobile phase as shown above (Figure 3.2.4). 
 
Figure 3.2.4: Analytical HPLC chromatogram of the A. aestivus tubers MeOH 
(Observed at 220 nm) 
 
3.2.6  Screening of A. aestivus extracts for cytotoxic activity 
The cytotoxic activity, according the MTT assay, of both the AED and AEM extracts of 
leaves and tubers was assessed against five cancer cell lines; EJ138 (human bladder 
carcinoma), Hep G2 (human liver hepatocellular carcinoma), A549 (human lung 
carcinoma), MCF7 (human breast adenocarcinoma), and prostate cancer cell lines (PC3). 
The DCM A. aestivus tuber extract showed high cytotoxic activity against both the human 
lung carcinoma A549 and the prostate cancer PC3 cell lines with IC50 = 16 and 19 µg/mL, 
respectively. However, the MeOH and n-hexane A. aestivus tuber extracts did not show 
any activity (Table: 3.2.5a).  A. aestivus leaves (DCM extract) showed moderate cytotoxic 
against both the human liver hepatocellular carcinoma HepG2 cells and the human lung 




The selectivity index (SI) of the active DCM extract of A. aestivus tubers was assessed by 
comparing the cytotoxicity results of the human normal prostate cell line (PNT2) with 
those of human prostate cancer cell line (PC3).  The extract revealed high degree of 
cytotoxic selectivity towards the prostate cancer cells (SI = 26), which indicated the 
relative safety of the extract on the normal human cells. The IC50 values of A. aestivus 
tuber extracts in both cell lines and the selectivity index are summarized in Table 3.2.5b. 
Table 3.2.5a: The IC50 (µg/mL) of n-hexane, DCM and MeOH extracts of both A. 
aestivus leaves and tubers on the selection of five human cancer cell lines  




AELH AELD AELM AETH AETD AETM 
EJ138 ˃ 100 ˃ 100 ˃ 100 ˃ 100 ˃ 100 ˃ 100 
Hep G2 ˃ 100 70 ± 0.62 ˃ 100 ˃ 100 ˃ 100 ˃ 100 
A549 ˃ 100 90 ± 1.25 ˃ 100 ˃ 100 16 ± 0.76  ˃ 100 
MCF7 ˃ 100 ˃ 100 ˃ 100 ˃ 100 ˃ 100 ˃ 100 
PC3 ˃ 100 ˃ 100 ˃ 100 80 ± 0.94 19 ± 1.04  ˃ 100 
 
Values greater than 100 µg/mL were considered as non-cytotoxic (Sahranavard et al. 2012). 










Table 3.2.5b: The IC50 (µg/mL) values for AET DCM extract on PC3 and PNT2 cells 
and the selectivity index (SI) using the normal human prostate cells (PNT2). 
Cell type IC50 values 
(µg/mL) (AETD) 
PC3 19 ± 1.04 
PNT2 500 ± 0.81 
Selectivity index 26 
 
Selectivity index (SI)= The IC50 (µg/mL) of extracts against the normal cells divided by the IC50 (µg/mL) of extracts 
against the cancer cells, where IC50 is the concentration required to reduce viability by 50% of the cell population 
(Badisa, et al., 2009). 
 
3.2.7  Chromatographic fractionation of the extracts 
Following the systematic, bioassay-guided phytochemical and cytotoxic/anticancer study 
on A. aestivus, further fractionation of the active extract (AETD) was performed. 
However, the inactive MeOH extract of A. aestivus leaves was fractionated with the aim 
of isolating major metabolites to have thorough understanding of the phytochemistry of 
A. aestivus. 
3.2.7.1  Vacuum liquid chromatography fractionation (VLC) 
The active extract AETD was further fractionated two times by VLC over silica gel using 
two different solvent systems to collect seven fractions each time (Figure 3.2.5 and 3.2.6), 




                
Observed under naked eye                                Sprayed with anisaldehyde 
Figure 3.2.5:  TLC analysis (mobile phase: 5% MeOH in DCM) of the VLC (1) 
fractions of the AETD 
 
Table 3.2.6: Weights of the VLC (1) fractions of the extract AETD (1.855 g) 
Fraction Mobile phase gradient Weight of fraction (mg) 
AETDF1 100% n-hexane 2.4 
AETDF2 10% EtOAc in n-hexane 2.2 
AETDF3 30% EtOAc in n-hexane 10.8 
AETDF4 50% EtOAc in n-hexane 10.0 
AETDF5 80% EtOAc in n-hexane 160.0 
AETDF6 100% EtOAc 1272.3 
AETDF7 50% MeOH in EtOAc 110.0 
    









Observed under naked eye                                      Long (366 nm) UV
 
Short UV (254 nm) 
Figure 3.2.6:  TLC analysis (mobile phase: 5% MeOH in DCM) of the VLC (2) 
fractions of AETD 
 
 Table 3.2.7: Weights of the VLC (2) fractions of the extract AETD (200 g) 
Fraction Mobile phase gradient Weight of fraction (mg) 
AETDF1 100% n-hexane 4.8 
AETDF2 50% DCM/n in hexane 2.7 
AETDF3 100% DCM 3.0 
AETDF4 10%  MeOH in DCM 140 
AETDF5 20%  MeOH in DCM 11 
AETDF6 30%  MeOH in DCM 4.0 







3.2.7.2  Solid phase extraction (SPE) 
The MeOH extract of A. eastivus leaves (AELM) (1.8 g) was fractionated by SPE to 
collect four fractions (Figures 3.2.7- 3.2.10; Table 3.2.8).  
Table 3.2.8: Weights of the SPE fractions of the MeOH extract of A. eastivus leaves 
Fraction Mobile phase gradient Weight of fraction (mg) 
AELMF1 20% MeOH/H2O 1043.3 
AELMF2 50% MeOH/H2O 51.2 
AELMF3 80% MeOH/H2O 35.3 










Figure 3.2.8: Analytical HPLC chromatogram of SPE fraction 2 of AELM (observed at 
220 nm)
 
Figure 3.2.9: Analytical HPLC chromatogram of SPE fraction 3 of AELM (observed at 
220 nm)
 





3.2.8  Screening of A. aestivus fractions for cytotoxic activity 
The cytotoxic activity of the DCM fractions obtained from both the two VLC 
chromatographic fractionation of A. aestivus tubers was assessed against the most 
sensitive cancer cell line (human prostate cancer cell line PC3). The highest activity was 
revealed in the DCM F4 obtained from the VLC (2) with IC50 value of 21 µg/mL. The 
IC50 values for the DCM fractions of A. aestivus tubers on PC3 are summarised in Tables 
3.2.9 and 3.2.10. 
Table 3.2.9: The IC50 (µg/mL) of DCM fractions from VLC (1) AET on PC3 (human 
prostate cancer cell line). 
Fraction F1 F2 F3 F4 F5 F6 F7 
IC50 µg/mL >100 >100 >100 >100       73 ± 0.52 
All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Table 3.2.10: The IC50 (µg/mL) of DCM fractions from VLC (2) AET on PC3 (human 
prostate cancer cell line) 
Fraction F1 F2 F3 F4 F5 F6 F7 
IC50 µg/mL >100 >100 >100 21 ± 1.56  98 ± 0.67 >100 >100 
All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 







3.2.9  Isolation of compounds from A. aestivus  
3.2.9.1  The MeOH extract (AEM) 
The MeOH extract of AELM  
Isolation of compounds from the SPE fractions 2, 3 and 4 of AELM was done using semi-
preparative HPLC technique (Agilent) employing a 30-100% gradient of MeOH in water 
for 30 min with a volume of injection of 200 µL and a flow rate of 2 mL/min.The 
following compounds were isolated: AELMF2-1 (2.9 mg, tR = 10.3 min) (Figure 3.2.11) 
from SPE fraction 2, AELMF3-4 (5.7 mg, tR = 22 min) (Figure 3.2.12) from SPE fraction 
3, and AELMF4-2 (1.8 mg, tR =19.5) (Figure 3.2.13) from SPE fraction 4. 
 
 
Figure 3.2.11: HPLC chromatograms of isolated compounds from SPE fraction 2 






Figure 3.2.12: HPLC chromatogram of isolated compounds from SPE fraction 3 AELM 




Figure 3.2.13: HPLC chromatogram of isolated compounds from SPE fraction 4 AELM 
(observed at 254 nm) 
 
The MeOH extract of AETM  
The total MeOH extract (AETM) (1.33 g) was fractionated every 5 min by preparative 
reversed-phase HPLC using a gradient solvent system 30-100% MeOH in water and a 
flow rate of 10 mL/min. Six fractions [F1= 14 mg (0-5 min), F2= 12.3 mg (5-10 min), F3 
= 80.3 mg (10-15 min), F4 = 53.6 mg (15-20 min), F5 = 24.2 mg (20-25 min), F6 = 69 





Figure 3.2.14: Fractionation of AETM extract every 5 min (observed at 290, 254, 310 
nm) 
 
HPLC-MS screening of AETM Fraction 4:  
AETM Fraction 4 exhibited the most interesting 1H NMR spectrum and HPLC (10-100% 
ACN/H2O gradient) chromatogram (Figure 3.2.15), so it was analysed by HPLC-MS to 
detect the molecular weights of the major metabolites, and thus to tentatively identify 
aleo-emodin 271 [M+H]+ and aleo-emodin acetate 312 [M+H]+, chrysophanol 255 
[M+H]+, chrysophanol-10,10'-bianthrone 479 [M+H]+, and p-hydroxy transferulate 315 






                     Figure 3.2.15: Analytical HPLC chromatogram of AETM Fraction 4 






       
       





    



















3.2.9.2  The DCM extract (AED) 
The DCM extract of AELM   
The total DCM extract (AELDM) (500 mg) was separated by preparative reversed-phase 
HPLC using a gradient solvent system 30-100% ACN in water and a flow rate of 10 
mL/min. This led to the isolation of AELD-3 (1 mg, tR =25.2 min) and AELD-5 (1.4 mg, 
tR =35.3 min) (Figure 3.2.17). 
 
Figure 3.2.17:  HPLC chromatograms of isolated compounds from the DCM extract 
(observed at 254, 290 and 366 nm) 
 
The DCM extract of AET        
Two pure compounds were completely crystalized from the VLC fractions 4 (VLC 1) 
and 3 (VLC 2) as following: AETD4 (10.8 mg, Rf = 9.5) (Figure 3.2.18) and AETD3 (3 






Figure 3.2.18:   
Crystals from the DCM extract of A. aestivus tubers VLC (1) (AETD4) 
 
 
Figure 3.2.19:   
Crystals from the DCM extract of A. aestivus tubers VLC (2) (AETD3) 
 
Separation of the active DCM VLC (2) Fraction 4  
The active DCM fraction 4 purified from VLC (2) (140 mg) of A. aestivus tubers was 




afforded two major compounds: AETD4-6 (1.2 mg, tR= 23.1 min), AETD4-11 (2 mg, tR 
= 30.2 min), (Figure 3.2.20). 
     
Figure 3.2.20: HPLC chromatogram of isolated compounds from the active AETD 
fraction 4 (VLC 2) (observed at 366 nm) 
 
3.2.10 Characterization of isolated compounds from A. aestivus  
3.2.10.1  Characterization of flavonoid 
Characterization of AELF3-4 and AELF4-2 as the flavonoids luteolin (22) 
One flavonoid 22 was isolated from the SPE fractions F4 of AELM (Figure 1.3). The UV-
Vis spectrum of this compound exhibited two major absorption peaks (Figure 3.2.21) at 
λmax: 256, 270 (sh) nm (Band –II) and 348 nm (Band –I) indicating this compound to be 
flavonoid (Mabry et al., 1970). The ESIMS m/z showed a peak at: 287 [M+H]+, indicated 
that the molecular formula could be C15H10O6 (Figure 3.2.22). 
1H NMR spectrum (600 
MHz, CD3OD) Table (3.2.11) and Figure (3.2.23) showed several common features for 
flavonoid skeleton, which include the presence of two meta-coupling aromatic protons 
assigning to H-6 at δH (6.46, d, J= 2.0 Hz, 1H ) and H-8 at δH (6.23, d, J = 2.0 Hz, 1H) in 




ortho- meta coupled aromatic protons assigning to H-2` at δH (7.42, d , J = 2.4 Hz) and 
H-6` at δH (7.41, dd, J = 8.4 Hz, J= 2.4. Hz) in ring B. A sharp singlet indicating the 
olefinic proton in the ring C at δH (6.56, H-3). This compound could be assigned to be 
luteolin (22). The COSY experiment showed proton-proton correlation from H-6`↔H 
2`and H-6`↔H 5`. The further evidence of 13C NMR (150 MHz, CD3OD) Table (3.2.11) 
and Figure (3.2.24) showed the existence of 15 carbon signals were typical for flavone 
nucleus including 12 aromatic carbons attributed to two aromatic rings, two olefenic at δC 
165.0 (C-2) and 102.5 (C-3), and the most deshielded carbon was assigned for carbonyl 
group of chromen nucleus δC 182.5 (C-4). All signals were comparable to the published 











Figure 3.2.22:  MS spectrum of Luteolin (22) 
 
 







Figure 3.4.24:  13C NMR spectrum (75 MHz, CD3OD) of luteolin (22) 
 
Table 3.2.11: ¹H NMR (600 MHz, CD3OD) and ¹³C NMR (150 MHz, CD3OD) of luteolin 
(22)  
 Chemical Shift δ (ppm) and J in 
Hz 
 Chemical Shift δ (ppm) and J in 
Hz 
Position 1H 13C Position 1H 13C 
2  165.0 10  103.9 
3 6.56, s, 1H 102.5 1`  119.8 
4  182.5 2` 7.42, d, 2.4 112.8 
5  161.8 3`  145.7 
6 6.46, d, 2.0, 1H 98.8 4`  149.6 
7  164.7 5` 6.92, d, 8.4, 1H 115.4 
8 6.23, d, 2.0, 1H 93.6 6` 7.41, dd; 8.4, 2.4 122.3 









3.2.10.2  Characterization of anthraquinones 
Four anthraquinone compounds were isolated; one from the (AEL) DCM extract and the 
others from the VLC fractions 3 and 4 purified from the (AET) DCM extract. They were 
identified as two anthrones: aloe-emodin (13), and chrysophanol (79) (Figure 3.2.25) and 
two bianthrones: chrysophanol-10, 10’-bianthrone (80), and C-α-rhamnopyranosyl 
bianthracene-9,9',10 (10'H)-trione glycoside (81). 1H NMR (600 MHz, CDCl3) reaveled 
the presence of four highly downfield proton signals as sharp singlets at δH (12.00 and 
12.10 ppm) corresponding to hydroxyl groups involved in hydrogen bonding. 13C NMR 
and DEPT (150 MHz, CD3OD) and (150 MHz, CDCl3) showed two carbonyl groups at 
δC (182.1, 193.5, 193.5) in the anthraquinones 13, 79, and 80, respectively, a methyl group 
at (δH-2.47; δC-22.3) in compound 79 and two methyl groups in compound 80 at (δH-2.47; 
δC-22.3). All these data supported the suggestion of anthraquinone compounds Tables 
(3.2.12-3.2.14) and Figures (3.2.26, 3.2.33, and 3.2.35).  
   
Compounds R1 R2 
Aloe-emodin (13) CH2OH H 
Chrysophanol (79) H CH3 
 
Figure 3.2.25: Structure of anthraquinones isolated from A. aestivus 
 
Characterization of AELD-5 and AELMF4-3 as aloe-emodin anthrone (13) 
 
Orange powder, The 1H NMR (600 MHz, CD3OD) (Figure 3.2.26 and Table 3.2.12) 




signals include two meta-coupled aromatic protons assigning to H-1 at δH (7.35, d, J= 1.0 
Hz, 1H) and H-3 at δH (7.34, d, J= 1.0 Hz, 1H), a broad singlet assigned for H6 and H8 at 
δH 7.82 (1H, br s), and ortho-coupled protons assigned to H-7 at δH (1H, t, J= 7.9 Hz). 
The protons of both the oxygenated carbon, which appeared as a sharp singlet at δH 4.86 
(2H, s) and the downfield proton singlets at δH (12.11 and 12.12 ppm) were clearly shown 
in the 1H NMR (600 MHz, CDCl3) spectrum (Figure 3.2.27).  The 
13C NMR (150 MHz, 
CD3OD) data (Table 3.2.13) showed that compound 13 has 15 carbon signals including 
two carbonyl carbons at δC 182.3 (C-9) and 187.5 (C-10), one hydroxyl aliphatic carbon 
at δC 62.7 (C-11), and 12 aromatic carbons including two hydroxyl aromatic carbons at 
δC 164.9 (C-4) and 166.4 (C-5). The important HMBC correlations (Figure 3.2.28)   from 
H3→C-11 (3J), and H1→C-11 (3J) confirmed the position of the oxygenated carbon 
attached to position 2 indicating that this anthraquinone was aloe-emodin anthrone (13). 
All signals were comparable to the published data of aloe-emodin and suggested the 
molecular formula C15H10O5 (Danielsen et al., 1992). The ESIMS m/z: 273 [M+H]
+, 
which does not correspond to aloe-emodin, the reason might be that the compound was 
in solution for a time, so the carbonyl group was reduced to a hydroxyl group, when 





Figure 3.2.26:  1H NMR spectrum (600 MHz, CD3OD) of aloe-emodin anthrone 
(13) 
 






            Figure 3.2.28: HMBC correlations (600 MHz, CD3OD) of aleo-emodin 
anthrone (13) 
 
Figure 3.2.29:  Reduction of aloe-emodin anthrone (13) 
 




 Characterization of AETDF3 as chrysophanol anthrone (79)  
Orange red crystals, The 1H NMR (600 MHz, CDCl3) (Table 3.2.12 and Figure 3.2.32) 
showed ortho-meta coupled  aromatic protons assigning to H-6 at δH (7.83, dd, J = 1.2 
Hz, J = 7.5 Hz, 1H) and H-7 at δH (7.30, dd, J = 1.1 Hz, J=8.3 Hz, 1H),  ortho-coupling 
at δH (7.67, d, J = 7.4 Hz, 1H ) assigned to H-5, one singlet peak assigning to H-2 at δH  
(7.10, s, 1H) indicating the substitution at position 3 and the two highly downfield shifted 
proton signals at δH (12.00, 12.10). All these data indicated that this compound might be 
anthraquinone. The DEPT data (150 MHz, CDCl3) (Table 3.2.13) confirmed that 
compound 79 is an anthraquinone anthrone where it exhibited 15 carbon atoms including 
12 aromatic, two carbonyl groups at δC 193.5 (C-9), 179.5 (C-10), a methyl group at δC 
22.3 (-CH3). The ESIMS m/z: 255 [M+H]
+ confirmed the molecular formula C15H10O4 as 
chrysophanol (79) (Figure 3.2.31). All data were comparable to the published data 
(Coopoosamy & Magwa, 2006).        
 
 
Figure 3.2.31: Structure of chrysophanol (79) 















Table 3.2.12: 1H NMR (600 MHz) for the anthrone anthraquinones: aloe-emodin (13) 
and chrysophanol (79)  
                             13        79 
 
Position 
Chemical Shift δ (ppm), multiplicity and J in Hz 
13** 79* 
1 7.35, d, 1.02, 1H  
2  7.10, s, 1H 
3 7.34, d, 1.02, 1H  
4  7.69, s, 1H 




6 7.82, br s, 1H 7.83, dd, 1.2, 7.5, 1H 
7 7.77, t, 1H 7.30, dd; 1.14, 8.3, 1H 
8 7.82, br s, 1H  
3-OCH3  2.47, s, 3H 
8-OH  12.00, s 
1-OH  12.10, s 
 **= (CD3OD), *= (CDCl3)  
 
Table 3.2.13: 13CNMR (150 MHz) of aloe-emodin (13) and DEPT NMR (75 MHz) of 
chrysophanol (79)  
 
Position 
Chemical Shift δ (ppm)  
Position 
Chemical Shift δ (ppm) 
13C   13** DEPT   79* 13C   13** DEPT   79* 
1 121.0 162.8 9 182.3 193.5 
2 155.0 121.4 10 187.5 179.5 
3 124.0 149.3 10a 115.6  
4 164.9 120.0 3-CH3  22.3 
5 166.4 119.9 8-OH   
6 124.0 137.0 1-OH   
7 136.9 124.6 COOH 168.6  
8 117.2 162.8    
**= (CD3OD), *= (CDCl3) 
Characterization of AETDF4 and AETD4-11 as chrysophanol-10, 10’-bianthrone 
(80) 
 
Brownish red crystals; The ESIMS m/z: 477  [M+H]+, confirmed the molecular formula 
C30H22O6. 
1H NMR (600 MHz, CDCl3) spectrum (Figure 3.2.34) showed data similar to 
chrysophanol as  dimer. The ortho-meta coupled  aromatic protons assigning to H-6 and 
H-6` at δH (7.83, dd, J = 1.2 Hz, J = 7.5 Hz, 1H) and H-7 and H-7` at δH (7.29, dd; J = 1.1 
Hz, J = 8.3 Hz, 1H),  ortho-coupling at δH (7.67, d, J = 7.4 Hz, 1H ) assigned to H-5 and 
H-5`, one singlet peak assigning to H-2 and H-2` at δH  (7.10, s, 1H) indicating the 




and 12.10 for 8-OH, 12.20 and 12.40 for 1-OH). DEPT NMR (150 MHz, CDCl3) Table 
(3.2.14) and Figure (3.2.33) showed two carbonyl groups δC 193.6 (C-9, 9`), two methyl 
groups at (H-1.27; C-22.3) and the singlet peak at (H-4.41; C-56.4) assigned to the 10, 
10` C-C linkage indicating that compound 80 is bianthrone anthraquinone. The bianthrone 
nucleus was confirmed by the 30 signals including 24 aromatic carbons. All data 
confirmed the compound 80 as chrysophanol-10,10’-bianthrone (Figure 3.2.33) and were 








    
 
Figure 3.2.34:  1H NMR spectrum (600 MHz, CDCl3) of chrysophanol 10, 10`-
bianthrone (80) 
 
Table 3.2.14: ¹H NMR (600 MHz, CDCl3) and DEPT NMR (150 MHz, CDCl3) of 
chrysophanol-10, 10’-bianthrone (80)  
 Chemical Shift δ (ppm), J in Hz  Chemical Shift δ (ppm), J in Hz 
Position 1H DEPT Position 1H DEPT 
1  162.4 1`  162.4 
2 6.70, s, 1H 116.0 2` 6.70, s, 1H 116.0 
3  148.0 3`  148.0 
4 7.10, s, 1H 120.0 4` 7.10, s, 1H 120.0 
5 7.67, d, 7.4, 1H 120.8 5` 7.67, d, 7.4, 1H 120.8 
6 7.83, dd, 1.2, 7.5, 1H  137.0 6` 7.83, dd, 1.2, 7.5, 1H  137.0 
7 7.29, dd; 1.14, 8.3, 1H 115.5 7` 7.29, dd; 1.14, 8.3, 1H 115.5 
8 6.42, d,15.6, 1H 162.7 8` 6.42, d,15.6, 1H 162.7 
9  193.6 9`  193.6 




3-CH3 1.27, s, 3H 22.3 3`-CH3 1.27, s, 3H 22.3 
8-OH 12.00, s  8-OH 12.10, s  
1-OH 12.20, s  1-OH 12.40, s  
 
 
Characterization of AETDF4-6 as C-α-rhamnopyranosyl bianthracene-9, 9’, 10 
(10'H)-trione glycoside (81)  
Brownish yellow powder, the UV-Vis spectrum (Figure 3.2.36) of this compound 
exhibited four major absorption peaks at λmax: 224 nm, 256, 368 and 440 nm indicating 
this compound to be anthraquinone (Anouar et al., 2014). The ESIMS m/z showed a peak 
at: 637 [M-H]-, indicating  the molecular formula  C36H30O11 (Figure 3.2.35). 
1H NMR 
(600 MHz, CD3OD) (Figure 3.2.37 and Table 3.2.15) showed four ortho-coupling 
aromatic protons; the first one at δH (7.27, dd, J = 7.0, 10.0,) assigned for H-5 and H-5`, 
the second at δH  7.67 (t, J = 8.0) assigned for H-6, the third and fourth ortho-coupling 
were at δH 7.58 (d, J = 8.0) pointed for H-7 and  at δH 7.26 (d, J = 9.0) assigned for H-6`, 
respectively. Compound 80 showed also three aromatic singlet  protons, two are separated 
by a methyl group at δH (6.75, H-2`) and (6.94, H-4`) and a singlet proton at δH (7.34, H-
2). A sharp singlet at δH 4.58 assigned for H-10`, indicated the proton attached to the C-
glycosidic linkage. This compound could be assigned as bianthracene. The 13C NMR (150 
MHz, CD3OD) Table (3.2.15) showed three carbonyl groups at δC 196.2 (C -9), 184.3 
(C-10), and 194.9 (C-9`) indicating that compound 81 (Figure 3.2.35) is bianthracene-
trione. From the HSQC and HMBC correlations (Figures 3.2.38 and 3.2.39). The H-10`→ 
C-2`` HMBC correlation confirmed the C-glycoside linkage of compound 80 (the lack of 




linkage of the two anthrone moieties in the bianthrone, All data were comparable to the 
published data (Adinolfi et al., 1991).          
 
Figure 3.2.35: Structure of C-α-rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione 
glycoside (81) 
                                                                                                       
 
Figure 3.2.36: The UV aborbance (MeOH) of C-α-rhamnopyranosyl bianthracene-9, 9’, 






Figure 3.2.37:  1H NMR spectrum (600 MHz, CD3OD) of C-α-rhamnopyranosyl 
bianthracene-9,9',10 (10'H)-trione glycoside (81) 
 
Table 3.2.15:  ¹H NMR (600 MHz, CD3OD) and ¹³C NMR (150 MHz, CD3OD) of C-α-
rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione glycoside (81)  
 
 Chemical Shift δ (ppm), J 
in Hz 
 Chemical Shift δ (ppm), J in Hz 
Position 1H 13C Position 1H 13C 
2 7.34, s 125.6 4` 6.94, s 120.5 
3  151.5 5` 7.27, dd: 7.0, 10.0 115.5 
4  129.3 6` 7.26, d, 9.0 134.5 
5 7.27, dd: 7.0, 10.0 124.5 7`  134.3 
6 7.67, t, 8.0 136.8 8`  160.7 
7 7.58, d, 8.0 121.6 9`  194.9 
8  163.0 10` 4.58 45.2 
9  196.2 11` 2.15, s 20.0 




11 2.44, s 20.8 3`` 4.04, dd, 3.4, 8.5  
1`  162.4 4`` 3.91, t, 2.9  
2` 6.75, s 115.5 5`` 3.39, dd: 2.4, 6.2 47.5 
3`  149.3 6``-12 1.07, d, 6.5  
 
   
 
 
Figure 3.2.38: HSQC correlations (600, 150 MHz, CD3OD) of C-α-rhamnopyranosyl 






Figure 3.2.39: HMBC correlations (600, 150 MHz, CD3OD) of C-α-rhamnopyranosyl 
bianthracene-9,9',10 (10'H)-trione glycoside (81) 
 
3.2.10.3  Characterization of ferulate derivative 
Characterization of ferulate derivative AELD-3 as p-hydroxy-phenethyl trans-ferulate 
(82) 
Colourless powder; The UV-Vis spectrum of this compound exhibited only one major 
absorption peaks at λmax: 318 nm. The ESIMS m/z showed a peak at: 315 [M+H]
+, 
significant peaks at m/z 193 [M+H]+ p-hydroxy phenethyl moiety and 120 [M+H]+ 
feruloyl moiety indicating that the molecular formula could be C18H18O5 (Figure 3.2.41). 
1H NMR (600 MHz, CD3OD) Table (3.2.16) and Figure (3.2.42) showed three aromatic 
signals; one ortho-meta coupling assigned to H-6 at δH 7.04 (dd, J = 8.2 Hz, J= 1.7 Hz, 
1H), one meta-coupling at δH 7.14 (d, J = 1.7 Hz, 1H) assigned to H-2. It also showed 
aromatic ortho coupling at δHs;  6.80 (d, J = 8.2 Hz, 1H, H-5), 7.07 (d, J = 8.0 Hz, 2H, H-
2`), 6.74 (d, J = 8.5 Hz, 2H, H-3`),  6.74 (d, J = 8.5 Hz, 2H, H-5`), 7.07 (d, J = 8.0 Hz, 




doublets assigning to H-7 and H-8 appeared at δH 7.45 (d, J = 15.7 Hz, 1H) and δH 6.42 
(d, J = 15.6 Hz, 1H) indicated that compound 82 was a trans isomer. A singlet peak at 
position 3.91(3H) indicated the presence of methoxy group in compound 82. 13C NMR 
(600 MHz, CD3OD) revealed the presence of 18 carbon signals including 12 aromatic 
protons and one carbonyl at δC 169.5 All the mentioned data confirmed that the structure 
is p-hydroxy-phenethyl trans-ferulate (Figure 3.2.40). comparable to the published data 
(Darwish & Reinecke, 2003). 
 
 
Figure 3.2.40: Structure of p-hydroxy-phenethyl trans-ferulate (82) 
                  
 
 





Table 3.2.16: ¹H NMR (600 MHz, CD3OD).and ¹³C NMR (150 MHz, CD3OD) of p-
hydroxy-phenethyl trans-ferulate (82)  
 Chemical Shift δ (ppm), J in Hz  Chemical Shift δ (ppm), J in Hz 
Position 1H 13C Position 1H 13C 
1   1`  131.5 
2 7.14, d, 1.7, 1H 111.7 2` 7.07, d, 8.0, 2H 130.9 
3  149.4 3` 6.74, d, 8.5, 2H  
4  150.1 4`  157.4 
5 6.80, d, 8.2, 1H 116.4 5` 6.74, d, 8.5, 2H  
6 7.04, dd; 8.2, 1.7, 1H 123.4 6` 7.07, d, 8.0, 2H  
7 7.45, d, 15.7, 1H 142.1 1`` 3.48, t, 7.3, 2H 42.7 
8 6.42, d, 15.6, 1H 118.9 2`` 2.77, t, 7.6, 2H 36.0 








Figure 3.2.41: MS spectrum (atmospheric solid analysis probe, +ve mode) of p-
hydroxy-phenethyl trans-ferulate (82) 
 
3.2.11  Cytotoxic effect of the isolated compounds from A. aestivus 
Results presented in Table 3.2.17 and Figures 3.2.43 and 3.2.44 show the IC50 values of 
the isolated compounds from the leaves and tubers of A. aestivus compared with the 
positive control etoposide. The cytotoxicity applied against both the human prostate and 




against prostate cancer cells. The most prominent cytotoxicity was observed with C-α-
rhamnopyranosyl bianthracene-trione glycoside (81), which was separated from the 
active fraction DCM VLC F4 of AET. It revealed highly significant results at the 
concentrations 1.9, 16.9, and 153.3 µM, while the lower doses (0.02 and 0.2 µM) showed 
non-significant results. The IC50 value of compound 81 was 62 µM.  
Compound 82 was tested against the hepatocellular carcinoma cells (HEPG2) but did not 
show any cytotoxic activity Table 3.2.17. 
Table 3.2.17:  The IC50 (µM) of different isolated compounds from A. eastivus tubers on 
PC3 lung cancer cells.   






Luteolin (22) 201±1.10  
 
NA 76.9 ±1.11  
after 48 h 
C-α-rhamnopyranosyl bianthracene-




Chrysophanol anthrone (79) No activity* 
    
NA No activity* 
 
Chrysophanol bianthrone (80) No activity* 
      




NA No activity* 
 
NA 
Etoposide (78) NA NA 61 ± 1.56 
 
 
*No activity at the highest concentration of 500uM      NA--- Non-applicable 
All experiments were carried out in triplicate on separate occasions. Data were expressed as means ± standard error of 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Figure 3.2.44: The cytotoxic activity of C-α-rhamnopyranosyl bianthracene-9,9',10 





Asphodelus L. (Asphodelaceae) is a genus distributed along the Mediterranean basin and 
has been reported for its biological activities such as anti-bacterial, anti-fungal, anti-
parasitic, cytotoxic and anti-inflammatory activity. Previous phytochemical studies 
identified the main classes of compounds as 1, 8-dihydroxyanthracene derivatives, 
flavonoids, phenolic acid, and triterpenoids from the different species such as; A. acaulis, 
A.aestivus, A.cerasiferus, A.fistulosus, A.albus, A.microcarpus, A.ramosus, and 
A.tenuifolius. The aerial parts of these plants mostly revealed the presence of flavonoids 
such as luteolin, isovitexin and isoorientin, phenolic acids, and few anthraquinones while 
the roots have been reported to have mainly anthraquinone derivatives such as aloe-
emodin, chrysophanol and triterpenoids derivatives (Malmir et al., 2018). 
In the present study, the cytotoxic activity of A. aestivus leaves and tubers from the 
Asphodelaceae family was tested using the MTT assay. This is the first time, to our 
knowledge, that the plant’s cytotixic activity has been assessed in the four human cancer 
cell lines, HepG2, EJ138, A549 and PC3. Only one other report is available on A. aestivus 
concerning its cytotoxic activity against the breast cancer cell line MCF7 (Aslantürk & 
Çelik, 2013).  A. aestivus tuber extracts showed higher level of cytotoxic activity than the 
leaves. The DCM tuber extract showed high cytotoxic activity against both the human 
lung carcinoma A549 and the prostate cancer PC3 cell lines with IC50 values 16 and 19 
µg/mL, respectively (Figure: 3.2.4) and (Table 3.2.5), while the MeOH and n-hexane 
extracts did not show any cytotoxic activity in the cell lines used.  A. aestivus leaves 
showed weak cytotoxicity against both the human liver hepatocellular carcinoma Hep G2 
and the human lung carcinoma A549 with IC50 value of 70 and 90 µg/ mL, respectively 




to A. aestivus tubers than normal prostate cells (PNT2) with high selective index (SI = 
26). This selectivity might be attributed to the presence of anthhraquinones as reported by 
Huang et al., in 2007. 
Anthraquinones are bioactive compounds derived from Aloe, Asphodelus, Purslane, 
Rhubarb, and Senna. Many biological studies revealed their antibacterial, antifungal, 
gastrointestinal and renal protective effects. In recent years, their reported anticancer 
activities have attracted more attention among several types of anthraquinones such as 
emodin, aloe-emodin, and rhein (Huang et al., 2007).  
In this study, four anthraquinones were isolated from A. aestivus; three from the tubers 
(VLC fractions (3 and 4): chrysophanol anthrone (79), chrysophanol-10,10'-bianthrone 
(80), and C-α-rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione glycoside (81) and 
one anthraquinone from the leaves (DCM extract): aloe-emodin (13).  Compounds 79, 80, 
and 81 were isolated for the first time from this species (Malmir et al., 2018). However, 
compound 81 had been isolated from A. ramosus tubers in 1991 and chyrosphanol 1-O-
gentiobioside was only reported in A. aestivus while chrysophanol anthrone (79) isolated 
only in this study.  
The three compounds 79-81 isolated from the VLC tuber fractions were tested for their 
cytotoxicity against the PC3 cell line. The bianthracene-trione (81) obtained from the 
active VLCF4, showed good cytotoxicity with IC50 value of 62 µM, which is reported for 
the first time, and might be responsible for the high potency of this fraction (IC50 value = 
21 µg/mL).  Compounds 79 and 80 did not show any activity. It has also been previously 
reported that chrysophanol (79) has weak cytotoxic activity (Huang et al., 2007), and it 




anthraquinones. In addition, chrysophanol has been reported as an antitumor agent acting 
against the growth and proliferation of a mouse lymphocytic leukemic cell line (L1210), 
however, this result was not replicated in a human leukemia cell line (HL-60) (Lee et al., 
2011). Furthermore, anthraquinones including chrysophanol showed antiproliferative 
effects in human colon cancer cells (SW620) and human breast cancer cells (MCF7 and 
MDA-MB-231) (Lee et al., 2011). 
Additionally, in this study, p-hydroxy-phenethyl trans-ferulate (82) was isolated for the 
first time from A. aestivus leaves. It was previously isolated from Heracleum lanatum 
(Nakata et al., 1982), Oenanthe javanica (Fujita et al., 1995) and Coriandum sativum 
(Taniguchi et al., 1996) and has been reported to have antioxidant properties. Compound 
82 was isolated from the DCM extract of A. aestivus leaves (AELD). This extract (DCM) 
showed moderate cytotoxicity against the HEPG2 cell lines with IC50 value of 70 µg/mL, 
so compound 82 was tested for its cytotoxicity against the HEPG2 cell lines but did not 
show any activity. The activity of the DCM extract may be due to the presence of 
cytotoxic aloe-emodin (compound 13), but unfortunately, an accidental loss of the sample 
meant it could not be tested. 
Flavonoids belong to a group of natural substances with variable phenolic structures, 
which are abundant in various fruits and vegetables, and in all parts of the plants. They 
have been reported to have a wide spectrum of biological activities such as 
antiinflammatory, antiallergic, antiviral, and anticarcinogenic activity (Nijveldt et al., 
2001). Luteolin is a natural flavonoid found in fruits and vegetables. It usually occurs in 
its glycosylated form in celery, green pepper, perilla leaf and camomile tea. Luteolin has 




Recent studies have been aimed more on its reported potent anticancer activity against 
various tumor cells e.g. breast, liver, skin, and prostate cancer cell lines (Song et al., 
2017). Our study revealed the isolation of luteolin (22) from both the SPE fractions 3 and 
4 purified from the MeOH extract of A. aestivus leaves. Luteolin (22) was tested for its 
cytotoxicity against both the PC3 prostate cancer and A549 lung cancer cell lines. It 
showed moderate cytotoxicity with IC50 value of 201 µM for the prostate cancer cells 
after a 24 h treatment and with an IC50 value of 76.9 µM for the lung cancer cells after a 
48 h treatment period. The cytotoxic activity of luteolin has also previously reported on 
both PC3 and A549 cell lines (Han et al., 2016). 
Conclusion 
The current findings support the traditional use of A. aestivus for the treatment of tumours. 
These results suggest that the cytotoxicity is higher in the tubers than in the leaves. The 
observed toxicity in the roots was contributed to by various cytotoxic anthraquinones e.g. 
(C-α-rhamnopyranosyl bianthracene-9,9',10 (10'H)-trione glycoside 81). While the 
cytotoxic activity revealed in the leaves was due to the presence of cytotoxic flavonoids 





3.3  Ruta chalepensis 
3.3.1  Extraction  
Sequential Soxhlet extraction of the dried and ground aerial parts of Ruta chalepensis 
(RCA) (349.13 g) afforded three extracts: n-hexane (RCH), dichloromethane (RCD), and 
MeOH (RCM).  The percentage yields of these extracts are summarized in Table 3.3.1 
Table 3.3.1: Percentage yield of the three extracts obtained from R. chalepensis aerial 
parts 
Extract % Yield 
n-Hexane (RCH) 2.6 
DCM (RCD) 1.15 
MeOH (RCM) 19.8 
 
 
3.3.2 Preliminary analytical TLC screening 
The developed TLC plates of three extracts obtained from R. chalepensis were viewed 
under short (254 nm) and long (366 nm) UV light. The TLC plates showed blue 
fluorescent spots, which may indicate the presence of coumarins (Lee 1965).  The TLC 
plates then sprayed with anisaldehyde reagent followed by heating at 100ºC for 5 min to 
reveal many violet coloured spots with Rf values ranging from 0.16 to 0.94 (Table 3.3.2) 
The violet colour suggested the presence of alkanes and terpenes in the n-hexane extract 






            Short UV (254 nm)       Long UV (366 nm)      Sprayed with anisaldehyde 
Mobile phase: n-Hexane: EtOAc = 80:20 
Figure 3.3.1:  TLC for the three extracts of R. chalepensis aerial parts 
 
Table 3.3.2: Rf values of different extracts of R. chalepensis aerial parts 
n-Hexane Rf values DCM Rf values 
0.01, 0.11, 0.29, 0.43, 0.56, 0.74, 0.84 0.01, 0.11, 0.29, 0.43, 0.56, 0.70, 0.74, 0.84 
 
3.3.3  Analytical HPLC screening of the MeOH extract of R. chalepensis 
aerial parts 
The MeOH extract of R. chalepensis aerial parts (10 mg/mL) was analysed by Dionex 
Ultimate 3000 analytical HPLC coupled with a photodiode detector using a gradient 
mobile phase, 30-100% MeOH/H2O for 30 min with a volume of injection of 20 µL and 






Figure 3.3.2: Analytical HPLC chromatogram of the MeOH extract of R. chalepensis 
aerial parts (observed at 220 nm) 
 
Table 3.3.3: UV-Vis data for all major peaks obtained from diode array detector 
Peak No. Retention Time (min) UV-Vis absorbances (λmax) (nm) 
1 4.8 218, 281, and 326 
2 7.7 219, 246,300, and 340 
3 15.8 243 and 325 
4 17.2 249 and 321 
5 22.1 335 
6 23.9 242 and 291 







3.3.4  Screening of R. chalepensis extracts for cytotoxic activity 
The cytotoxic activity, according to the MTT assay, of the n-hexane, DCM, and MeOH 
extracts of R. chalepensis aerial parts was assessed against five cancer cell lines; EJ138 
(human bladder carcinoma), Hep G2 (human liver hepatocellular carcinoma), A549 
(human lung carcinoma), MCF7 (human breast adenocarcinoma), and prostate cancer cell 
lines (PC3). The RCD extract showed the highest activity throughout all the extracts 
against the different cancer cell lines with IC50= 25, 15, 55, 60, and 50 µg/mL, 
respectively while, the n-hexane, and the MeOH extracts did not show any activity (Table 
3.3.4a).  
Table 3.3.4a: The IC50 (µg/mL) of n-hexane, DCM and MeOH extracts of R. 





RCH RCD RCM 
EJ138 ˃ 100 25 ± 0.98 ˃ 100 
Hep G2 ˃ 100 15 ± 0.77 ˃ 100 
A549 ˃ 100 55 ± 0.66 ˃ 100 
MCF7 ˃ 100 60 ± 1.40 ˃ 100 
PC3 ˃ 100 50 ± 1.29 ˃ 100 
 
Values greater than 100 µg/mL were considered as non-cytotoxic (Sahranavard et al. 2012). 





The selectivity index (SI) of the active DCM extract of R. chalepensis aerial parts was 
assessed comparing the cytotoxicity results of the human normal prostate cell line (PNT2) 
with those of human prostate cancer cell line (PC3). The extract revealed low degree of 
cytotoxic selectivity towards the prostate cancer cells (SI= 0.84), which indicated the low 
safety of the extract on the normal human cells. The IC50 values of R. chalepensis aerial 
parts extracts in both cell lines and the selectivity index are summarized in Table 3.3.4b. 
Table 3.3.4b: The IC50 (µg/mL) values for RC DCM extract on PC3 and PNT2 cells 
and the selectivity index (SI) using the normal human prostate cells (PNT2). 
Cell type IC50 values 
(µg/mL) (RCD) 
PC3 50 ± 1.29 
PNT2 42 ± 0.57 
Selectivity index 0.84 
 
Selectivity index (SI) = The IC50 (µg/mL) of extracts against the normal cells divided by the IC50 (µg/mL) of extracts 
against the cancer cells, where IC50 is the concentration required to reduce viability by 50% of the cell population 
(Badisa, et al., 2009). 
 
3.3.5  Chromatographic fractionation of the extracts 
Following the systematic, bioassay-guided phytochemical and cytotoxic/anticancer study 
on R. chalepensis aerial parts, further fractionation of the active DCM extract was 
performed. However, both the inactive MeOH and n-hexane extracts of R. chalepensis 
aerial parts were fractionated with the aim of isolating major metabolites to have complete 





3.3.5.1  Vacuum liquid chromatography (VLC) 
The DCM (2.05 g) and n-hexane (3.26 g) extracts of R. chalepensis aerial parts were 
further fractionated by VLC over silica to collect seven fractions from the n-hexane 
extract (Figure 3.3.3) and six fractions from the DCM extract (Figures 3.3.4), the weights 
of fractions are listed in Table 3.3.5      
 
Long UV (366 nm)              Sprayed with anisaldehyde 
Figure 3.3.3: TLC analysis (mobile phase: Toluene: EtOAc /Acetic acid = 25:24:1) of 
the VLC fractions of the n-hexane extract of R. chalepensis aerial parts 
 
 
                                 Long UV (366 nm)            Short UV (254 nm) 
Figure 3.3.4:  TLC analysis (mobile phase: 20% EtOAc in n-hexane) of the VLC 
fractions of the DCM extract of R. chalepensis aerial parts 






Table 3.3.5: Weights of the VLC fractions of the extracts RCH and RCD 








RCHF1 100%n-hexane 121 RCDF1 100% n-hexane 9 
RCHF2 10% EtOAc /n-
hexane 
140 RCDF2 5% EtOAc /n-
hexane 
3 
RCHF3 30% EtOAc /n-
hexane 
65 RCDF3 10% EtOAc /n-
hexane 
1.4 
RCHF4 50% EtOAc /n-
hexane 
517.8 RCDF4 15% EtOAc /n-
hexane 
72.7 
RCHF5 80% EtOAc /n-
hexane 
527.3 RCDF5 20% EtOAc /n-
hexane 
56.4 
RCHF6 100% EtOAc 469.9 RCDF6 30% EtOAc /n-
hexane 
80 
RCHF7 50% MeOH/ 
EtOAc 




3.3.5.2  Solid phase extraction (SPE) 
The MeOH extract of R. chalepensis aerial parts (RCM) was fractionated by SPE to 
collect four fractions (Figures 3.3.5-3.3.8; Table 3.3.6).  
Table 3.3.6: Weights of the SPE fractions of the MeOH extract of R. chalepensis aerial 
parts. 
Fraction Mobile phase gradient Weight of fraction (mg) 
RCMF1 20% MeOH/H2O 2440 
RCMF2 50% MeOH/H2O 298.6 
RCMF3 80% MeOH/H2O 80.9 





       
  
Figure 3.3.5: Analytical HPLC chromatograms of SPE fraction 1 of RCM (observed at 250 
nm)    
 





    
     
   Figure 3.3.7: Analytical HPLC chromatograms of SPE fraction 3 of RCM (observed at 250 
nm)    
       
Figure 3.3.8: Analytical HPLC chromatograms of SPE fraction 4 of RCM (observed at 250 
nm) 
 
3.3.6  Screening of R. chalepensis DCM fractions for cytotoxic activity 
The cytotoxic activity of the DCM fractions of R. chalepensis aerial parts was assessed 
against the most sensitive cancer cell line (hepatocellular carcinoma cell line HEPG2).  
Unfortunately, all the fractions gave IC50 values >100 µg/mL. For this reason, the 
fractions were tested again on another sensitive cancer cell line (human bladder carcinoma 




85 µg/mL. The IC50 values for the DCM fractions of R. chalepensis aerial parts on EJ138 
are summarised in Table 3.3.7 
Table 3.3.7: The IC50 (µg/mL) of the VLC DCM fractions of R. chalepensis aerial parts 
fractions against EJ138 (human bladder carcinoma cells). 
Fraction F1 F2 F3 F4 F5 F6 F7 
IC50 (µg/mL) >100 >100 >100 91.44 ±1.96 98 ±1.98 95.3 ± 3.31 85.24 ± 1.93 
     Data were expressed as means a ± standard error of the mean derived from n ≥12 from three separate occasions 
 
3.3.7  Isolation of compounds from R. chalepensis 
3.3.7.1  The MeOH extract (RCM) 
Isolation of compounds from the SPE fractions 2, 3 and 4 of RCM utilised semi-
preparative and preparative reversed-phase HPLC technique (Agilent) employing a 30-
100% gradient of MeOH in water for 30 min with a volume of injection of 200 µL and a 
flow rate of 2 mL/min  
The following compounds were isolated from RCMF2: RCMF2-1 (37 mg, tR = 15.9 min), 
RCMF2-2 (43 mg, tR = 16 min), RCMF2-3 (27 mg, tR = 18.6 min) and RCMF2-4 (13.4 
mg, tR = 20.3 min) (Figure 3.3.9) from SPE fraction 2. RCMF2-2 and RCMF2-4 were 
further purified using 20-50% MeOH/H2O gradient to get the two pure compounds 






Figure 3.3.9: HPLC chromatogram of isolated compounds from SPE fraction 2 RCM 
(observed at 310 nm) 
 
Figure 3.3.10: Purification of the compound RCMF2-2 (observed at 310 nm) 
 






Figure 3.3.12: Analytical HPLC chromatogram of RCMF2-3 (observed at 250 nm) 
 
Figure 3.3.13: Analytical HPLC chromatogram of RCMF2-4-1 (observed at 250 nm) 
 
The following compounds were obtained from RCMF3: RCMF3-1 (10.8 mg, tR = 15.6), 
RCMF3-2 (16.8 mg, tR = 17.5,), RCMF3-3 (27 mg, tR = 19.2), RCMF3-4 (5.7 mg, tR = 
22.4), RCMF3-5 (4.6 mg, tR = 23.7) and RCMF3-6 (1.8 mg, tR = 25.5,) (Figure 3.3.14). 
The compound RCMF3-2 was further purified using 20-70 % MeOH/H2O gradient to get 





Figure 3.3.14: HPLC chromatogram of isolated compounds from RCM SPE fraction 3 
(observed at 310 nm) 
 
Figure 3.3.15: Purification of the compound RCMF3-2 (observed at 310 nm) 
 
3.3.7.2 The DCM extract (RCD) 
 Separation of the DCM Fraction 5  
The DCM Fraction 5 (56.4 mg) of R. chalepensis aerial parts was analyzed by prep-HPLC 
using a gradient solvent system 30-100% MeOH in water. This lead to the isolation of the 






Figure 3.3.16: HPLC chromatogram of isolated compounds from the RCD fraction 5 
(observed at 366 nm) 
 
Separation of the DCM Fraction 6  
The DCM fraction 6 (80 mg) of R. chalepensis aerial parts was analyzed by prep-HPLC 
using a gradient solvent system 30-100% MeOH in water. This lead to the separation of 
many impure peaks (Figure 3.3.17). Peak 2 was further purified and lead to the isolation 
of the two compounds: RCDF6-1 (12.0 mg, tR = 24.2) and RCDF6-2 (10.2 mg, tR =25.2) 
(Figure 3.3.18).  
 
 
Figure 3.3.17: HPLC chromatograms of isolated compounds from the RCD F6 






Figure 3.3.18: Purification of peak 2 isolated from RCD F6 (observed at 310 nm) 
Separation of the active DCM Fraction 7  
The active DCM fraction 7 (217.9 mg) of R. chalepensis aerial parts was analyzed by 
prep-HPLC using a gradient solvent system 50-100% MeOH in water. This lead to the 
isolation of the compounds: RCDF7-9 (5 mg, tR = 17.9) and RCDF7-12 (8 mg, tR = 23.8) 
(Figure 3.3.19). The compound RCDF7-9 was further purified using a gradient of 50-80% 
MeOH/water to get the pure compound RCDF7-9-2 (1.3 mg, tR = 11.4) (Figure 3.3.20). 
 





Figure 3.3.20: Purification of the compound RCDF7-9 (observed at 310 nm) 
 
3.3.7.3  The n-hexane extract (RCH) 
Crystals from n-hexane layer 
A pure compound was completely crystalized from the VLC fractions 2 as a white crystal: RCHF2 
(140 mg) (Figure 3.3.21).  
 
                    Figure 3.3.21: Crystals of the compound RCHF2 from R. chalepensis  
 
Separation of the n-hexane VLC Fraction 4  
The n-hexane VLC fraction 4 was chromatographed over silica gel plates 20x20 using 20% 
EtOAc in n-hexane as mobile phase (Figure 3.3.22), the plates showed three separated bands under 
the long (366 nm) and the short UV light (254 nm). The three bands yielded the compounds: 




mg, Rf = 0.62). The RCHF4-3 mixture was further purified by PTLC (mobile phase: 20% 
EtOAc in n-hexane) into two compounds: RCHF4-3-1 (2.5 mg, Rf = 0.88) and RCHF4-3-
2 (3.0 mg, Rf =0.97) (Figure 3.3.23). 
 
Long UV (366 nm)                       Short UV (254 nm) 




n-Hexane: EtOAc = 80:20 








Separation of the n-hexane VLC Fraction 7  
The n-hexane VLC Fraction 7 was chromatographed over TLC silica gel plates 20x20 
using 50% MeOH/ EtOAc as a mobile phase. This yielded the pure compounds; RCHF7-
2 (0.7 mg, Rf = 0.3) and RCHF7-7 (1.7 mg, Rf = 0.9) (figure 3.3.24).                       
 
Figure 3.3.24: Isolation of the compounds RCHF7-2 and RCHF7-7 from RCH F7 
Separation of the n-hexane VLC Fraction 5+ 6+ 7  
Portions from the n-hexane fractions 5, 6, and 7 (Figure 3.3.25) were mixed together (300 
mg) and fractionated with VLC using a small Büchner funnel with a gradient of 0% -
100% EtOAc in n-hexane , then 2% and 5% MeOH/ EtOAc) to yield 13 fractions (Table 
3.3.8).  
 






Table 3.3.8: Different weights of Fraction 5+6+7 from n-hexane layer of R. chalepensis 
Fraction Mobile phase gradient The weight of fraction (mg) 
RCHF 100 %-H 100% n-hexane 0.9 
RCHF 10% 10% EtOAc /n-hexane 0.8 
RCHF 20% 20% EtOAc /n-hexane 13.5 
RCHF 30% 30% EtOAc /n-hexane 10 
RCHF 40% 40% EtOAc /n-hexane 34.7 
RCHF 50% 50% EtOAc /n-hexane 63.4 
RCHF 60% 60% EtOAc /n-hexane 48.5 
RCHF 70% 70% EtOAc /n-hexane 41.4 
RCHF 80% 80% EtOAc /n-hexane 18.7 
RCHF 90% 90% EtOAc /n-hexane 16.6 
RCHF 100% -E 100% EtOAc 8.0 
RCHF 2% 2% MeOH/ EtOAc 22.7 
RCHF 5% 5% MeOH/ EtOAc 16 
 
RCHF-40%  
The fraction RCHF-40 % (34.7 mg) was chromatographed over TLC silica gel plates 
20x20, using 50% MeOH/EtOAc as a mobile phase. This lead to the isolation of the pure 





         
Mobile phase: EtOAc: MeOH = 50:50 
Figure 3.3.26: Isolation of compounds from RCH fraction 40% 
RCHF-50%  
The fraction RCHF-50% (63.4 mg) was isolated by prep-HPLC using a gradient solvent 
system 30-100% MeOH in water. This lead to the isolation of the pure compound RCHF 
50%-10 (3.2 mg, tR= 25.6) and a mixture RCHF50% (9 mg, tR =12.5) (Figure 3.3.27). The 
mixture was purified with PTLC using T:E:A/25:24:1 as a mobile phase, which lead to 
the isolation of the compond: RCHF50%-3 (2.3 mg, Rf = 0.73) (Figure 3.3.28). 
 
Figure 3.3.27: HPLC chromatogram of isolated compounds from the RCH fraction 50% 





Mobile phase: EtOAc: MeOH = 50:50 
Figure 3.3.28: Isolation of compounds from RCH fraction 50% 
 RCHF-60%  
The fraction RCHF-60% (48.5 mg) was isolated by prep-HPLC using a gradient solvent 
system 50-100% MeOH in water. This lead to the isolation of the pure compound: RCHF 
60%- 4 (5.2 mg, tR = 17.9), RCHF 60%-5 (3.1 mg, tR =22.3) (Figure 3.3.29). 
 
Figure 3.3.29: HPLC chromatogram of isolated compounds from the RCH fraction 60% 





RCHF 80%  
The fraction RCHF 80% (18.7 mg) was isolated by prep-HPLC using a gradient solvent 
system 30-100% MeOH in water. This lead to the isolation of the pure compound: RCHF-
80%-3 (3 mg, tR = 19.3) (Figure 3.3.30). 
 
Figure 3.3.30: HPLC chromatogram of isolated compounds from RCH fraction 80% 
(wavelength = 310 nm) 
 
3.3.8 Characterization of isolated compounds from R. chalepensis aerial parts 
3.3.8.1 Characterization of flavonoids 
Two flavonoids 52 and 83 were isolated from the SPE fractions F2 of RCM (Figure 
3.3.31). The UV-Vis spectrum of these two compounds exhibited two major absorption 
peaks in the ranges 270-275 (Band –II) and 330-360 nm (Band –I) indicating these 







Rutin (52) H 
Methoxy rutin (83) CH3 
 
Figure 3.3.31: Structure of flavonoids isolated from R. chalepensis aerial parts 
 
Characterization of RCMF2-3 as rutin (52) 
Yellow powder; The UV-Vis spectrum (MeOH) of this compound exhibited two major 
absorption peaks at λmax: 257 and 355 nm indicating this compound to be a flavonoid 
(Mabry et al., 1970). The ESIMS m/z showed a peak at: 611 [M+H]+, indicating that the 
molecular formula could be C27H30O16. 
1H NMR (600 MHz, CD3OD) Tables 3.3.7 and 
Figure 3.3.32 exhibit the common features for flavonoid protons, which include the 
presence of two aromatic meta-coupling protons assigning to; H-6 at δH 6.23 (d, J = 2.1 
Hz,1H) and H-8 at δH 6.42 (d, J = 2.0 Hz,1H) and at δH 7.69 (d, J = 1.9 Hz,1H), 7.65 (d, 
2.2,1H) assigned for H-2` and H-6`, one aromatic ortho-coupled proton assigning to H-5` 
at δH (d, J =8.5 Hz,1H) and one ortho- meta coupling at δH 7.65 (dd, J = 2.2, J = 8.3,1H) 
assigned for H-6`.  The 1H NMR spetrum also showed a doublet at δH 1.14 (d, J = 6.2 Hz, 
3H) and a signal for the anomeric proton appeared at δH 4.54 (br s) indicated the presence 




proton H-1``. The signals for the carbon atoms of both rhamnose and glucose moieties 
were also observable in the 13C NMR spectrum, the signal at δC 18.0 confirmed rhamnose 
(Table 3.3.10). All these data confirmed that compound 52 is rutin glycoside and were 
comparable to the published data (Markham, et al., 1987; Terashima, et al., 1999; 
Shaoguang Li et al., 2014; Souravh Bais & Naveena Abrol. 2016).  
 
Figure 3.3.32: 1H NMR spectrum (600 MHz, CD3OD) of rutin (52) 
 
Characterization of RCMF2-4-1 as methoxy rutin (83) 
Yellow amorphous powder. The UV-Vis spectrum (MeOH) of this compound showed 
two major absorption peaks at λmax: 255 and 354 nm, which indicate that this compound 
might be flavonoid (Mabry et al., 1970), The ESIMS m/z exhibited a peak at: 625 [M+H]+, 
indicating that the molecular formula could be C28H32O16. 
1H NMR (600 MHz, CD3OD) 
and 13C NMR (150 MHz, CD3OD) ; Tables (3.3.9 and 3.3.10) and Figure (3.4.33) showed 
similar data to rutin (52) with an extra singlet peak at δH 3.92 (3H) compared with rutin 
(Figure 3.3.34) indicating that this compound is methoxy rutin. The NOESY experiment 




group on C-3`, which was indicated by the close correlation between the unbonded 
protons H-2`↔ CH3 in space (Figure 3.3.  35). The HMBC (Figure 3.3.36) also confirmed 
the position of –OCH3 by the correlation from -OCH3 protons → δC C-3` (147.5). All data 
were comparable to the published data (Markham, et al., 1987; Shaoguang Li et al., 2014; 
Souravh Bais & Naveena Abrol. 2016).                                                                  
 







Table 3.3.9: 1H NMR (600 MHz, CD3OD) for flavonoid glycosides: Rutin (52) and 






Chemical Shift δ (ppm), multiplicity and J in Hz 
52 83 
6 6.23 (d, 2.1,1H) 6.24 (d, 2.1,1H) 
8 6.42 (d, 2.0,1H) 6.44 (d, 2.2,1H) 
2` 7.69 (d, 1.9,1H) 7.97 (d, 2.2,1H) 
5` 6.89 (d, 8.5,1H) 6.94 (d, 8.5,1H) 
  6`                                                                                              7.65 (dd; 8.3, 2.2,1H) 7.66 (dd; 8.4, 1.98,1H) 
1`` 5.12 (d, 7.7, ,1H) 5.27 (d, 7.6,1H) 
6`` 3.82 (d, 10.2, 2H) 3.92 (s, 3H) 
H3-6```  1.14 (d, 6.2, 3H) 1.12 (d, 6.3,3H) 
 
Table 3.3.10: 13C NMR (150 MHz, CD3OD) for the flavonoid glycosides rutin (52) and 
methoxy rutin (83)  
Position Chemical Shift δ (ppm) 
52  83   52  83 
2 159.5 156.9 6` 123.7 120.3 
3 135.7 132.0 1`` 104.8 103.1 
4 179.5 178.8 2`` 75.9 75.9 
5 163.2 160.6 3`` 71.5 72.3 
6 100.0 98.7 4`` 77.4 76.7 
7 166.2 166.3 5`` 78.3 76.0 
8 95.0 93.6 6`` 68.7 67.1 
9 158.5 157.8 1``` 102.5 100.9 
10 105.7 104.6 2``` 72.2 72.2 
1` 123.2 124.3 3``` 72.4 72.3 
2` 117.8 114.9 4``` 74.1 74.2 
3` 146.0 147.5 5``` 69.8 68.4 
4` 150.4 150.4 6``` 18.0 16.8 






Figure 3.3.34:  1H NMR spectrum (600 MHz, CD3OD) of methoxy rutin (83) compared 
with rutin (52) 
 





Figure 3.3.36:  HMBC correlation of methoxy rutin (83) 
 
3.3.8.2 Characterization of disinapoylsucrose 
Characterization of RCMF2-2-2 as 3``, 6`-disinapoylsucrose (84) 
White amorphous powder. The ESIMS m/z showed a peak at: 753 [M-H]-, indicating that 
the molecular formula could be C34H42O19; 
1H NMR (600 MHz, CD3OD); (Figure 3.4.38) 
showed two singlet peaks at δH 3.90 (3H x2, s, -OCH3) assigning to four methoxy groups, 
doublets at δH 7.69 (lH, d, J = 15.7 Hz,), δH 7.61 (lH, d, J = 16.3 Hz), δH 6.49 (lH, d, J = 
16 Hz) and δH 6.47 (lH, d, J = 16.6 Hz), assigning to four trans protons -CH=CH-, two 
aromatic singlet peaks at δH 6.95 (s, 1H) and δH 6.91 (s, 1H). The 
1H NMR spectrum also 
showed an anomeric proton of d-glucose at δH 5.52 (l H, d, J = 4.8 Hz, H-1`) and 5.54 (l 
H, dd, J= 8.0 Hz, H-4) assigning for sucrose. All these data indicated that this compound 




structure where it showed 34 carbon signals including two carbonyl carbons at δC 169.2 
and δC 168.4 assigned for C-9 in both I and II moieties. The HMBC correlations (Figure 
3.3.40) performed for the first time on compound 3. It showed indirect correlations from 
H6`→C-9 (3J) and H5`→C-9 (4J) confirmed the skeleton structure of compound 84 
(Figure 3.3.37). All data were comparable to the published data (Chen et al., 2001; Wu et 
al., 2014, Jin et al., 2016).   
 
Figure 3.3.37: Structure of 3``, 6`-disinapoylsucrose (84) 
 















3.3.8.3 Characterization of coumarins 
Characterization of RCHF7-7, RCHF7-C, RCH 50%-3, RCH 40% 3-3, and RCDF7-
9-2 as bergapten (63) 
Yellow powder; The ESIMS m/z of this compound showed a molecular ion peak  at 215 
[M+H]+  indicating the molecular formula C12H8O4,  which was supported by 12 carbon 
signals in the 13C NMR (600 MHz, CDC13) Table (3.3.11). Also the appearance of six 
signal peaks corresponding to six aromatic carbon atoms (between δC 93.9 to 159.6 ppm), 
four olefinic carbon atoms at δC 112.0 (C-3) and δC 139.2 (C-4), carbonyl group at δC 161.5 
(C-2) may indicate that this compound is coumarin. ¹H NMR spectrum (600 MHz, CDC13) 
Table (3.4.12) and Figure (3.3.41) showed coumarin proton signals at δH 7.59 (d, J = 2.4, 
1H, H-2`), δH 7.01(d, J = 2.4, 1H, H-3`), δH 6.28 (d, J = 9.8,1H, H-3 ) and δH 8.16 (d, J = 
9.8, 1H, H-4), one aromatic proton signal at δH  7.13 (1H, s, H-8), one proton signals at 
δH 4.27 (3H, s, -OCH3). All data confirmed this compound as bergapten 63 (Figure 1.9) 
and were comparable to the published data (Wu et al., 2003; Chunyan et al., 2008). 
 




Figure 3.3.41: 1H NMR spectrum (600 MHz, CDC13) of bergapten (63) 
 
Characterization of RCMF3-4, RCDF7-12, RCDF6-2, RCHF4-2, RCHF50%-10, 
RCHF 60%-5 as chalepin (64) 
 
White crystals; UV (MeOH) λmax: 207, and 332 nm,
 the ESIMS m/z of this compound 
showed a molecular ion peak at 315 [M+H]+ indicating the molecular formula C19H22O4. 
1H NMR (600 MHz, CDC13); Table (3.4.10) and (Figure 3.3.42) showed characteristic 
peaks for chalepin, which include two aromatic singlets at δH 7.19 and 7.48 assigning for 
H-4 and H-9, respectively, a singlet at δH 6.71 assigned for H-5, one multiplet at δH 3.20 
for H-3, a triplet assigned for H-2 at δH 4.71 (J = 9.0 Hz) and two doublet of doublets at 
δH 6.17 (dd; J =11.0 Hz, J =17.4 Hz) and δH 5.08 (dd, J =3.5 Hz, J =10.6 Hz) assigning 
for H-4` and H-5`, respectively. 13C NMR (600 MHz, CDC13) Table 3.3.12 confirmed 
the structure, which showed 19 carbon signals including four methyls at δC 24.2, 26.1 and 




for H-4` and H-5`, respectively. All data confirmed this compound as chalepin (64) 
(Figure 1.9) and were comparable to the published data (Richardson et al., 2016).  
                                               
 
Figure 3.3.42: 1H NMR spectrum (600 MHz, CDC13) of chalepin (64) 
 
Characterization of RCDF5, RCDF6-1, and RCHF60%-4 as chalepensin (65) 
White crystals; UV (MeOH) λmax: 268, and 320 nm, ESIMS m/z showed a molecular ion 
peak at 255 [M+H]+, indicating the molecular formula C16H14O3. 
1H NMR (600 MHz, 
CD3OD); (Tables 3.4.11) and (Figure 3.3.43) showed two aromatic single protons at δH 
6.94 (H-5) and δH 7.46 (H-8) and one olefinic singlet at δH 7.92 (H-4), two multiplets at 
δH 6.22 (H-12) and δH 5.10 (H-13), two broad singlets at δH7.86 and δH 4.89 assigned for 
H-2` and H-3`and one large singlet at δH 1.51 (6H) assigning for two methyl groups. All 
these protons data indicated that this compoud might be the coumarin chalepnsin 65 




confirmed the structure, which includes two methyls at δC 27.0 (C-14 and C-15), a 
carbonyl carbon at δC 162.0 (C-2), two peaks at δC 146.9 and δC 112.8 assigned for C-12 
and C-13, respectively. NOESY experiment (Figure 3.3.44) performed for the first time 
on chalepnsin confirmed also the close correlation between the unbonded protons H-12 
and H-13↔ CH3 protons in space. All data were comparable to the published data (Wu et 
al., 2003). 










Figure 3.3.44:  NOESY spectrum (600 MHz, CD3OD) of chalepensin (65) 
Table 3.3.11: 1H NMR (600 MHz) of the coumarins: bergapten (63), chalepin (64) and 




Chemical Shift δ (ppm), multiplicity and J in Hz 
63* 64* 65** 
2  4.71, t, 9  
3 6.28, d, 9.8, 1H 3.20, m  
4 8.16, d, 9.8, 1H 7.19, s 7.92, s 
5 ---- 7.48, s 6.94, s 
5 -OCH3 4.27, s, 3H ----  
8 7.13, s, 1H ----- 7.46, s 
9 ----- 6.71, s  




13   5.10, m 
14-CH3, 15-CH3   1.51, s, 6H 
    
2` 7.59, d, 2.4, 1H ----- 7.86, br s 
3` 7.01, d, 2.4, 1H ----- 4.89, br s 
4`  6.17, dd; 11.0, 17.4  
5`  5.08, dd; 3.54, 10.56  
                 *= (CDCl3), **= (CD3OD) 
 
 
Table 3.3.12: 13CNMR (150 MHz) of the coumarins: bergapten (63, chalepin (64) and 
chalepensin (65)  
 
Position 
Chemical Shift δ (ppm)  
Position 
Chemical Shift δ (ppm) 
63* 64* 65** 63* 64* 65** 
2 161.5 90.9 162.0 13   112.8 
3 112.0 29.6 133.9 14   27.0 
4 139.2 123.2 140.7 15   27.0 
5 149.5 138.0 121.5 2` 144.8 25.1 146.9 
6 119.1 132.2 126.5 3` 105.0 25.1 107.7 
7 159.6 159.5 157.5 4`  145.8  
8 93.9  107.7 5`  112.1  
8 a  154.8  1``  71.8  
9 151.5 97.2 152.6 2``  24.2  
10 105.7 162.4 117.5 3``  26.1  
11  154.8 41.5 5 (O-CH3) 60.1   
12   146.9     







3.3.8.4 Characterization of alkaloids 
Characterization of RCMF3-2-2 and RCH 80%-3 as kokusaginine (61) 
Yellow powder; ESIMS m/z showed a molecular ion peak at 260 [M+H]+ indicated the 
molecular formula C14H13NO4.  Signals of the 
1H NMR (600 MHz, CDCl3); Table (3.4.13) 
and (Figure 3.3.45) at δH 4.0 (6H, s) and at δH 4.40 (3H, s) can be assigned clearly to - 
OCH3-6, OCH3-7 and OCH3-4, respectively. The 
1H NMR spectrum also showed signals 
of two aromatic protons at δH 7.49 and δH 7.34 assigning for H-5 and H-8, two methine 
protons at  δH 7.57 (d, J = 2.7 Hz, 1H) assigned for H-1` and δH 7.1 9 (d, J =2.7 Hz, 1H) 
assigned for H-2`. The 13C NMR (150 MHz, CD3OD) (Figure 3.3.46 and Table 3.4.14) 
confirmed the methoxy peaks at δC 58.9, 56.0 and 56.1 assigning for 4-OCH3, 6-OCH3 
and 7-OCH3, respectively, the two olefinic methine carbons at δC 104.6, and142.6, which 
assigned for C-1` and C- 2`, respectively. All these data confirmed the identity of 
compound 61 as kokusaginine (Figure 1.9). All data were comparable to the published 
data for kokusaginine (Wu et al., 2003).  
















Characterization of RCMF3-1 as graveoline (60)  
Yellow powder; ESIMS m/z showed a molecular ion peak at 280 [M+H]+ indicating the 
molecular formula C17H13NO3. 
1H NMR (600 MHz, CD3COCD3): (Table 3.4.13 
and(Figure 3.3.47) showed two ortho- meta coupling at δH 7.10 (ddd, J = 2.8, J = 1.6, J 
=10.5, 1H and δH 7.84, dd, J = 5.8, J= 1.3, 1H, two ortho-couplings at δH 7.48 (t, J = 6. 8, 
1H) and at δH 8.39 (d, J = 8.6, 1H), one aromatic singlet at 6.21 assigned for H-3 and N-
CH3 protons at 3.77, a singlet at 6.19 assigning for O-CH2-O protons. The 
13C NMR (150 
MHz, CD3COCD3) (Table 3.4.14 and Figure 3.3.48) showed 17 carbon signals including 
carbonyl carbon at δC 182.0 (C-4) and δC 101.9 assigned for O-CH2-O carbon. All data 
were compared to the published data and confirmed that this compound is graveoline (60) 
(Figure 1.9) (Wu et al., 2003).  









Figure 3.3.48: 13C NMR spectrum (150 MHz, CD3COCD3) of graveoline (60) 
 
Characterization of RCMF3-6 as 4-hydroxy-2-nonyl-quinoline (85) 
Yellow powder; ESIMS m/z showed a molecular ion peak at 272 [M+H]+ indicating 
compound with formula C18H25NO. 
1H NMR (600 MHz, MeOD) (Table 3.4.13 and 
Figure 3.3.50) showed four ortho coupled protons at δH 8.23 (d, J = 8.4 Hz, 1H),  δH 7.70 
(t, J = 8.6 Hz, 1H), δH 7.41 (t, J = 7.7 Hz, 1H) and δH 7.60 (d, J = 8.3 Hz, 1H), one singlet 
at 6.30 assigned for H-3, two triplets at δH 2.74 (t, J = 8.5 Hz, 2H, H-1`) and at δH 0.91 (t,  
J= 6.1 Hz, 3H, H-9`) and multiplet at δH 1.79, 2H, H-2`). The 
13C NMR (150 MHz, 
CD3COCD3) (Figure 3.3.51 and Table 3.4.14) showed 18 carbon signals including six 
aromatic carbons. All data were compared to the published data and confirmed that this 
compound is 4-hydroxy-2-nonyl-quinoline (Figure 3.3.49) (Royt et al., 2001). 
                              
 







Figure 3.3.50: 1H NMR spectrum of 4-hydroxy-2-nonyl-quinoline (85) 
 
 









Table 3.3.13: 1H NMR spectrum (600 MHz, CDCl3) for alkaloids: kokusaginine (61), 
Graveoline (60), 4-hydroxy-2-nonyl-quinoline (85) 
Position Chemical Shift δ (ppm), multiplicity and J in Hz 
1H 61** 60 * 85** 
3  6.21, s, 1H 6.3, s, 1H 
4-OCH3 4.40, s, 3H   
5 7.49, s 8.39, d, J= 8.6, 1H 8.23, d, 8.4, 1H 
6 4.0, s, 6H, -OCH3 7.10, ddd; 2.8, 1.6, 10.5, 1H 7.70, t, 8.6,1H 
7 4.0, s, 6H, -OCH3 7.84, dd; 5.8, 1.3, 1H 7.41, t, 7.7, 1H 
8 7.34, s 7.48, t, J= 6. 8, 1H 7.60, d, 8.3, 1H 
1` 7.57, d, 2.7, 1H  2.74, t, 8.5, 2H 
2` 7.1 9, d, 2.7, 1H 7.11, s, 1H 1.79, m, 2H 
9`   0.91, t, 6.1, 3H 
N-CH3  3.77, s, 3H  
O-CH2-O  6.19, s, 2H  























Table 3.3.14: 13CNMR (chemical shift) for alkaloids: kokusaginine (61), graveoline (60), 
4-hydroxy-2-nonyl-quinoline (85) (CD3OD) 
 




3.3.8.5 Characterization of alkane  
Characterization of RCHF2 crystals as tetradecane (86) 
Transparent crystals; 1H NMR (600 MHz, MeOD); (Figure 3.3.53). MS showed the 
highest significant peak at m/z: 197 [M-H]-.  Consequently, the expected molecular weight 
was 198 attributed to the tetradecane C14H30 (Figure 3.3.52). 
                                                   






Figure 3.3.53: 1HNMR spectrum (400 MHz, CDCl3) of tetradecane crystals (86) 
 
3.3.8.6 Characterization of dehydromoskashan derivatve 
Characterization of RCHF4-3-2 as dehydromoskachan derivatve (87)  
White powder; ESIMS m/z showed a molecular ion peak at 419 [M+H]+ (Figure 3.3.55a) 
indicating compound with formula C25H38O5 and a peak at 135 (Figure 3.3.55b) indicating 
the fragment of dehydromoskachan moiety (Ulubelen 1988). 1H NMR (600 MHz, CDCl3) 
(Figure 3.3.56) showed aromatic protons as following: one ortho coupling at δH 6.71 (d, 
J = 7.7 Hz, 1H), one broad singlet δH 6.68 (s, 1H) and one ortho-meta coupling at δH 6.61 
(dd, J = 1.4 Hz, J = 7.8 Hz, 1H) assigning for H-5, H-3 and H-6, respectively. The 1H 
NMR also showed one singlet at δH 5.90 assigned for O-CH2-O (s, 2H), two multiplets at 
δH 5.80 (m, 1H) and δH 5.34 (m, 3H) assigned for H-17` and H-18`, respectively. A triplet 
at δH 4.05 (t, J =6.7, 4H) assigned for H-13`. The 
13C NMR (150 MHz, CDCl3) (Figure 
3.3.57) showed 25 carbon signals including six carbons in the aromatic region (100-150 
ppm). The HSQC (Figures 3.3.58) confirmed the attached protons to their carbon atoms; 
H-3, H-5, H-6→ C-3, C-5, C-6 in the aromatic regions. The HMBC (Figures 3.3.59) 




                           







































   3.3.9 Cytotoxic effect of the isolated compounds from R. chalepensis aerial 
parts 
 
Results presented in Table 3.3.15 and Figures 3.23 -3.24 showed the IC50 values of the 
isolated compounds from R. chalepensis aerial parts compared with the etoposoid 
standard. The cytotoxicity was observed only in chalepin (64) and 4-hydroxy-2-nonyl-
quinoline (85) against the human lung carcinoma cell lines (A549) with IC50 values of 92 
and 97.6 µM, respectively. However, chalepin (64) revealed also moderate cytotoxicity 
against the human urinary bladder cancer cell lines (EJ138) with IC50 value of 117 µM. 






Table 3.3.15:  The IC50 (µM) of different isolated compounds from R. chalepensis aerial 






   (A549) 
IC50 µM  
 (E-138) 
Rutin (52) No activity * No activity * No activity * 
Methoxy rutin (83) No activity * No activity * No activity * 
Sinapoyl glycoside (84) No activity * NA NA 
Bergapten (63) No activity * No activity * No activity * 
Chalepin (64) No activity * 92 ± 1.47 117±1.58 
Chalepensin (65) No activity * 200±1.61 (48 h) No activity * 
Kokusaginine (61) No activity * No activity * No activity * 
Graveoline (60) No activity * No activity * No activity * 
4-Hydroxy-2-nonyl-quinoline (85) No activity * 97.6 ± 1.22 NA 
Dehydromoskashan derivatves (87) Not applied No activity * Not applied 
Etoposide (78) NA 61 ± 1.56 NA 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Figure 3.3.60: The cytotoxic activity of chalepin (64) against EJ138 cells according to 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard error 
of the mean derived from n ≥12 from three separate occasions. 
Figure 3.3.62: The cytotoxic activity of 4-hydroxy-2-nonyl quinolinol (85) against 
A549 cells according to the MTT assay  
 
 
3.3.10 The LDH results 
Results of the LDH assay presented in Figure 3.3.63 suggest that chalepin (64) isolated 
from the three extracts of RC causes cytotoxicity at IC50 values of 92 µM to the lung 
cancer cell lines (A549), through at least in part cell membranes damage by measuring 
the LDH activity at two absobances: 490 and 690 nm. The LDH activity was performed 
using a commercial cytotoxicity assay kit produced by Roche (REF 11644793001). The 
necrotic percentage was 20.4 %, which was expressed using the formula: (sample 







                      
Data were expressed as means a ± standard error of the mean derived from n =24. 
Figure 3.3.63: LDH Release result for chalepin (64) against the lung cancer cell lines 
(A549) 
Discussion 
The family Rutaceae is a family of flowering plants, herbs, shrubs or trees, which is 
widely distributed throughout the tropical regions, especially in Australia and the 
Mediterranean region (Roy& Rahman, 2016). It has been reported for its biological 
activities such as anti-rheumatic, scorpion repellent as contrceptive, abortifacient, 
emmenagogue for women and in the treatment of some dermatological diseases (De 
Natale and Pollio, 2012). Previous phytochemical studies on the family Rutaceae and 
ruta species have detected many alkaloids, coumarins, flavonoids, glycosides and tannins 
(Martinez-Perez et al., 2017). 
In the present study, the cytotoxic effect of R. chalepensis (RC) aerial parts from the 

































Assessment of plasma membrane damage 
resulting from chalepin treatment according 




adenocarcinoma), HepG2 (human liver hepatocellular carcinoma), EJ138 (human bladder 
carcinoma), A549 (human lung carcinoma), and PC3 (human prostate carcinoma) using 
the MTT assay. The DCM extract of (RC) aerial parts was the most potent cytotoxic 
extract against all the tested cell lines with IC50 values of 25, 15, 55, 60 and 50 µg/mL, 
respectively, whilst the n-hexane and MeOH extracts showed little or no cytotoxicity.  
Selectivity index (SI) for R. chalepensis aerial parts was also determined using the human 
normal prostate cell line (PNT2).  The aerial parts revealed low degree of cytotoxic 
selectivity on prostate cancer cells (SI=0.84). Eleventh known compounds were isolated 
from the different fractions of R. chalepensis including three alkaloids (graveoline 60, 4-
hydroxy-2-nonyl-quinoline 85 and kokusaginine 61), three coumarins (bergapten 63, 
chalepin 64 and chalepensin 65), two flavonoid glycosides (rutin 52 and methoxy rutin 
83), one sinapoyl glycoside 84, one alkane [tetradecane (86)] and a new 
dehydromoskachan derivative (87). All the isolated compounds were tested for 
cytotoxicity against the human liver HepG2 hepatocellular carcinoma, the lung A549 and 
bladder EJ138 cell lines for 24 h. Both the furanocoumarin chalepin (64) and the alkaloid 
4-hydroxy-2-nonyl-quinoline (85) showed a good cytotoxicity against the A549 with IC50 
value of 92 and 97.6 µM, respectively whilst, 64 showed toxicity also against EJ138 with 
IC50 = 117 µM. Chalepin (64) has also been reported as an excellent cytotoxic agent 
against lung cancer cells A549 (Richardson et al., 2016). The furanocoumarin chalepensin 
(65) reported a variety of pharmacological activities, including antifertility, antiplatelet 
aggregation, cytotoxic effects on breast (MCF-7), colon (HT-29), kidney (A-498), lung 




human uterus carcinoma (HeLa), human adult T-cell leukemia/lymphoma (V)  and murine 
melanoma (B16F10) cells (Quintanilla-Licea, et al., 2014; Nakano et al., 2017).  
However, in our study the cytotoxic effect of chalepensin (65) against the lung A549 
cancer cell lines after 48 h was mild (IC50 = 200 µM). The three furanocoumarins 6365 
are characterized by the psoralen nucleus with a furan ring attached with coumarin 
nucleus (Figures 3.3.64). The major differences between the three furanocoumarins are: 
the presence of dimethyl allyl group at position 3 in both 64 and 65; the presence of the 
isopropyl alcohol group as a substituent on the furan ring at position 5` in chalepin (64); 
the lack of unsaturation at positions 4` and 5` in 64. It has been suggested that the 
substitution in the pyrone ring may increase the chemical reactivity of coumarin molecule 
(Emerole et al., 1981). The lack of unsaturation and the presence of dimethyl allyl group 
might also modify the cytotoxicity of 64. It is, therefore, significant to note that compound 
64 showed high cytotoxic activity while coumarin 65 showed little cytotoxicity and 63 
did not.  
 






Preliminary findings derived from using the lactate dehydrogenase (LDH) release assay 
indicated that chalepin-induced cell death might at least in part, involve plasma membrane 
damage and necrosis (Figures 3.3.63). 
Graveoline (60) is an alkaloid, which has been extracted previously from Ruta species 
and been conducted on its possible anti-cancer effect. However, it reported 
antiproliferative activity on HeLa cancer cells with IC50 values of 3.35 μg/mL (Wu et al., 
2003). It has been reported by An et al. in 2010 that the synthetic graveoline derivatives 
have anti-angiogenesis potential. In addition, a study applied by Ghosh et al., 2014 
revealed that graveoline-induced both apoptotic and autophagic cell death in skin 
melanoma cells (A375) with IC50 values of 22.23 μg/mL. The alkaloid kokusaginine (61) 
also reported proliferative activity on HeLa cells and KB cancer cells with IC50 values of 
3.9 μg/mL and 7.5 μg/mL, respectively (Wu et al., 2003; Molnar et al., 2013) and there 
is no report on its activity against the lung cancer cells. However, in this study graveoline 
(60) and kokusaginine (61) did not show any activity against three types of cancer cell 
lines, the lung (A549), bladder (EJ138) and the hepatocarcinoma (HEPG2) cell lines. 
Flavonoids are ubiquitous in nature. They have been reported in prevention of cancer. 
Their anticancer activity depends on their chemical structure, concentration, and the type 
of cancer. Rutin (52) and methoxy rutin (83) were isolated from the MeOH extract of RC. 
Both flavonoids were tested for their cytotoxicity against lung cancer cell lines (A549) 
but did not exhibit any cytotoxicity. It has also been reported that 52 did not show any 
cytotoxic activity against lung and liver cancer cell lines while it showed activity against 




Sinapic acid is widespread in the plant kingdom (fruits, vegetables, cereal grains, oilseed 
crops, and some spices and medicinal plants) and as such is common in the human diet. 
Derivatives of sinapic acid are characteristic compounds in the Brassicaceae family. 
Sinapic acid shows antioxidant, antimicrobial, anti‐inflammatory, anticancer, and anti‐
anxiety activity (Ni´ciforovi´c & Abramovi 2014). However, the 3``, 6`-
disinapoylsucrose (84) isolated from the RCM fraction 2 did not reveal any cytotoxicity 
against the hepatocellular cancer (HEPG2) at the concentration of 247 uM. 
In addition to the above-mentioned compounds, compound 87 has been isolated in this 
study from the n-hexane layer of R. chalepensis aerial parts. 1D and 2D NMR spectra 
clearly indicated the structure of compound 87 as dehydromoskachan C derivative. We 
searched this compound in various databases, but we could not find any match so, it is 
likely to be a new compound. Similar moskachans A, B, C, and D have been isolated 
previously from R. chalepensis (Ulubelen 1988). Compound 87 tested for its activity 
against the lung cancer cell lines (A549) and did not show any activity. However, 
moskachan D reported promising cytotoxic property against A549 cell line with IC50 
values of 18.5 ± 0.65 μg/mL (Richardson et al., 2016). 
 
Conclusion 
In conclusion, R. chalepensis aerial parts showed a high cytotoxicity against different 
cancer cell lines with low selectivity index of 0.84 on prostate cancer cells.  
Our findings suggest that among furanocoumarins under investigation, compound 64 was 
the most cytotoxic coumarin, 65 exerted mild cytotoxic effect and 63 was not cytotoxic. 




among the other alkaloids 60 and 61. The alkaloid 85 was isolated for the first time from 
R. chalepensis. Therefore, the cytotoxicity of R. chalepensis aerial parts may be due to 
the presence of both the furanocoumarin  64 and the alkaloid 85. Thus, chalepin (64) and 
4-hydroxy-2-nonyl-quinoline (85) could be promising candidates for the development of 
anticancer agents. The mechanism of action of chalepin (64) might involve with little 
extent the plasma membrane damage resulting in the release of LDH enzyme. The study 
revealed a novel compound of moskachan type 87 but did not show any cytotoxic activity 
against the lung cancer cell lines. Further work should be applied on this compound on 




3.4 Arbutus pavarii 
3.4.1 Extraction  
Sequential Soxhlet extraction of the dried and ground aerial parts of Arbutus pavarii 
(APL) leaves (150 g) afforded three extracts: n-hexane (APH), dichloromethane 
(APD), and MeOH (APM). The percentage yields of these extracts are summarized in 
Table 3.4.1 
Table 3.4.1: Percentage yield of the three extracts obtained from A. pavarii (APL) 
leaves 
Extract % Yield 
n-Hexane (RCH) 4.42 
DCM (RCD) 1.8 




3.4.2 Preliminary analytical TLC screening 
The developed TLC plates of three extracts obtained from A. pavarii leaves were 
viewed under short (254 nm) and long (366 nm) UV light. After spraying with 
anisaldehyde reagent followed by heating at 100ºC for 5 min, some violet coloured 
spots have appeared mainly in both the n-hexane and the DCM layer, which may 
indicate the presence of phenols, terpenes or sugars. (Figure: 3.4.1). Different Rf 






         
Short UV (254 nm)       Long UV (366 nm)      Sprayed with anisaldehyde 
Mobile phase: Toluene: EtOAc /Acetic acid = 25:24:1 
Figure 3.4.1:  TLC for the three extracts of A. pavarii leaves 
 
Table 3.4.2: Rf values of different extracts of A. pavarii leaves 
n-Hexane Rf values DCM Rf values 
0.54, 0.62, 0.84  0.58, 0.69, 0.8, 0.92 
 
3.4.3  Analytical HPLC screening for MeOH extract of A. pavarii leaves  
The MeOH extract of A. pavarii leaves (10 mg/mL) was analysed by Dionex Ultimate 
3000 analytical HPLC coupled with a photodiode detector using a gradient mobile 
phase, 30-100% MeOH/H2O for 30 min with a volume of injection of 20 µL and a 





Figure 3.4.2: Analytical HPLC chromatogram the MeOH extract of A. pavarii 
leaves (observed at 320 nm) 
 
Table 3.4.3: UV-Vis data for all major peaks obtained from diode array detector 
Peak No. Retention Time (min) UV-Vis absorbances (λmax) (nm) 
1 3.9 223, 241and 275 
2 12.0 265and 355 
3 13.0 257 and 356 













3.4.4  Screening of A. pavari extracts for cytotoxic activity 
The cytotoxic activity, according to the MTT assay, of both the DCM, and MeOH 
extracts of A. pavarii leaves was assessed against five cancer cell lines; EJ138 (human 
bladder carcinoma), Hep G2 (human liver hepatocellular carcinoma), A549 (human 
lung carcinoma), MCF7 (human breast adenocarcinoma), and prostate cancer cell lines 
(PC3). The n-hexane extract was not tested for cytotoxicity due to its insolubility in 
DMSO. The DCM extract showed the highest activity against the prostate cancer cell 
lines with IC50 = 26 µg/mL while, the MeOH extract showed activity against the breast 
cancer cell lines (MCF7) and prostate cancer cell lines (PC3) with IC50 value of 60 and 
98 µg/mL respectively (Table 3.4.4a). The selectivity index (SI) of the active DCM 
extract of A. pavarii leaves was assessed comparing the cytotoxicity results of the 
human normal prostate cell line (PNT2) with those of human prostate cancer cell line 
(PC3). The extract revealed cytotoxic selectivity towards the prostate cancer cells (SI= 
3.5), which indicated the safety of the extract on the normal human cells.  The IC50 
values of A. pavarii leaves extracts in both cell lines and the selectivity index are 
summarized in Table 3.4.4b. 
Table 3.4.4a: The IC50 (µg/mL) of DCM and MeOH extracts of A. pavarii leaves on 






EJ138 90 ± 0.60 ˃ 100 
Hep G2 ˃ 100 ˃ 100 
A549 ˃ 100 ˃ 100 
MCF7 ˃ 100 60 ± 0.36 
PC3 26 ± 0.52 98 ± 0.20 
 




(Sahranavard et al. 2012) 
Table 3.4.4b: The IC50 (µg/mL) values for AP DCM extract on PC3 and PNT2 cells 
and the selectivity index (SI) using the normal human prostate cells (PNT2). 
 
 
Selectivity index (SI) = The IC50 (µg/mL) of extracts against the normal cells divided by the IC50 (µg/mL) of 
extracts against the cancer cells, where IC50 is the concentration required to reduce viability by l 50% of the cell 
population (Badisa, et al., 2009). 
 
 
3.4.5  Chromatographic fractionation of the extracts 
Following the systematic, bioassay-guided phytochemical and cytotoxic/anticancer 
study on A. pavarii leaves, further fractionation of both the active DCM and MeOH 
extracts was performed.  
3.4.5.1  Vacuum liquid chromatography (VLC) 
The DCM (2.4 g) extract of A. pavarii leaves was further fractionated over silica using 
VLC to collect seven fractions (Figure 3.4.3), the weights of fractions are listed in 
Table 3.4.5      
Cell type IC50 values 
(µg/mL) (APD) 
PC3 26 ± 0.52 
PNT2 90 ± 0.26 





Figure 3.4.3:  TLC analysis (mobile phase: 20% EtOAc in n-hexane) of the VLC 
fractions of the DCM extract of A. pavarii leaves      
 
                         
Table 3.4.5: Weights of the VLC fractions of the extract APD 
Fraction Mobile phase gradient Weight of fraction (mg) 
APDF1 100% n-hexane 150 
APDF2 10% EtOAc /n-hexane 64.2 
APDF3 30% EtOAc /n-hexane 41.7 
APDF4 50% EtOAc /n-hexane 165.7 (a)+477 (b) 
APDF5 80% EtOAc /n-hexane 117.0 
APDF6 100% EtOAc 130.8 
APDF7 50% MeOH/ EtOAc 97.1 
 
3.4.5.2  Solid phase extraction (SPE) 
The MeOH extract of A. pavarii leaves (APM) was fractionated by SPE to collect four 
fractions (Table 3.4.6).  





Fraction Mobile phase gradient Weight of fraction (mg) 
APMF1 20% MeOH/H2O 1627.2 
APMF2 50% MeOH/H2O 230.7 
APMF3 80% MeOH/H2O 19.0 
APMF4 100% MeOH/H2O 45.6 
 
 
3.4.6  Screening of A. pavarii leaves DCM fractions for cytotoxic activity 
The cytotoxic activity of the DCM fractions of A. pavarii leaves was assessed against 
the most sensitive cancer cell line (prostate cancer cell line PC3).  The highest activity 
was revealed in in the VLC DCM F4b with IC50 value of 30 µg/mL. The IC50 values 
for the DCM fractions of A. pavarii leaves on PC3 are summarised in Table 3.4.7 
Table 3.4.7: The IC50 (µg/mL) of DCM fractions of A. pavarii leaves fractions on PC3 
(human prostate cancer cell line). 
Fraction F1 F2 F3 F4 a F4 b F5 F6 F7 
IC50 µg/mL >100 >100 >100 40 ± 0.18 30 ± 0.25 98 ± 0.40 >100 >100 
            
3.4.7  Isolation of compounds from A. pavarii leaves 
3.4.7.1  The MeOH extract     
The MeOH extract of A. pavarii leaves was analyzed by preparative reversed-phase 
HPLC employing a 30-100% gradient of MeOH in water for 30 min with a volume of 
injection of 900 L and a flow rate of 10 mL/min. This yielded the compound APM-





Figure 3.4.4: HPLC chromatograms of separated compounds from the APM extract 
(observed at 254, 280 and 366 nm) 
The active MeOH F4 of A. pavarii leaves was analyzed by preparative reversed-phase 
HPLC (Agilent) employing a 50-100% gradient of MeOH in water for 30 min. This 
yielded the compound APLMF4-5 (3 mg, tR = 33.02 min) (Figures 3.4.5).  
 
Figure 3.4.5: HPLC chromatogram of separated compounds from SPE fraction 4 of 
APM (observed at 215 nm) 
 
3.4.7.2  The DCM extract (APD)  
 Separation of the active DCM Fraction 4  
The active DCM Fraction 4b (477 mg) of A. pavarii leaves was was analyzed by prep-




isolation of the compounds : APDF4-1 (0.6 mg, tR= 17.2), APDF4-4 (0.2 mg, tR = 
32.1) (Figure 3.4.6)  
 
Figure 3.4.6: HPLC chromatogram of separated compounds from the active VLC F4 
of APD (observed at 215 nm) 
 
3.4.8  Characterization of isolated compounds from A. pavarii leaves 
3.8.4.1  Characterization of hydroquinone glycoside 
Characterization of APLM-1 as hydroquinone-D-glucopyranoside (arbutin 53) 
White powder; UV (MeOH) λmax: 212 and 282 nm; ESIMS m/z showed a 
pseudomolecular ion peak at 273 [M+H]+ indicating compound with formula 
C12H16O7. 
1H NMR (600 MHz, CD3COCD3) (Figure 3.4.7) and 
13C NMR (150 MHz, 
CD3COCD3) Table (3.4.8) spectra showed two aromatic ortho-coupled protons at δH 
6.97(d, J = 8.9 Hz, 2H) and δC 118.1, δH 6.77 (d, J = 9.0 Hz, 2H) and δC 121.3 and a 
sugar (glucose) moiety. The 1H-13C HSQC experiment of 53 (Figure 3.4.8) showed 
the direct attachment between the anomeric proton at δH 4.81 (H-6`) and the carbon 
(δC103.2), protons at δH 6.97 (H-3 and H-5) and the carbon (δC116.3) and the protons 
at δH 6.77 (H-2 and H-6) with the carbon (δC118.8). All comparable data confirmed 
that compound 53 might be arbutin (Figure 1.7) (Avelino-Flores et al., 2015; Das et 









Figure 3.4.7:  1H NMR spectrum of (600 MHz, CD3COCD3) of arbutin (53) 
 






Table 3.4.8:  ¹H NMR (600 MHz, CD3COCD3) and ¹³C NMR (150 MHz, CD3COCD3) 
of arbutin (53)  
 
 Chemical Shift δ (ppm), J in Hz 
Position 1H 13C 
1  151.8 
2 6.77, d, J= 9.0  118.8 
3 6.97, d, J=8.9 116.3 
4  151.8 
5 6.97, d, J=8.9 116.3 
6 6.77, d, J= 9.0 118.8 
2` 3.5, d,  77.5 
3` 3.5, m   
4` 3.7, dd, J=3.6, 
J=11.2 
 
5` 3.91, dd, 
J=1.8, J=11.4 
71.5 
6` 4.81, d, J= 7.6 103.2 
7` 3.45, d, J= 3.9 62.7 
 
3.4.8.2  Characterization of pentacyclic triterpenes 
Characterization of APLM4-5 as ursolic acid (88)  
White amorphous powder; UV (MeOH) λmax: 204 nm. ESIMS m/z exhibited sodiated 
molecular ion peak at 479 [M+Na]+ (Figure 3.4.12) indicating compound with formula 
C30H48O3. 
1H NMR (600 MHz, CD3OD) Table (3.4.7) and Figure (3.4.13) showed 
methyl protons at δH 0.80, 0.86, 0.90, 0.97, 0.98, 0.99 and 1.14. The characteristic 
signal of 13C NMR spectra Figure (3.4.14) was seen at δ 180.3 due to carboxylic acid 
at C-28 and the two olefinic carbons at δC 125.6 (C-12) and 138.3 (C-13) indicating 




be deduced from the COSY spectrum was between the H-11↔H-12 and the H-2↔H-
3 (Figure 3.4.15). The 1H-13C HSQC experiment (Figure 3.4.16) showed the 
attachment of protons to carbon atoms. All comparable data confirmed that compound 
88 is the pentacyclic triterpene ursolic acid Figure (3.4.10) (Mishra et al., 2016).                                                                       
 
 
Figure 3.4.10: Structure of ursolic acid (88) 
 
 





Figure 3.4. 12: MS spectrum (TOF MS ES+) of ursolic acid (88) 
 
Figure 3.4.13: 1H NMR spectrum (600 MHz, CD3OD) of ursolic acid (88) 
 





Figure 3.3.15:  COSY experiment of ursolic acid (88) 
 
        






Table 3.4.9:  ¹H NMR (600 MHz, CD3OD) and ¹³C NMR (150 MHz, CD3OD) of 
ursolic acid (88)  
 
 Chemical Shift δ (ppm), J in Hz  Chemical Shift δ (ppm), J in 
Hz 
Position 1H 13C Position 1H 13C 
1 1.56, t, J= 3.6, 2H 38.5 16 1.74, m, 2H 24.0 
2 1.73, m, 2H 27.4 17  48.0 
3 3.17, dd, J= 4.8, J= 
11.5 ,1H 
78.4 18 2.23, d, J= 11.0, 1H 53.0 
4  38.6 19 1.51, t, J= 3.2, 1H 39.1 
5 0.77, d, J= 10.5, 1H 55.4 20 1.44, m, 1H 38.6 
6 1.63, m, 2H 18.1 21 1.63, m, 2H 30.4 
7 1.35, m, 2H 33.0 22 2.21, dt, J= 3.7, J= 
8.82, 2H 
36.7 
8  39.4 23 0.91, s, 3H 23.0 
9 1.09, t, J= 3.2, 1H 47.4 24 0.89, s, 3H 23.9 
10  36.7 25 0.86, s, 3H 16.3 
11 1.95, dd, J= 3.7, J= 
8.8, 2H 
23.9 26 0.89, s, 3H 18.1 
12 5.24, t, J= 3.5, 1H 125.5 27 1.02, s, 3H 26.5 
13  138.3 28  180.3 
14  41.9 29 0.90, d, J= 6.5, 3H 16.4 
15 2.06, t, J= 4.6, J= 13.3, 
2H 
 
30.4 30 0.79, d, J= 5.2, 3H 20.2 
 
 
Characterization of APLD4-4 as betulinic acid methyl ester (89) 
White amorphous powder; UV (MeOH) λmax: 208 nm (Figure 3.4.18). ESIMS 
exhibited the sodiated molecular ion peak at m/z at 493 [M+Na]+ indicating a 
compound with a moecular formula C31H50O3. 
1H NMR (600 MHz, CDCl3) Table 




1.00, a doublet coupled protons a δH 3.21 (dd, J = 4.4, J= 11.1, 1H) assigned for H-3, 
a signal at 3.52 assigning for –OCH3, two singlet protons at δH 4.77 and 4.64 assigning 
for (H-29) and a multiplet at 3.02 (m, 1H, H-19). All data were comparable to the 
published data for betulinic acid methyl ester and confirmed that the compound 89 is 
betulinic acid methyl ester (Figure 3.4.17) (Mishra et al., 2016).    
   















Figure 3.4.19: 1H NMR spectrum (600 MHz, CDCl3) of betulinic acid methyl ester 
(89) 
 
3.4.9 Cytotoxic effect of ursolic acid (88) from A. pavarii leaves 
Ursolic acid (88) isolated from the MeOH fraction 4 of A. pavarii leaves revealed high 
cytotoxicity against the human prostate cancer cell lines (PC3) with IC50 value of 8.22 
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All experiments were carried out in triplicate on separate occasions. Data were expressed as means a ± standard 
error of the mean derived from n ≥12 from three separate occasions. 
Figure 3.4.20: The cytotoxic activity of ursolic acid (88) against PC3 cells according 




3.4.10 The LDH results 
Results of the LDH assay presented in Figure 3.3.68 suggest that urosolic acid (88) 
isolated from the MeOH extract of APL at IC50 value of 8.22 µM causes cytotoxicity 
to the prostate cancer cell lines (PC3), through at least in part cell membranes damage 
by measuring the LDH activity at two absorbances: 490 and 690 nm. The LDH activity 
was performed using a commercial cytotoxicity assay kit produced by Roche (REF 
11644793001). The necrotic percentage was 53.4 %, which was expressed using the 




Data were expressed as means a ± standard error of the mean derived from n =24. 
Figure 3.4.21: LDH Release result for ursolic acid (88) against the prostate cancer 
cell lines (PC3) 
 
Discussion 
The Ericaceae family or heather family is found most commonly in acid and infertile 
growing conditions. Many genera from the family Ericaceae are used traditionally as 
antiseptics, diuretics, laxatives and in the treatment of arthritis, headache, hypertension 




























LDH Release result for ursolic acid (2) 




which belongs to the family Ericaceae, is distributed in the Mediterranean region and 
Europe and revealed the presence of many constituents such as flavonoids, glycosides, 
phenolic compounds, sterols and triterpenes (Hasan et al., 2011). A. pavarii is a 
species endemic to Al-Jabal El-Akhdar on the eastern coast of Libya (González–
Elizondo. et al., 2012; Alsabri et al., 2013; Miguel et al., 2014). The plant revealed 
many compounds that have been documented to reduce the risk of cancer such as: 
flavonoids (apigenin epicatechin, hespiridin, querecetin, naringin and rutin), simple 
phenolics (arbutin, gallic acid, pyrogallol) (El Hawary et al., 2016). 
There are only limited studies performed on A. pavarii to study its effect as cytotoxic 
plant (Hasan et al., 2011; Alsabri et al., 2013; El Hawary et al., 2016). The anti-
proliferative activity of A. pavarii aerial parts on breast (MCF7 and T47D), 
hepatocarcinoma HEPG2, and lung (A549) cancer cells was evaluated by the MTT 
assay and the results were less than 30 μg/ml (Alsabri et al., 2013; El Hawary et al., 
2016).  
In the present study, the cytotoxic effect of A. pavarii leaves (APL) was tested against 
five human cancer cell lines, MCF7 (human breast adenocarcinoma), HepG2 (human 
liver hepatocellular carcinoma), EJ138 (human bladder carcinoma), A549 (human 
lung carcinoma), and PC3 (human prostate carcinoma) using the MTT assay. The n-
hexane extract was not tested for cytotoxicity due to its insolubility in DMSO. The 
DCM extract showed the highest activity against the prostate cancer cell lines with 
IC50= 26 µg/mL while, the MeOH extract showed activity against the breast cancer 
cell lines (MCF7) with IC50= 60 µg/mL. Selectivity index (SI) for APL was also 
determined using the human normal prostate cell line (PNT2). The leaves revealed 
cytotoxic selectivity on prostate cancer cells (SI= 3.5), which indicated the safety of 




 Three pure compounds were isolated from both the DCM and MeOH fractions of 
APL including one phenolic glycoside: arbutin (53) and two-pentacyclic triterpenes 
ursolic acid (88) and betulinic acid methyl ester (methyl betulate) (89). The two 
triterpenes 88 and 89 were isolated for the first time from A. pavarii leaves. However, 
pentacyclic triterpenes were isolated from the fruits of A. unedo; α- and β-amyrin, 
lupeol and a new natural triterpene (olean-12-en-3β, 23-diol) (Miguel et al., 2014).  
 Pentacyclic triterpenes reported many biological activities such as antibacterial, 
antitumor and antimalarial. Ursolic acid has been reported to possess a wide range of 
biological activities and it was widely used in Chinese herbal medicines (Wu et al., 
2014).  Ursolic acid (88) reported cytotoxicity against PC3, LNCaP and DU145 
prostate cancer cells with IC50 of 35 μM, 47 μM and 80 μM, respectively (Park et al., 
2013). The cytotoxic activity of betulin (90) and its derivatives has also been reported. 
They showed selective cytotoxicity against many different tumour cell lines and are 
promising chemotherapeutic agents for the treatment and prevention of different types 
of diseases (Csuk 2012). 
 Ursolic acid (88) was tested in this study for cytotoxicity against the human prostate 
cancer cell lines (PC3) and revealed higher cytotoxicity (IC50= 8.22 µM) compared 
with that reported in literature. Our findings also indicated that ursolic acid induced 
cell death might involve the plasma membrane damage resulting in the release of LDH 
enzyme from the necrotic prostate cancer cell lines (PC3) cells (Figure 3.1.54). The 
necrotic percentage was calculated as 53.4 %, by using the formula (sample 
value/maximal release) × 100% (Chan et al., 2013). Methyl betulinate (89) was 
isolated from the active VLC DCM F4b of A. pavarii leaves, which revealed activity 
against the prostate cancer cell line (PC3) with IC50 value of 30 µg/mL. Its presence 




Arbutin (53) is a hydroquinone-D-glucopyranoside that leads to the expression of 
genes inducing apoptosis in human melanoma cancer cells (Avelino-Flores et al., 
2015) and also exhibited high cytotoxicity against MCF-7/Adr (human breast cancer 
cell lines: Adriamycin-resistant) (Berdowska et al., 2013), therefore is also probably 
involved in the observed activity of the APLM extract against the breast cancer cell 
lines (MCF7) (IC50 = 60 µg/mL).  
Conclusion 
In conclusion, A. pavarii leaves showed a high cytotoxicity against two types of cancer 
cell lines; the prostate (PC3) cancer cell lines (DCM extract) and the breast (MCF7) 
cancer cell lines (MeOH extract). The cytotoxicity observed with A. pavarii leaves 
might be due to the presence of the cytotoxic pentacyclic triterpenes ursolic acid (88) 
and betulinic acid methyl ester (89) and the hydroquinone- -D-glucopyranoside 
arbutin (53). 
 
The leaves revealed cytotoxic selectivity on prostate cancer cells (SI= 3.5), which 























4.0  Conclusion   
In conclusion, the phytochemical and cytotoxic/anticancer study on the four medicinal 
plants from the Libyan flora; A. aestivus, A. pavarii, J. phoenicea and R. chalepensis, 
has provided evidence in support for their traditional uses as antitumour agents. They 
seem to be promising candidates as anticancer plants and accumulate naturally 
occurring compounds with interesting cytotoxic/anticancer activities and different 
selectivity indexes on prostate cancer cells. A. aestivus showed the highest selectivity 
on prostate cancer cells among the four plants while R. chalepensis lacks this 
selectivity. 
The importance of clinically anticancer drug is its ability to be selective on cancer 
cells. Therefore, the high selectivity of A. aestivus species (SI=26) towards prostate 
cancer cells deserves more additional studies which might aid to develop an anticancer 
drug from it.  A. pavarii and J. phoenicea also revealed moderate selectivity on 
prostate cancer cells with SI= 3 and 5, respectively. 
Bioassay-guided fractionation of these plants led to the isolation of 29 compounds 
including a new dehydromoskachan C derivative and six compounds isolated for the 
first time from these plant species. The plants contained a diversity of secondary 
metabolites, which have proved their importance in the treatment of many ailments 
including cancer. The four plants under study revealed alkaloids, anthraquinones, 




metabolites isolated for the first time in our study are: The biflavonoid, sumaflavone 
(76) from J. phoenicea leaves, the alkaloid, 4-hydroxy-2-nonyl-quinoline (85) and the 
glycoside, 3``,6`disinapoylsucrose (84) from R. chalepensis aerial parts, the 
anthraquinone glycoside, C-α-rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione 
(81) from A. aestivus tubers and the ferulic acid derivative, p-hydroxy-phenethyl 
trans-ferulate (82) from A. aestivus leaves and the pentacyclic triterpenes, methyl 
betulinate (89) and ursolic acid (88) from A. pavarii leaves. Three compounds revealed 
good cytotoxicity against the most sensitive cancer cell lines in each plant using the 
MTT assay. Sumaflavone (76) and 4-hydroxy-2-nonyl-quinoline (85) exhibited good 
cytotoxicity against the lung cancer cell lines with IC50 values of 77 and 97.6 µM, 
respectively. C-α-rhamnopyranosyl bianthracene-9, 9’, 10 (10'H)-trione (81) and 
ursolic acid (88) revealed high cytotoxicity against the prostate cancer cell lines with 
IC50 values of 62 µM and 8.22 µM, respectively.  
However, this study revealed also highly cytotoxic compounds, which had been 
reported in the literature, the biflavonoid cupressoflavone (24) from J. phoenicea 
leaves and the coumarin chalepin (64) from R. chalepensis aerial parts against the lung 
cancer cell lines with IC50 value of 65 and 92 µM, respectively. Cupressoflavone (24) 
is tested for the first time in this study for its cytotoxicity. Findings also indicated that 
chalepin (64), cupressoflavone (24) and ursolic acid (88)-induced cell death might 
involve the plasma membrane damage resulting in the release of LDH enzyme from 
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Juniperus phoenicea L. (Family: Cupressaceae) is a well-
known Libyan medicinal plant, which has been used in 
Libyan traditional medicine for centuries for the treatment 
of various human ailments including tumours and 
cancers. In fact, in Egypt around 1500 BC was the first 
recorded use of using the Juniperus phoenicea 
medicinally, which was to relieve joint and muscle pain. 
This plant is used in folk medicine to treat rheumatism, 
gout, oedema, diarrhoea, poor appetite and urinary tract 
diseases. It is also reported to eliminate gastrointestinal 
bacteria and parasites.1,2 There are some reports on its use 
as a female contraceptive by some tribes.1 The juniper 
berry was studied as a possible treatment for diet 
controlled diabetes mellitus.3  
Several compounds, i.e., terpenoids (monoterpenes: 
predominantly α-pinene, α-phyllandrene and δ-3-carene; 
sesquiterpenes: mainly δ-cadinene; diterpenes), phenolics 
(e.g., flavonoids and biflavones, phenylpropanoids and 
lignans), furanone glycosides, hydrocarbons, and sterols, 
have been isolated from the leaves and berries of J. 
phoenicea grown in different countries.4-8 
Podophyllotoxin and deoxypodophyllotoxin were also 
found in the aerial parts of many Juniperus species 
including J. phoenicea.9  
Various biological activities for J. phoenicea have been 
reported to date. The essential oils from this plant 
exhibited moderate antibacterial and antifungal 
activities.5-8,10-13  Elmhdwi et al.14 demonstrated that the 
extracts from J. phoenicea had antibacterial activity 
against both Gram-positive and Gram-negative bacteria 
including multiple-drug-resistant (MDR) strains. This 
activity was attributed to the abundance of α-pinene and 
the overall chemical constituents of these extracts. 
Antioxidant activity of this plant was detected using the 
ABTS radical-scavenging assay with the strongest 
A B S T R A C T 
Background: The current study was undertaken to assess the cytotoxicity of the leaves of 
Libyan Juniperus phoenicea (Cupressaceae) against human cancer cell lines. 
Methods: The cytotoxicity of the n-hexane, dichloromethane (DCM) and methanol 
(MeOH) extracts of the leaves of J. phoenicea (JP), obtained from sequential Soxhlet 
extractions, was assessed against four human cancer cell lines: EJ138 (human bladder 
carcinoma), HepG2 (human liver hepatocellular carcinoma), A549 (human lung 
carcinoma) and MCF7 (human breast adenocarcinoma) using the MTT assay.   
Results: The cell line A549 was the most sensitive to the JP extracts, with the highest level 
of cytotoxicity with the IC50 values of 16, 13 and 100 µg/mL for the DCM, n-hexane and 
MeOH extracts, respectively.  However, generally the most potent cytotoxic extract across 
the other cells tested was the n-hexane extract, followed by the DCM extract, whilst the 
MeOH extracts showed little or no cytotoxicity.  The percentage of viability of cells 
decreased as the concentration of test compounds increased. The cytotoxicity of various 
chromatographic fractions from the extracts was also studied against the A459 cells. For 
the n-hexane fractions, the IC50 values were 160, 62, 90, 30, 9.5 and 40 µg/mL for fractions 
1 to 5 and 7, respectively. Fractions 4 and 5 showed the greatest effect. DCM fractions 2, 
3 and 4 had the IC50 values of 60, 92 and 19 µg/mL, respectively, and DCM fractions 5 to 
8 were non-cytotoxic. Fractions 1 and 2 of the MeOH extract were non-cytotoxic, whereas 
cytotoxicity was observed for fractions 3 and 4 with IC50 values of 50 and 85 µg/mL, 
respectively.  
Conclusion: The outcome of the present study suggested that the JP leaves possess 
cytotoxic activities. The high level of cytotoxicity of the n-hexane and DCM extracts 
suggested that lipophilicity might affect the cytotoxicity of JP, where the less polar  
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antioxidant effect being found with the MeOH extract.6 
The aqueous extract of J. phoenicia showed anti-
diarrhoeal effect in vivo on experimental rat models of 
diarrhoea by reducing intestinal fluid accumulation and 
inhibiting intestinal motility.2  Akkol et al.15 revealed 
remarkable anti-inflammatory and antinociceptive 
activities of five Juniperus species. Cairnes & Ekundayo9 
showed that the ethanolic extract of J. phoenicea twigs 
and leaves and two isolated compounds, 
desoxypodophyllotoxin and p-peltatin-methyl ether, were 
cytotoxic in the KB cell cultures (human cervix 
carcinoma). A MeOH extract of J. phoenicea from Saudi 
Arabia and Indonesia displayed high cytotoxicity in Vero 
(normal monkey kidney) and HEP-2 (human laryngeal 
carcinoma) cell lines.16 In addition, this plant also 
displayed significant cytotoxicity against both MCF7 
(human breast adenocarcinoma) and HCT-116 (human 
colon carcinoma) cell lines.1  
As a part of our continuing phytochemical and bioactivity 
studies on Libyan medicinal plants,17-22 we now report on 
the cytotoxicity of the extracts and fractions of the leaves 
of J. phoenicea growing in Libya against four human 
cancer cell lines: human bladder carcinoma cell line 
(EJ138), human hepatocellular carcinoma cell line 
(HepG2), human lung carcinoma cell line (A549) and 
human breast adenocarcinoma cell line (MCF7).  
 
Materials and Methods 
Plant material 
The leaves of Juniperus phoenicea L. were collected from 
Al-Jabal Al Akhdar, Libya, in 2013. The plant material 
was identified at the Faculty of Science Herbarium, 
Tripoli-Libya, and a voucher specimen (no. D68122) has 
been retained there.  Leaves of this plant were air-dried, 
powdered and kept in a tightly closed amber coloured 
container for subsequent studies. 
 
Extraction  
Ground leaves of J. phoenicea (86.5 g) were Soxhlet-
extracted, sequentially, with n-hexane, DCM and MeOH, 
800 mL each.  Ten cycles were allowed for each 
extraction, and the temperature of the heating mantle for 
all extractions was kept constant at 60°C. The extracts 
were filtered and evaporated to dryness using a rotary 
evaporator at a temperature not exceeding 45°C under 
reduced pressure.  All extracts were stored at 4°C.   
 
Fractionation techniques  
The crude extracts of J. phoenicea leaves were separated 
into various fractions using vacuum liquid 
chromatography (VLC) on silica gel for the n-hexane and 
DCM extracts, and solid-phase extraction (SPE) on 
reversed-phase C18 silica for the MeOH extract.23,24. The 
n-hexane extract (4.6 g) was fractionated by VLC eluting 
with n-hexane-ethyl acetate mixtures of increasing 
polarity to yield seven fractions: F1: 82.5 mg, F2: 555 mg, 
F3: 998.7 mg, F4: 655.5 mg, F5: 118.8 mg F6: 22.1 mg, 
F7: 103.7 mg.  Similarly, the DCM extract (1.289 g) was 
fractionated by VLC, starting elution with n-hexane-
DCM mixtures, then increasing polarity with MeOH to 
yield eight fractions: F1: 15 mg, F2: 20 mg, F3: 41 mg, 
F4: 134 mg, F5: 128.5 mg F6: 9.3 mg, F7: 2.7 mg and F8: 
2.4 mg. The dried MeOH extract (1.4 g) was re-suspended 
in 10% MeOH in water, and subjected to solid phase 
extraction (SPE) using a cartridge (20 g) pre-packed with 
reversed-phase silica C18 (ODS). A step gradient was 
applied starting with 20% MeOH in water, then 50%, 80% 
and 100% MeOH in water (200 mL each).  Four fractions 
were collected: F1: 895 mg, F2: 135 mg, F3: 54 mg, F4: 
25 mg, and these fractions were dried using a rotary 
evaporator and a freeze dryer.    
 
MTT assay 
The cytotoxic activity of the n-hexane, DCM and MeOH 
extracts of J. phoenicea were assessed against EJ138 
(human bladder carcinoma), HepG2 (human liver 
hepatocellular carcinoma), A549 (human lung carcinoma) 
and MCF7 (human breast adenocarcinoma) cell lines. In 
addition, fractions obtained from n-hexane, DCM and 
MeOH extracts of J. phoenicea were also assessed for 
cytotoxicity against the cell line A549, as the extracts 
showed the highest level of activities against this cell line. 
The cells were seeded into 24-well plates (5 x 104 
cells/well) and incubated under 5% CO2, 95% humidity at 
37oC for 24 h. The different extracts or isolated fractions 
were diluted in medium containing DMSO (0.01% (v/v) 
(including the negative control), to achieve extract 
concentrations of (0, 0.8, 4, 20, 100 and 500 µg/mL) or 
isolated fraction concentrations of (0, 0.4, 2, 10, 50 and 
250 µg/mL). These doses were then used to treat the cells 
for 24 h before assessment using the MTT assay25 
following the standard protocol. Briefly, each treatment 
was removed from the 24-well plates of cells and replaced 
with MTT solution (0.5 mg/mL MTT in medium (1 
mL/well)). The cells were then incubated under 5% CO2, 
95% humidity at 37oC for 2 h. The MTT solution was then 
removed from each well of cells and replaced with 
isopropanol (0.5 mL/well) to lyse the cells, and to release 
and solubilise the blue formazan product. The absorbance 
reading (540 nm) of lysates from treated cells in each well 
on each occasion was recorded and was expressed as a 
percentage of the mean value of the control absorbance on 
each occasion. The results for each treatment and dose 
derived from at least 12 wells (n≥12) from three or more 
separate occasions. To determine IC50 values, data were 
presented in EXCEL graphs with the dose value (µg/mL) 
on the X-axis on a log10 scale and the % viability 
compared to control on the Y-axis. The IC50 values are 
determined from the trend line of the data points. 
 
Statistical analysis 
All experiments were carried out in triplicate on separate 
occasions. Data were expressed as means ± standard error 
of the mean. The graphs were plotted using nonlinear 
regression with the use of Microsoft Excel version 2013. 
 
Results and Discussion   
In the present study, the cytotoxic effect of J. phoenicea 
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leaf extracts against four human cancer cell lines, MCF7, 
HepG2, EJ138 and A549, was determined using the MTT 
assay. Although cytotoxicity of J. phoenicea against 
MCF7 was reported previously,4 to the best of our 
knowledge, this is the first report on the assessment of 
cytotoxicity of J. phoenicea   J. phoenicea leaf extracts 
and fractions against HepG2, EJ138 and A549 cell lines.  
The extracts of J. phoenicea showed the highest level of 
cytotoxic activity against the human lung 
adenocarcinoma cell line A549 with the IC50 values of 16, 
13 and 100 µg/mL, respectively, for the n-hexane, DCM 
and MeOH extracts (Table 1). Whilst the DCM extract 
appeared to be the most cytotoxic extract against the A549 
cells, the n-hexane extract was the most cytotoxic across 
the board against HepG2, EJ138 and MCF7 having 
respective IC50 values of 10, 40 and 14 µg/mL. The DCM 
extract also resulted in cytotoxicity in all cell lines tested 
with IC50 values of 50 µg/mL for EJ138 cells, 42 µg/mL 
for HepG2 cells, 16 µg/mL for MCF7 cells and 13 µg/mL 
for A549 cells. The MeOH extract showed low-level of 
cytotoxicity in EJ138 (IC50 130 µg/mL), HepG2 (IC50 900 
µg/mL), A549 (IC50 100 µg/mL) and MCF7 (IC50 >1000 
µg/mL) (Table 1). According to Sahranavard et al,26 plant 
extracts are only considered to be cytotoxic to cells if the 
IC50 value is <100 μg/mL, therefore these MeOH extract 
results were regarded as non-cytotoxic to each of the cell 
lines tested. The higher level of cytotoxic activity of the 
n-hexane and DCM extracts suggested that lipophilicity 
might have an impact on the cytotoxic activity of J. 
phoenicea, where the less polar (high lipophilic) 
compounds showed the strongest cytotoxic effect. 
However, it is known that lipophilicity is one of the major 
factors that influences the transport, absorption, and 
distribution of chemicals in biological systems. 
Bioassay-guided phytochemical and biological 
fractionation is an approach whereby a crude extract of 
plant is fractionated and re-fractionated, continually 
monitored fractions by appropriate bioassay(s), until a 
pure biologically active fraction/compound is found.24 To 
adopt this approach, n-hexane, DCM and MeOH extracts 
were further fractionated by two different techniques: 
solid-phase extraction for MeOH extract and VLC for the 
n-hexane and DCM extracts to get different fractions 
(four fractions from MeOH extract, seven fractions from 
n-hexane extract and eight fractions from DCM extract). 
All fractions were tested for cytotoxicity against the A549 
cell line, as these cells appeared to be the most sensitive 
to the all three extracts. Taken that IC50 values >100 
μg/mL are considered as non-cytotoxic, n-hexane 
fractions 1 (F1) and 6 (F6), DCM fractions 1, and 5 to 8 
(F1, F5, F6, F7 and F8) and MeOH fractions 1 and 2 (F1 
and F2) were all regarded as non-cytotoxic in the A549 
cells. However, n-hexane fractions 2 to 5 and 7 (F2, F3, 
F4, F5 and F7) were cytotoxic. In addition, DCM 
fractions 2 to 4 (F2, F3 and F4) and MeOH fractions 3 and 
4 (F3 and F4) were also considered cytotoxic (Table 2). 
The most potent fractions appear to be n-hexane fraction 
5 (F5) with an IC50 value of 10 µg/mL and DCM fraction 
4 (F4) with an IC50 value of 19 µg/mL. 
Whilst the MeOH fraction 1 (F1), which was the most 
polar fraction of all, was found to be non-cytotoxic, an 
interesting observation was that doses 2, 10 and 50 µg/mL 
did appear to trigger proliferation in the A549 cells with 
approximately a 20% increase in viability compared to the 
control (0 µg/mL) (Figure 1). However, further 
interrogation of these data indicated that only the 50 
µg/mL dose resulted in a statistically significant 
difference compared to the control (P<0.05).  There was 
high variability in the data resulting from fraction 1 (F1), 
and this might have contributed to this anomaly. 
Several phytochemicals, e.g., alkaloids, flavonoids, 
lignans, phenols, steroids and terpenes have been 
demonstrated to possess prominent cytotoxic properties 
against cancer cells.27 
Notably, all these groups of phytochemicals have 
previously been isolated from the leaves and berries of J. 
phoenicea and other Juniperus species grown in different 
countries.9,28-30 Podophyllotoxin, which is also present in 
J. phoenicea at a low level,31 is a well-known cytotoxic 
compound against cancer cell lines. Its cytotoxicity is 
mediated by inhibition of microtubule formation and this 
compound serves as a unique starting compound for the 
semisynthesis of anticancer drugs that are known to 
inhibit topoisomerase II such as etoposide, teniposide, or 
etopophos.31 
 
 Table 1. The IC50 (µg/mL) of n-hexane, DCM and MeOH extracts of J. phoenicea on a selection of four cancer cell lines. 
Cell type IC50 values (µg/mL)  
n-Hexane DCM MeOH 
Human bladder carcinoma cells (EJ138) 40 50 130 
Human hepatocellular carcinoma cells (HepG2) 10 42 900 
Human lung carcinoma cells (A549) 16 13 100 
Human breast adenocarcinoma cells (MCF7) 14 16 > 1000 
The IC50 values for the n-hexane, DCM and MeOH extracts of J. phoenicea different on the cell lines of four different 
cancer types.  Values greater than 100 µg/mL were considered as non-cytotoxic. 
 
Table 2. The IC50 (µg/mL) of n-hexane, DCM and MeOH fractions of J. phoenicea fractions on A549 (human lung carcinoma) cells. 
Extracts IC50 values (mg/mL) of the fractions 
F1 F2 F3 F4 F5 F6 F7 F8 
n-Hexane 160 62 90 30 9.5 >1000 40 NA 
DCM >1000 60 92 19 >1000 >1000 >1000 >1000 
MeOH >1000 244 50 85 NA NA NA NA 
The IC50 values for the n-hexane, DCM and MeOH fractions of J. phoenicea on A549 human lung carcinoma cells. Values greater than 100 
µg/mL were considered as non-cytotoxic. NA = Not applicable. 
 
6 | Pharmaceutical Sciences, March 2018, 24, 3-7 






Figure 1. The cytotoxic activity of J. phoenicea MeOH fraction 1 
(F1) against A549 human lung carcinoma cell line. The asterisk * 
indicates a significant difference when compared to control 
(P<0.05) and ns indicates no significant difference to control. The 
results are mean values ±SEM derived from n≥12 from three 
separate occasions.  
 
Ren et al.32 detailed the anticancer effects of the 
flavonoids, which were shown to inactivate carcinogen, 
inhibit proliferation, arrest the cell cycle, induce apoptosis 
and differentiate, inhibit angiogenesis, prevent oxidation 
and reverse multidrug resistance. Previous studies had 
shown that many flavonoids and polyphenolic 
compounds were present in some Juniperus species.33-35  
 
Conclusion 
The outcome of the present study suggested that the J. 
phoenicea leaves possess cytotoxic activities. The high 
level of cytotoxic activities of the n-hexane and DCM 
extracts suggested that lipophilicity might affect the 
cytotoxic activity of J. phoenicea, where the less polar 
(high lipophilic) compounds might have the strongest 
cytotoxic effect.  As terpenes are the main lipophilic 
compounds previously reported from less polar extracts 
and essential oils of J. phoenicea, it is reasonable to 
assume that the cytotoxicity observed with the less polar 
extracts was contributed by various cytotoxic terpenes as 
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